<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pharmacology Antihyperlipidemics SDE</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <script src="https://cdn.jsdelivr.net/npm/sortablejs@1.14.0/Sortable.min.js"></script>
    <style>
        :root {
            --primary-blue: #3498db;
            --primary-dark-blue: #2980b9;
            --secondary-orange: #f39c12;
            --text-dark: #2c3e50;
            --text-light: #7f8c8d;
            --bg-light: #ecf0f1;
            --bg-white: #FFFFFF;
            --border-light: #e0e4eb;
            --success-green: #2ecc71;
            --danger-red: #e74c3c;
            --shadow-color: rgba(44, 62, 80, 0.1);
        }

        html, body {
            height: 100%;
            margin: 0;
            padding: 0;
            overflow: hidden;
        }

        body {
            font-family: 'Inter', sans-serif;
            background: var(--bg-light);
            color: var(--text-dark);
            box-sizing: border-box;
        }

        .quiz-wrapper {
            width: 100vw;
            height: 100vh;
            display: flex;
            flex-direction: column;
            position: relative;
        }

        .quiz-header {
            background: var(--bg-white);
            color: var(--text-dark);
            padding: 0.75rem 2rem;
            text-align: center;
            position: relative;
            border-bottom: 1px solid var(--border-light);
            flex-shrink: 0;
            z-index: 10;
        }
        
        .header-content {
            display: flex;
            align-items: center;
            justify-content: center;
            position: relative;
            max-width: 1200px;
            margin: 0 auto;
        }

        .logo {
            position: absolute;
            left: 0;
            font-size: 1.5rem;
            font-weight: 800;
            color: var(--primary-blue);
        }

        .animated-icon {
            position: absolute;
            right: 0;
            animation: inspect 4s ease-in-out infinite;
        }

        .animated-icon svg { width: 30px; height: 30px; fill: var(--primary-blue); }
        .quiz-header h1 { margin: 0; font-size: 1.4rem; font-weight: 600; }
        .version-info { font-size: 0.7rem; color: var(--text-light); margin-top: 0.2rem; }
        
        .quiz-content {
            padding: 1.5rem;
            flex-grow: 1;
            display: flex;
            flex-direction: column;
            align-items: center;
            justify-content: center;
            box-sizing: border-box;
            overflow: hidden;
        }
        
        #initial-screen { text-align: center; padding: 2rem; }
        #initial-screen h2 { font-size: 2.5rem; margin-bottom: 1rem; color: var(--primary-dark-blue); }
        #initial-screen p { font-size: 1.1rem; line-height: 1.6; max-width: 600px; margin: 1rem auto 2rem auto; color: var(--text-light); }
        #start-btn { background-color: var(--primary-blue); color: white; padding: 1rem 2.5rem; font-size: 1.1rem; font-weight: 600; border: none; border-radius: 50px; cursor: pointer; transition: all 0.3s ease; }
        #start-btn:hover { background-color: var(--primary-dark-blue); transform: scale(1.05); }
        
        #quiz-form {
            display: flex;
            flex-direction: column;
            width: 100%;
            height: 100%;
            background: var(--bg-white);
            border-radius: 16px;
            padding: 2rem;
            box-shadow: 0 15px 40px var(--shadow-color);
            border: 1px solid var(--border-light);
            overflow: hidden;
            box-sizing: border-box;
            opacity: 1;
            transform: scale(1);
            transition: opacity 0.3s ease-out, transform 0.3s ease-out;
        }
        
        #quiz-form.is-transitioning { opacity: 0; transform: scale(0.98); }

        .question-header { font-size: 1rem; margin-bottom: 1rem; padding-bottom: 1rem; flex-shrink: 0; border-bottom: 1px dashed var(--border-light); color: var(--text-light); font-weight: 500; }
        .question-header strong { font-weight: 700; color: var(--primary-blue); }
        .question-text { font-size: 1.25rem; font-weight: 500; line-height: 1.6; margin-top: 0; margin-bottom: 1rem; flex-shrink: 0; }
        
        .options-container { 
            flex-grow: 1;
            overflow: hidden;
            display: flex;
            flex-direction: column;
            justify-content: flex-start;
            padding: 0.5rem 0;
        }

        .options-container label { padding: 0.8rem 1.2rem; margin-bottom: 0.75rem; font-size: 1rem; border: 2px solid var(--border-light); border-radius: 10px; display: flex; align-items: center; transition: all 0.2s ease-in-out; cursor: pointer; }
        .options-container label:hover { background-color: var(--bg-light); border-color: var(--primary-blue); }
        .options-container input { margin-right: 1rem; flex-shrink: 0; transform: scale(1.2); accent-color: var(--primary-blue); }
        
        .question-footer { margin-top: 1rem; padding-top: 1rem; border-top: 1px dashed var(--border-light); display: flex; justify-content: space-between; align-items: center; flex-shrink: 0; }
        .flag-container label { cursor: pointer; font-weight: 500; color: var(--text-light); display: flex; align-items: center; }
        .flag-container input { margin-right: 0.5rem; }
        .confidence-slider-container { display: flex; align-items: center; gap: 1rem; }
        .confidence-slider-container label { font-weight: 500; color: var(--text-light); }
        .confidence-slider { max-width: 150px; }

        #navigation-btn { padding: 0.8rem 2rem; font-size: 1rem; background-color: var(--primary-blue); color: white; border: none; border-radius: 50px; font-weight: 600; cursor: pointer; transition: all 0.2s; }
        #navigation-btn:hover { background-color: var(--primary-dark-blue); transform: scale(1.05); }

        #results-area { animation: fadeIn 0.8s ease-out; box-sizing: border-box; width: 100%; height: 100%; overflow-y: auto; padding: 2rem; }
        .results-summary, #confidence-analysis, #study-focus, #results-details { background-color: var(--bg-white); margin: 0 auto 2rem auto; padding: 2rem; border-radius: 16px; box-shadow: 0 10px 30px var(--shadow-color); max-width: 1000px; }
        .results-summary { text-align: center; }

        .score-animation-container { width: 150px; height: 150px; border-radius: 50%; border: 8px solid var(--primary-blue); display: flex; justify-content: center; align-items: center; margin: 1.5rem auto; position: relative; background-color: var(--bg-white); }
        .score-animation-circle { position: absolute; top: 0; left: 0; width: 100%; height: 100%; border-radius: 50%; background: conic-gradient(var(--success-green) 0% 0%, var(--border-light) 0% 100%); transition: background 1.5s ease-out; }
        .score-animation-inner { position: relative; z-index: 2; background-color: var(--bg-white); width: calc(100% - 16px); height: calc(100% - 16px); border-radius: 50%; display: flex; justify-content: center; align-items: center; }
        .score-animation-text { font-size: 2.5rem; font-weight: 800; color: var(--text-dark); }
        
        #confidence-analysis h3, #study-focus h3, #results-details h2 { margin-top: 0; border-bottom: 2px solid; padding-bottom: 1rem; font-size: 1.5rem; margin-bottom: 1.5rem; }
        #confidence-analysis h3 { color: var(--primary-dark-blue); border-color: var(--primary-blue); }
        #study-focus h3 { color: #c0392b; border-color: #e74c3c; }
        #results-details h2 { color: var(--text-dark); border-color: var(--border-light); }
        
        .result-question { border: 1px solid var(--border-light); padding: 1.5rem; margin-bottom: 1.5rem; border-radius: 12px; }
        .result-question p strong { display: block; margin-bottom: 1rem; font-size: 1.1em; color: var(--text-dark); }
        .result-question ul { list-style-type: none; padding: 0; margin: 0; }
        .result-question li { padding: 0.8rem 1.2rem; border-radius: 8px; margin-bottom: 0.6rem; font-size: 1rem; }
        .correct-answer-label { background-color: var(--light-green-bg); color: #27ae60; font-weight: 600; }
        .incorrect-answer-label { background-color: var(--light-red-bg); color: var(--danger-red); text-decoration: line-through; }
        .missed-correct-answer-label { border: 2px dashed var(--success-green); }
        .rationale { margin-top: 1.5rem; padding: 1.2rem; border-radius: 10px; border-left: 4px solid var(--primary-blue); background-color: var(--light-blue-bg); font-size: 0.95rem; }

        .hidden { display: none !important; }
        .confetti { position: fixed; width: 10px; height: 10px; opacity: 0; animation: confetti-fall 5s linear forwards; border-radius: 50%; z-index: 9999; }
        @keyframes confetti-fall { 0% { transform: translateY(-10vh) rotate(0deg); opacity: 1; } 100% { transform: translateY(110vh) rotate(720deg); opacity: 0; } }
        @keyframes inspect { 0% { transform: rotate(-15deg); } 50% { transform: rotate(10deg); } 100% { transform: rotate(-15deg); } }
        @keyframes fadeIn { from { opacity: 0; } to { opacity: 1; } }
    </style>
</head>
<body>

    <div class="quiz-wrapper">
        <header class="quiz-header">
            <div class="header-content">
                <div class="logo">VSREP</div>
                <div>
                    <h1>Pharmacology Antihyperlipidemics - SDE</h1>
                    <div class="version-info">
                        <span>Engine: V4.0</span> | <span>Test: V1.0</span>
                    </div>
                </div>
                <div class="animated-icon">
                    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path d="M416 208c0 45.9-14.9 88.3-40 122.7L502.6 457.4c12.5 12.5 12.5 32.8 0 45.3s-32.8 12.5-45.3 0L330.7 376c-34.4 25.2-76.8 40-122.7 40C93.1 416 0 322.9 0 208S93.1 0 208 0S416 93.1 416 208zM208 352a144 144 0 1 0 0-288 144 144 0 1 0 0 288z"/></svg>
                </div>
            </div>
        </header>

        <main class="quiz-content">
            <div id="initial-screen">
                <h2>Welcome to the Diagnostic Exam</h2>
                <p>You will be presented with one question at a time. Once you answer, you cannot go back. Please read each question carefully before proceeding.</p>
                <button id="start-btn">Start Exam</button>
            </div>

            <form id="quiz-form" class="hidden"></form>

            <div id="results-area" class="hidden"></div>
        </main>
    </div>

<script>
    const fullQuizData = [
     {
        "questionText": "A 68-year-old client with hyperlipidemia is prescribed atorvastatin 40 mg daily. The nurse is providing discharge teaching. Which instructions are **critical** for the nurse to include? (Select all that apply.)",
        "options": {
            "A": "Report any unexplained muscle pain, tenderness, or weakness immediately to your healthcare provider.",
            "B": "You should expect your cholesterol levels to significantly decrease within 3 to 5 days of starting this medication.",
            "C": "It is important to have annual eye examinations while taking this medication.",
            "D": "You can stop taking this medication once your cholesterol levels reach the desired range.",
            "E": "Avoid consuming grapefruit juice while on this medication."
        },
        "correctAnswer": ["A", "C", "E"],
        "rationale": "A. Unexplained muscle pain, tenderness, or weakness can indicate rhabdomyolysis, a rare but serious adverse effect of statins that requires immediate medical attention. C. Statins can cause cataract formation, necessitating annual eye examinations. E. Grapefruit juice can increase the concentration of atorvastatin, potentially leading to increased side effects. B. While some positive effects may be seen in 3-5 days, it takes 2 to 4 weeks to achieve the full therapeutic effect of atorvastatin. D. Abruptly stopping statin drugs can cause a threefold rebound effect that may lead to acute myocardial infarction (AMI) and possible death; therapy is typically a lifetime commitment.",
        "type": "sata"
    },
    {
        "questionText": "A client with hypertriglyceridemia is prescribed gemfibrozil. The nurse notes the client is also taking warfarin. Which action is the nurse's **priority**?",
        "options": {
            "A": "Administer both medications as prescribed, monitoring for therapeutic effect.",
            "B": "Hold the gemfibrozil and notify the healthcare provider.",
            "C": "Administer the gemfibrozil and anticipate an increase in warfarin dosage.",
            "D": "Administer the gemfibrozil and monitor the client's International Normalized Ratio (INR) closely."
        },
        "correctAnswer": "D",
        "rationale": "D. Gemfibrozil is highly protein bound and competes for protein sites with anticoagulants like warfarin, increasing the risk of bleeding. The anticoagulant dose should be reduced, and the INR should be closely monitored to prevent hemorrhage. A, B, C. Administering both without close monitoring or holding the medication without assessment of INR could lead to adverse outcomes. Increasing warfarin dosage would exacerbate the bleeding risk.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin for hyperlipidemia. The nurse is preparing to administer the first dose. Which side effects should the nurse anticipate, and what interventions can help manage them? (Select all that apply.)",
        "options": {
            "A": "Flushing of the skin, which can be mitigated by taking aspirin prior to the dose.",
            "B": "Significant gastrointestinal upset, which can be reduced by taking the medication with meals.",
            "C": "Hyperglycemia, requiring immediate insulin administration.",
            "D": "Hypotension, particularly if large doses are administered.",
            "E": "Elevated serum liver enzymes, indicating a need to discontinue the medication immediately."
        },
        "correctAnswer": ["A", "B", "D"],
        "rationale": "A. Flushing of the skin is a common side effect of niacin, and it can be reduced by taking aspirin prior to the dose. B. Gastrointestinal disturbances (nausea, vomiting, diarrhea) are common with niacin and can be decreased by taking the drug with meals. D. Large doses of niacin can cause vasodilation, leading to dizziness and faintness (hypotension/syncope). C. Hyperglycemia is a side effect of niacin, but it does not typically require immediate insulin administration; it is a long-term concern. E. Elevated serum liver enzymes can occur with niacin, but a slight transient increase may be within normal range and does not always necessitate immediate discontinuation; monitoring is required.",
        "type": "sata"
    },
    {
        "questionText": "A client with intermittent claudication is prescribed cilostazol. Which finding in the client's medical history would prompt the nurse to question this medication order?",
        "options": {
            "A": "History of type 2 diabetes mellitus.",
            "B": "Current diagnosis of stable angina.",
            "C": "Documented history of heart failure.",
            "D": "Occasional use of over-the-counter ibuprofen."
        },
        "correctAnswer": "C",
        "rationale": "C. Heart failure is a contraindication for cilostazol due to its potential to exacerbate the condition. A. Diabetes mellitus is a risk factor for PAD but not a contraindication for cilostazol. B. Stable angina is not listed as a direct contraindication, though cardiovascular disease requires caution. D. Ibuprofen (an NSAID) can increase bleeding risk when taken with antiplatelet drugs like cilostazol, but it is a caution, not a direct contraindication that would immediately prompt questioning the order.",
        "type": "mc"
    },
    {
        "questionText": "A 55-year-old client's fasting lipid profile reveals a total cholesterol of 255 mg/dL, LDL of 170 mg/dL, and HDL of 32 mg/dL. The nurse recognizes these findings indicate a high risk for coronary artery disease. Which nonpharmacologic interventions should the nurse prioritize in teaching this client? (Select all that apply.)",
        "options": {
            "A": "Increasing total fat intake to 40% of daily caloric intake.",
            "B": "Initiating a regular exercise program, such as walking or bicycling.",
            "C": "Eliminating smoking, if applicable.",
            "D": "Reducing saturated fats and cholesterol in the diet to less than 300 mg/day.",
            "E": "Limiting dietary modifications, as they typically have minimal impact on cholesterol levels."
        },
        "correctAnswer": ["B", "C", "D"],
        "rationale": "B. Exercise is an important nonpharmacologic method to reduce cholesterol and increase HDL. C. Smoking increases LDL cholesterol and decreases HDL, making its elimination a priority. D. Saturated fats and cholesterol in the diet should be reduced, with total fat intake 30% or less of caloric intake and cholesterol intake 300 mg/day or less. A. Increasing total fat intake is contrary to the goal of cholesterol reduction. E. While dietary modification alone may only lower total cholesterol by 10% to 30% due to endogenous cholesterol production, it is still the first-line nonpharmacologic therapy and should not be limited.",
        "type": "sata"
    },
    {
        "questionText": "A client's laboratory results indicate an elevated homocysteine level. The nurse understands that this finding is significant because it is linked to an increased risk for which conditions?",
        "options": {
            "A": "Hypothyroidism and anemia.",
            "B": "Cardiovascular disease, stroke, and Alzheimer disease.",
            "C": "Peptic ulcer disease and gastroesophageal reflux.",
            "D": "Peripheral neuropathy and muscle cramps."
        },
        "correctAnswer": "B",
        "rationale": "B. A high level of homocysteine has been linked to cardiovascular disease, stroke, and Alzheimer disease. It may also promote blood clotting and damage the inner lining of blood vessels. A, C, D. These conditions are not directly linked to elevated homocysteine levels according to the provided content.",
        "type": "mc"
    },
    {
        "questionText": "A client is newly prescribed atorvastatin. The nurse is reviewing the medication's pharmacokinetics and pharmacodynamics. Which statements are accurate regarding this drug? (Select all that apply.)",
        "options": {
            "A": "The drug is highly protein bound at 98%.",
            "B": "Therapeutic lipid-lowering effects are typically observed within 3 to 5 days.",
            "C": "The peak time after a dose is usually 1 to 2 hours.",
            "D": "It is primarily excreted through the kidneys.",
            "E": "It has a relatively short half-life, necessitating multiple daily doses."
        },
        "correctAnswer": ["A", "C"],
        "rationale": "A. Atorvastatin is highly protein bound at 98%. C. The peak time after a dose of atorvastatin is 1 to 2 hours. B. While the positive effect of lowering lipids is seen in about 3 to 5 days, it takes 2 to 4 weeks to achieve the full therapeutic effect. D. Atorvastatin is primarily excreted in the feces. E. Atorvastatin has a half-life of 14 hours and is usually prescribed as a once-daily dose, not multiple daily doses.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is preparing to administer cholestyramine powder to a client. Which action is essential for the nurse to take to ensure proper administration and minimize adverse effects?",
        "options": {
            "A": "Administer the powder directly into the client's mouth, followed by a glass of water.",
            "B": "Mix the powder thoroughly in at least 60-180 mL of water or juice.",
            "C": "Advise the client to take the medication on an empty stomach to maximize absorption.",
            "D": "Instruct the client that constipation is a rare side effect of this medication."
        },
        "correctAnswer": "B",
        "rationale": "B. Cholestyramine is a gritty powder that must be mixed thoroughly in 60-180 mL of water or juice to ensure proper administration and prevent GI discomfort. A. Administering the powder directly into the mouth is unsafe and can lead to choking or aspiration. C. The drug should be taken with and followed by sufficient fluids to avoid GI discomfort, and it is typically taken before meals. D. Constipation is a common side effect of cholestyramine and can be decreased by increasing fluid and fiber intake.",
        "type": "mc"
    },
    {
        "questionText": "A client taking simvastatin reports experiencing new onset muscle aches and weakness, accompanied by a low-grade fever. The nurse's **immediate** concern is the possibility of which serious adverse reaction? (Select all that apply.)",
        "options": {
            "A": "Myalgia.",
            "B": "Rhabdomyolysis.",
            "C": "Tendon rupture.",
            "D": "Hemolytic anemia.",
            "E": "Peripheral neuropathy."
        },
        "correctAnswer": ["B", "C"],
        "rationale": "B. Rhabdomyolysis, a muscle disintegration that can be fatal, is a serious skeletal muscle adverse effect reported with statin use, and muscle aches/weakness with fever/malaise are key indicators. C. Tendon rupture is also listed as a rare but serious adverse reaction of statins. A. Myalgia (muscle pain) is a common early complaint with statins, but when accompanied by fever/malaise, it raises concern for the more serious rhabdomyolysis. D. Hemolytic anemia and E. Peripheral neuropathy are listed as life-threatening adverse reactions or side effects of atorvastatin, but rhabdomyolysis and tendon rupture are specifically linked to muscle symptoms.",
        "type": "sata"
    },
    {
        "questionText": "A client asks the nurse how ezetimibe helps lower cholesterol. The nurse's best explanation is that ezetimibe works by:",
        "options": {
            "A": "Inhibiting the enzyme HMG-CoA reductase in the liver.",
            "B": "Binding with bile acids in the intestine to prevent reabsorption.",
            "C": "Inhibiting cholesterol absorption in the small intestine.",
            "D": "Increasing the excretion of cholesterol in the bile."
        },
        "correctAnswer": "C",
        "rationale": "C. Ezetimibe is a cholesterol absorption inhibitor that acts on the cells in the small intestine to inhibit cholesterol absorption. A. This describes the mechanism of action for statins. B. This describes the mechanism of action for bile-acid sequestrants. D. While it reduces serum cholesterol, its primary mechanism is inhibiting absorption, not directly increasing excretion in bile.",
        "type": "mc"
    },
    {
        "questionText": "A client is starting cilostazol for intermittent claudication. Which teaching points are crucial for the nurse to include? (Select all that apply.)",
        "options": {
            "A": "It may take 1.5 to 3 months to experience the full therapeutic effect of this medication.",
            "B": "You should avoid smoking, as it can worsen vasospasm.",
            "C": "You may experience dizziness or orthostatic hypotension, so change positions slowly.",
            "D": "It is safe to take over-the-counter aspirin for pain relief without consulting your doctor.",
            "E": "Taking this medication with grapefruit juice will enhance its effectiveness."
        },
        "correctAnswer": ["A", "B", "C"],
        "rationale": "A. The desired therapeutic response for cilostazol may take 1.5 to 3 months. B. Smoking increases vasospasm and should be avoided when taking peripheral vasodilators. C. Dizziness and orthostatic hypotension are common side effects, and changing positions slowly helps prevent falls. D. Aspirin or aspirin-like compounds should only be used with the healthcare provider's approval due to increased bleeding risk with cilostazol (an antiplatelet). E. Grapefruit juice will increase cilostazol levels and should be avoided.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is explaining the action of pentoxifylline to a client with intermittent claudication. The nurse should describe pentoxifylline as primarily working to:",
        "options": {
            "A": "Directly dilate peripheral arteries.",
            "B": "Inhibit platelet aggregation.",
            "C": "Decrease blood viscosity and improve erythrocyte flexibility.",
            "D": "Reduce cholesterol synthesis in the liver."
        },
        "correctAnswer": "C",
        "rationale": "C. Pentoxifylline is classified as a hemorrheologic agent or blood viscosity reducer agent. It improves microcirculation and tissue perfusion by decreasing blood viscosity and improving the flexibility of erythrocytes. A. This describes direct-acting vasodilators like cilostazol. B. This is a dual action of cilostazol, but not the primary action of pentoxifylline. D. This describes the mechanism of action for statins.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed a statin medication. The nurse understands that which laboratory parameters require routine monitoring due to potential adverse effects of this drug class? (Select all that apply.)",
        "options": {
            "A": "Serum creatinine and blood urea nitrogen (BUN).",
            "B": "Serum liver enzyme levels (e.g., ALT, ALP, GGT).",
            "C": "Complete blood count (CBC).",
            "D": "Creatine phosphokinase (CPK) if muscle symptoms occur.",
            "E": "Serum electrolytes, specifically potassium."
        },
        "correctAnswer": ["B", "D"],
        "rationale": "B. Statin drugs can cause a dose-related increase in liver enzyme levels, so serum liver enzymes (ALP, ALT, GGT) should be monitored. D. If the patient complains of muscle pain or tenderness, CPK levels should be monitored to assess for rhabdomyolysis. A, C, E. While these are important general lab parameters, they are not specifically highlighted as routine monitoring for statin-induced adverse effects in the provided text, unlike liver enzymes and CPK for muscle symptoms.",
        "type": "sata"
    },
    {
        "questionText": "A client has been taking atorvastatin for several years. The client informs the nurse that they plan to stop taking the medication because their cholesterol levels are now within the desired range. The nurse's **most appropriate** response is:",
        "options": {
            "A": "That's great news! You can gradually taper off the medication over the next few weeks.",
            "B": "Stopping this medication abruptly can lead to a serious rebound effect, potentially causing a heart attack.",
            "C": "You can stop the medication, but you'll need to strictly adhere to a low-fat diet.",
            "D": "Your healthcare provider will need to prescribe a different medication to maintain your cholesterol levels."
        },
        "correctAnswer": "B",
        "rationale": "B. Abruptly stopping statin drugs can cause a threefold rebound effect that may cause death from acute myocardial infarction (AMI). Antihyperlipidemic therapy is often a lifetime commitment for maintaining decreased serum lipid levels. A, C, D. These options provide incorrect or incomplete information that could lead to serious adverse outcomes for the client.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's health history. Which factors indicate an increased risk for coronary artery disease (CAD) related to lipid metabolism? (Select all that apply.)",
        "options": {
            "A": "Total cholesterol > 240 mg/dL.",
            "B": "LDL > 160 mg/dL.",
            "C": "HDL > 60 mg/dL.",
            "D": "Triglycerides > 190 mg/dL.",
            "E": "ApoB-100 as the major component of HDL."
        },
        "correctAnswer": ["A", "B", "D"],
        "rationale": "A. A total cholesterol level greater than 240 mg/dL indicates high risk for CAD. B. An LDL level greater than 160 mg/dL indicates high risk for CAD. D. A triglyceride level greater than 190 mg/dL indicates high risk for CAD. C. An HDL level greater than 60 mg/dL is desirable and indicates a lower risk, not increased risk. E. ApoB-100 is the major component of LDL and VLDL, not HDL, and its presence is a better indicator of CAD risk than LDL alone.",
        "type": "sata"
    },
    {
        "questionText": "A client taking cilostazol for intermittent claudication also regularly consumes green tea and occasionally takes ginger supplements. The nurse should educate the client that these substances can have which effect when combined with cilostazol?",
        "options": {
            "A": "Decrease the therapeutic effect of cilostazol.",
            "B": "Increase the risk of hypokalemia.",
            "C": "Increase cilostazol drug levels and prolong bleeding time.",
            "D": "Cause severe gastrointestinal distress."
        },
        "correctAnswer": "C",
        "rationale": "C. Green tea will increase cilostazol levels, and ginger may prolong bleeding time when taken with cilostazol. A. These substances generally increase, not decrease, the effects or side effects. B. Licorice, not green tea or ginger, may cause hypokalemia with cilostazol. D. While GI upset can be a side effect of cilostazol, severe GI distress is not specifically noted as a direct interaction with these substances.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin. The nurse provides education on managing common side effects. Which statements indicate the client understands the teaching? (Select all that apply.)",
        "options": {
            "A": "I should take this medication on an empty stomach to improve absorption.",
            "B": "I can take a low dose of aspirin about 30 minutes before my niacin to help with flushing.",
            "C": "If I experience dizziness or faintness, it might be due to vasodilation from the niacin.",
            "D": "I should expect the flushing to worsen over time.",
            "E": "Taking this medication with meals can help reduce stomach upset."
        },
        "correctAnswer": ["B", "C", "E"],
        "rationale": "B. Aspirin can be taken concomitantly to reduce the flushing associated with niacin. C. Large doses of niacin can cause vasodilation, leading to dizziness and faintness (syncope). E. Taking niacin with meals helps to decrease gastrointestinal discomfort. A. Niacin should be taken with meals to decrease GI discomfort, not on an empty stomach. D. Flushing is common initially but should decrease with continued use of the drug and careful titration.",
        "type": "sata"
    },
    {
        "questionText": "A client taking cholestyramine reports persistent constipation and abdominal discomfort. The nurse should recommend which intervention to alleviate these symptoms?",
        "options": {
            "A": "Taking an antacid 30 minutes before the cholestyramine.",
            "B": "Increasing fluid intake and consuming foods high in fiber.",
            "C": "Switching to a liquid diet until symptoms subside.",
            "D": "Discontinuing the medication and notifying the healthcare provider immediately."
        },
        "correctAnswer": "B",
        "rationale": "B. Constipation is a common side effect of cholestyramine and can be decreased or alleviated by increasing intake of fluids and foods high in fiber. A. Antacids can decrease the effect of cholestyramine. C. A liquid diet is not indicated and would not address the constipation. D. Discontinuing the medication without consulting the provider is inappropriate, as constipation is a manageable side effect.",
        "type": "mc"
    },
    {
        "questionText": "A nurse is assessing a client for signs of peripheral arterial disease (PAD). Which findings would support this diagnosis? (Select all that apply.)",
        "options": {
            "A": "Warm and pink extremities.",
            "B": "Numbness and coolness of the extremities.",
            "C": "Pain and weakness in a limb when walking that subsides at rest.",
            "D": "Presence of leg ulcers.",
            "E": "Strong peripheral pulses."
        },
        "correctAnswer": ["B", "C", "D"],
        "rationale": "B. Numbness and coolness of the extremities are characteristic symptoms of PAD. C. Claudication, defined as pain and weakness of a limb when walking but no symptoms at rest, is a hallmark of PAD. D. Leg ulcers are a possible manifestation of PAD, indicating severe arterial insufficiency. A. Warm and pink extremities and E. Strong peripheral pulses indicate adequate blood flow, which would be inconsistent with PAD.",
        "type": "sata"
    },
    {
        "questionText": "A client with normal cholesterol levels and blood pressure has a positive high-sensitivity C-reactive protein (hsCRP) test result. The nurse understands that this finding is significant because it indicates:",
        "options": {
            "A": "The client is experiencing an acute bacterial infection.",
            "B": "The client is at high risk for developing coronary artery disease (CAD).",
            "C": "The client has a severe inflammatory response unrelated to cardiovascular health.",
            "D": "The client's liver function is impaired."
        },
        "correctAnswer": "B",
        "rationale": "B. A positive hsCRP test can indicate that the patient is at high risk for CAD, even if cholesterol levels and blood pressure are normal. It detects an inflammatory process caused by atherosclerotic plaque buildup. A. While standard CRP responds to acute inflammation, hsCRP is specifically used for cardiovascular risk assessment. C. The test is specifically associated with cardiovascular inflammation. D. hsCRP is produced in the liver but a positive test indicates inflammation, not necessarily impaired liver function.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed gemfibrozil. The nurse identifies which key considerations for this medication? (Select all that apply.)",
        "options": {
            "A": "It is primarily effective for reducing LDL cholesterol.",
            "B": "It is highly protein bound.",
            "C": "It should be taken with food to enhance absorption.",
            "D": "It can increase the risk of bleeding if taken with oral anticoagulants.",
            "E": "Liver enzyme monitoring is important during therapy."
        },
        "correctAnswer": ["B", "D", "E"],
        "rationale": "B. Gemfibrozil is highly protein bound. D. It should not be taken with anticoagulants because they compete for protein sites, increasing bleeding risk. E. Elevated hepatic enzymes are a possible side effect, necessitating monitoring. A. Gemfibrozil is more effective for reducing triglyceride and VLDL levels than for reducing LDL. C. Gemfibrozil is typically taken 30 minutes before morning and evening meals, not necessarily with food to enhance absorption.",
        "type": "sata"
    },
    {
        "questionText": "A client is prescribed ezetimibe. The nurse explains that this medication works by:",
        "options": {
            "A": "Inhibiting the hepatic synthesis of cholesterol.",
            "B": "Increasing the excretion of bile acids.",
            "C": "Blocking the absorption of dietary and biliary cholesterol in the small intestine.",
            "D": "Reducing the synthesis of triglycerides in the liver."
        },
        "correctAnswer": "C",
        "rationale": "C. Ezetimibe is a cholesterol absorption inhibitor that acts on the cells in the small intestine to inhibit cholesterol absorption from dietary and biliary sources. A. This is the mechanism of statins. B. This is the mechanism of bile-acid sequestrants. D. While ezetimibe reduces triglycerides, its primary mechanism is absorption inhibition, not direct synthesis reduction.",
        "type": "mc"
    },
    {
        "questionText": "A nurse is reviewing the medical history of a client newly prescribed a statin. Which conditions would be considered contraindications for statin therapy? (Select all that apply.)",
        "options": {
            "A": "History of controlled hypertension.",
            "B": "Acute hepatic disease.",
            "C": "Pregnancy.",
            "D": "Breastfeeding.",
            "E": "Well-managed type 2 diabetes mellitus."
        },
        "correctAnswer": ["B", "C", "D"],
        "rationale": "B. Statin drugs are contraindicated for patients with liver disorders, including acute hepatic disease. C. Statins are contraindicated in pregnancy. D. Statins are contraindicated in breastfeeding. A. Controlled hypertension and E. Well-managed type 2 diabetes mellitus are not contraindications; in fact, statins may be beneficial for clients with these conditions due to their cardiovascular risk reduction.",
        "type": "sata"
    },
    {
        "questionText": "A client with hyperlipidemia expresses frustration that diet modification alone has not significantly lowered their cholesterol levels. The nurse's explanation should include which accurate information?",
        "options": {
            "A": "Dietary modification alone typically lowers total cholesterol levels by 50% to 70%.",
            "B": "Approximately 75% to 85% of serum cholesterol is derived internally, limiting the impact of diet alone.",
            "C": "Adherence to dietary restrictions is usually long-lived, making diet a highly effective sole therapy.",
            "D": "Diet modification is only effective for reducing triglycerides, not cholesterol."
        },
        "correctAnswer": "B",
        "rationale": "B. Because 75% to 85% of serum cholesterol is endogenously (internally) derived, dietary modification alone will typically lower total cholesterol levels by only 10% to 30%. A. The stated percentage is much higher than what is typically achieved by diet alone. C. Adherence to dietary restrictions is often short-lived, which is why many patients do not respond to diet modification alone. D. Dietary modification aims to reduce both cholesterol and triglycerides.",
        "type": "mc"
    },
    {
        "questionText": "A client taking cilostazol for intermittent claudication reports new onset palpitations and dizziness. The nurse assesses the client's vital signs and notes a heart rate of 105 bpm and blood pressure of 98/60 mmHg. Which adverse effects of cilostazol are consistent with these findings? (Select all that apply.)",
        "options": {
            "A": "Tachycardia.",
            "B": "Orthostatic hypotension.",
            "C": "Angina.",
            "D": "Hypertension.",
            "E": "Myalgia."
        },
        "correctAnswer": ["A", "B"],
        "rationale": "A. Tachycardia is a common side effect of cilostazol, consistent with a heart rate of 105 bpm. B. Dizziness and a blood pressure of 98/60 mmHg (potentially indicating a drop from baseline) are consistent with orthostatic hypotension, a known side effect. C. Angina is an adverse reaction but not directly indicated by these specific vital signs alone. D. Hypertension is not a typical adverse effect; hypotension is more common. E. Myalgia is a side effect but does not align with the reported palpitations, dizziness, and vital signs.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is caring for a client who may have overdosed on pentoxifylline. Which clinical manifestation would the nurse anticipate?",
        "options": {
            "A": "Bradycardia and hypertension.",
            "B": "Tachycardia and blurred vision.",
            "C": "Severe muscle pain and dark urine.",
            "D": "Increased erythrocyte flexibility and improved tissue perfusion."
        },
        "correctAnswer": "B",
        "rationale": "B. Reactions to an overdose of pentoxifylline include tachycardia, hypotension (which can lead to compensatory tachycardia), and blurred vision. A. Bradycardia and hypertension are contrary to expected overdose effects. C. Severe muscle pain and dark urine are indicative of rhabdomyolysis, a side effect of statins, not pentoxifylline. D. These are the therapeutic effects of pentoxifylline, not signs of overdose.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is caring for a client receiving antihyperlipidemic therapy. Which nursing interventions are appropriate for this client? (Select all that apply.)",
        "options": {
            "A": "Monitoring blood lipid levels every 6 to 8 weeks for the first 6 months.",
            "B": "Instructing the client to fast for 4-6 hours before a lipid-level profile.",
            "C": "Monitoring laboratory tests for liver function, such as ALT and ALP.",
            "D": "Advising the client that GI upset is common and suggesting taking the drug with sufficient water.",
            "E": "Encouraging the client to increase intake of animal fats and cholesterol."
        },
        "correctAnswer": ["A", "C", "D"],
        "rationale": "A. Blood lipid levels should be monitored every 6 to 8 weeks for the first 6 months after statin therapy, then every 3 to 6 months. C. Liver function tests (ALT, ALP, GGT) should be monitored due to the potential for liver disorders with antihyperlipidemics. D. GI upset is common with most antihyperlipidemics, and taking the drug with sufficient water or meals can alleviate discomfort. B. A 12- to 14-hour fasting lipid profile is typically ordered, not 4-6 hours. E. Clients should be encouraged to consume foods low in animal fats and cholesterol, not increase them.",
        "type": "sata"
    },
    {
        "questionText": "A client's lipid panel shows an elevated low-density lipoprotein (LDL) level. The nurse understands that this finding is significant because:",
        "options": {
            "A": "LDL is known as 'friendly' lipoprotein and helps remove cholesterol from the bloodstream.",
            "B": "Elevated LDL levels are associated with a decreased risk for atherosclerotic plaques.",
            "C": "LDL contains 50% to 60% of the cholesterol in the bloodstream, and high levels increase heart disease risk.",
            "D": "LDL primarily carries triglycerides, not cholesterol."
        },
        "correctAnswer": "C",
        "rationale": "C. LDL, the 'bad' lipoprotein, contains 50% to 60% of cholesterol in the bloodstream. An elevated LDL increases the risk for developing atherosclerotic plaques and heart disease. A. HDL is known as the 'friendly' or 'good' lipoprotein. B. Elevated LDL levels are associated with an *increased* risk for atherosclerotic plaques. D. VLDL carries mostly triglycerides; LDL primarily carries cholesterol.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia and hypertension is prescribed a combination drug of atorvastatin and amlodipine. The nurse understands that this combination aims to achieve which therapeutic effects? (Select all that apply.)",
        "options": {
            "A": "Decrease blood pressure.",
            "B": "Increase blood clotting.",
            "C": "Enhance the antihyperlipidemic effect.",
            "D": "Reduce the risk of rhabdomyolysis.",
            "E": "Improve peripheral blood flow through vasodilation."
        },
        "correctAnswer": ["A", "C"],
        "rationale": "A. Amlodipine is an antihypertensive drug used to decrease blood pressure. C. Atorvastatin is an antihyperlipidemic, and its combination with amlodipine enhances the antihyperlipidemic effect. B. This combination does not increase blood clotting; antiplatelet drugs decrease it. D. This combination does not inherently reduce the risk of rhabdomyolysis; statins still carry that risk. E. While amlodipine is a calcium channel blocker with vasodilatory properties, the primary intent of this combination drug is for hypertension and hyperlipidemia, not specifically to improve peripheral blood flow in the context of PAD.",
        "type": "sata"
    },
    {
        "questionText": "A client starting cilostazol for intermittent claudication asks how long it will take to feel better. The nurse's best response regarding the onset of action is:",
        "options": {
            "A": "You should notice significant improvement within a few days.",
            "B": "It typically takes 2 to 12 weeks to see the full therapeutic effect.",
            "C": "Relief is usually immediate due to its direct vasodilating action.",
            "D": "The effects are usually noticeable after 6 months of consistent use."
        },
        "correctAnswer": "B",
        "rationale": "B. Cilostazol has an onset of action within 2 to 12 weeks, meaning it takes time to achieve its full therapeutic effect. A, C, D. These timeframes are inaccurate for cilostazol's therapeutic onset.",
        "type": "mc"
    },
    {
        "questionText": "A client taking fenofibrate is also prescribed warfarin. The nurse should be particularly vigilant for which signs of increased bleeding risk? (Select all that apply.)",
        "options": {
            "A": "Increased energy levels.",
            "B": "Easy bruising or petechiae.",
            "C": "Black, tarry stools (melena).",
            "D": "Elevated International Normalized Ratio (INR).",
            "E": "Decreased appetite."
        },
        "correctAnswer": ["B", "C", "D"],
        "rationale": "B. Easy bruising or petechiae are signs of bleeding. C. Melena indicates gastrointestinal bleeding. D. An elevated INR indicates prolonged clotting time, increasing bleeding risk. Fenofibrate is highly protein bound and can displace warfarin, increasing its anticoagulant effect. A. Increased energy levels and E. Decreased appetite are not direct indicators of increased bleeding risk.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is educating a client about peripheral vasodilators. The nurse accurately explains that these drugs are generally more effective for peripheral vascular disorders resulting from:",
        "options": {
            "A": "Arteriosclerosis obliterans.",
            "B": "Thromboangiitis obliterans (Buerger disease).",
            "C": "Vasospasm, such as in Raynaud disease.",
            "D": "Arterial occlusions."
        },
        "correctAnswer": "C",
        "rationale": "C. Peripheral vasodilators are more effective for disorders that result from vasospasm (e.g., Raynaud disease) than from vessel occlusion or arteriosclerosis (e.g., arteriosclerosis obliterans, Buerger disease). A, B, D. These conditions involve vessel occlusion or arteriosclerosis, where vasodilators have limited effectiveness.",
        "type": "mc"
    },
    {
        "questionText": "A client taking atorvastatin should be instructed to report which symptoms to their healthcare provider immediately? (Select all that apply.)",
        "options": {
            "A": "Mild headache.",
            "B": "Muscle pain or tenderness.",
            "C": "Blurred vision.",
            "D": "Malaise accompanied by fever.",
            "E": "Occasional dyspepsia."
        },
        "correctAnswer": ["B", "D"],
        "rationale": "B. Muscle pain or tenderness, especially if accompanied by fever or malaise, should be reported immediately as it can indicate rhabdomyolysis. D. Malaise accompanied by fever, along with muscle symptoms, is a red flag for rhabdomyolysis. A. Mild headache and E. Occasional dyspepsia are common early complaints or side effects that typically do not require immediate notification unless severe or persistent. C. Blurred vision can be a side effect, and annual eye exams are needed, but it's not typically an 'immediate' report unless it's a sudden, severe change.",
        "type": "sata"
    },
    {
        "questionText": "When comparing bile acid sequestrants, the nurse recognizes that colesevelam is often preferred over cholestyramine and colestipol due to which advantage?",
        "options": {
            "A": "It is more effective at reducing VLDL and triglycerides.",
            "B": "It has fewer side effects like constipation, flatulence, and cramping.",
            "C": "It has a stronger effect on the absorption of fat-soluble vitamins.",
            "D": "It can be taken without regard to meals."
        },
        "correctAnswer": "B",
        "rationale": "B. Colesevelam has fewer side effects (less constipation, flatulence, and cramping) and less effect on the absorption of fat-soluble vitamins than the older bile-acid sequestrants, making it a first-choice agent. A. Fibrates are more effective for reducing VLDL and triglycerides. C. Colesevelam has *less* effect on fat-soluble vitamin absorption. D. The text does not specify it can be taken without regard to meals, but highlights its reduced side effects.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing general teaching to a client starting a new antihyperlipidemic medication. Which statements are appropriate to include? (Select all that apply.)",
        "options": {
            "A": "It may take several weeks for your blood lipid levels to decline.",
            "B": "You should continue your low-fat diet and exercise program even with medication.",
            "C": "Laboratory tests for blood lipids will be ordered periodically.",
            "D": "You can stop the medication once your cholesterol levels are normal.",
            "E": "Gastrointestinal discomfort is a common problem with most of these medications."
        },
        "correctAnswer": ["A", "B", "C", "E"],
        "rationale": "A. It may take several weeks for blood lipid levels to decline. B. Dietary changes and an exercise program must be continued even after drug therapy is initiated. C. Laboratory tests for blood lipids are usually ordered every 3 to 6 months. E. GI discomfort is a common problem with most antihyperlipidemics. D. Antihyperlipidemic therapy is often a lifetime commitment; abruptly stopping statins can cause a serious rebound effect.",
        "type": "sata"
    },
    {
        "questionText": "A client with an elevated homocysteine level asks the nurse about ways to lower it. The nurse should suggest increasing dietary intake or supplementation of which vitamins?",
        "options": {
            "A": "Vitamin C, Vitamin D, and Vitamin E.",
            "B": "Vitamin B6, Vitamin B12, and Folic Acid.",
            "C": "Vitamin A, Vitamin K, and Biotin.",
            "D": "Thiamine, Riboflavin, and Niacin."
        },
        "correctAnswer": "B",
        "rationale": "B. Three vitamins that can lower serum homocysteine levels are vitamin B6 (pyridoxine), vitamin B12 (cyanocobalamin), and folic acid. A, C, D. These vitamin combinations are not identified in the text as effective for lowering homocysteine.",
        "type": "mc"
    },
    {
        "questionText": "A client is being assessed for eligibility to receive cilostazol. The nurse identifies which conditions as contraindications or requiring caution? (Select all that apply.)",
        "options": {
            "A": "History of bleeding disorders.",
            "B": "Current pregnancy.",
            "C": "Well-controlled hypertension.",
            "D": "Hepatic disease.",
            "E": "History of dysrhythmias."
        },
        "correctAnswer": ["A", "B", "D", "E"],
        "rationale": "A. Bleeding disorders are a contraindication for cilostazol. B. Pregnancy is a caution for cilostazol. D. Hepatic disease is a caution for cilostazol. E. Dysrhythmias are a caution for cilostazol. C. Well-controlled hypertension is not listed as a contraindication or caution for cilostazol; in fact, some antihypertensives are used to manage PAD.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is explaining the effects of statin drugs to a client. The nurse should accurately state that statins primarily decrease LDL and VLDL, and have what effect on HDL?",
        "options": {
            "A": "Significantly decrease HDL.",
            "B": "No effect on HDL.",
            "C": "Slightly increase HDL.",
            "D": "Convert HDL to LDL."
        },
        "correctAnswer": "C",
        "rationale": "C. Statins decrease the concentration of cholesterol, decrease LDL, and slightly increase HDL cholesterol. A, B, D. These options are incorrect regarding the effect of statins on HDL.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed pentoxifylline for intermittent claudication. Which teaching points are important for the nurse to provide? (Select all that apply.)",
        "options": {
            "A": "Take this medication on an empty stomach for best absorption.",
            "B": "Avoid smoking while taking this medication.",
            "C": "Report any blurred vision or confusion to your healthcare provider.",
            "D": "If you are taking blood pressure medication, your dose may need to be adjusted.",
            "E": "You should expect immediate relief from your claudication symptoms."
        },
        "correctAnswer": ["B", "C", "D"],
        "rationale": "B. The patient should avoid smoking because nicotine increases vasoconstriction, counteracting the drug's effect. C. Blurred vision and confusion are potential side effects, and overdose reactions include blurred vision. D. Patients taking an antihypertensive drug along with pentoxifylline may need to have the antihypertensive dosage decreased to avoid side effects. A. Pentoxifylline should be taken with food to minimize GI upset. E. Pentoxifylline does not provide immediate relief; therapeutic effects take time.",
        "type": "sata"
    },
    {
        "questionText": "Before initiating statin therapy for a client, the nurse should anticipate obtaining which baseline laboratory study?",
        "options": {
            "A": "Complete blood count (CBC).",
            "B": "Serum creatinine.",
            "C": "Liver enzyme studies (e.g., ALT, ALP, GGT).",
            "D": "Thyroid stimulating hormone (TSH)."
        },
        "correctAnswer": "C",
        "rationale": "C. Baseline liver enzyme studies (ALP, ALT, GGT) should be obtained before initiating statin therapy because statins can cause a dose-related increase in liver enzyme levels and are contraindicated in acute hepatic disorders. A, B, D. While these are important lab tests, they are not specifically highlighted as baseline requirements for statin therapy in the provided text.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's diagnosis of hyperlipidemia Type IIB. The nurse understands that this type is characterized by an increase in which major lipids and is commonly associated with what condition? (Select all that apply.)",
        "options": {
            "A": "Increased LDL.",
            "B": "Increased VLDL.",
            "C": "Increased cholesterol.",
            "D": "Increased triglycerides.",
            "E": "Commonly associated with coronary artery disease."
        },
        "correctAnswer": ["A", "B", "C", "D", "E"],
        "rationale": "A, B, C, D. Hyperlipidemia Type IIB is characterized by increased VLDL, increased LDL, increased cholesterol, and increased triglycerides. E. Types II and IV hyperlipidemia are commonly associated with coronary artery disease.",
        "type": "sata"
    },
    {
        "questionText": "A nursing student asks about the function of chylomicrons. The nurse explains that chylomicrons are large particles that primarily:",
        "options": {
            "A": "Remove cholesterol from the bloodstream for excretion.",
            "B": "Transport fatty acids and cholesterol to the liver.",
            "C": "Contain 50% to 60% of the cholesterol in the bloodstream.",
            "D": "Are the major component of high-density lipoprotein (HDL)."
        },
        "correctAnswer": "B",
        "rationale": "B. Chylomicrons are large particles that transport fatty acids and cholesterol to the liver. A. HDL removes cholesterol from the bloodstream and delivers it to the liver for excretion. C. LDL contains 50% to 60% of the cholesterol in the bloodstream. D. ApoA-1 is the major component of HDL.",
        "type": "mc"
    },
    {
        "questionText": "A client taking atorvastatin is also prescribed a new macrolide antibiotic. The nurse should be aware of which potential drug interactions? (Select all that apply.)",
        "options": {
            "A": "Decreased effect of atorvastatin.",
            "B": "Increased risk of rhabdomyolysis.",
            "C": "Increased drug concentration of atorvastatin.",
            "D": "Decreased efficacy of the antibiotic.",
            "E": "Increased risk of hepatic toxicity."
        },
        "correctAnswer": ["B", "C", "E"],
        "rationale": "B. Macrolide antibiotics can increase statin drug effects, increasing the risk of rhabdomyolysis. C. Macrolide antibiotics can increase drug levels/concentration of statins. E. Increased drug levels can also lead to an increased risk of hepatic toxicity. A. The effect of atorvastatin would be increased, not decreased. D. The interaction primarily affects the statin, not the antibiotic's efficacy.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is educating a client about healthy lipid levels. The nurse correctly states that a desirable total cholesterol level is within which range?",
        "options": {
            "A": "<100 mg/dL.",
            "B": "150-200 mg/dL.",
            "C": "200-240 mg/dL.",
            "D": ">240 mg/dL."
        },
        "correctAnswer": "B",
        "rationale": "B. A desirable total cholesterol level is 150-200 mg/dL. A. <100 mg/dL is the desirable LDL level. C. 200-240 mg/dL is considered moderate risk. D. >240 mg/dL is considered high risk.",
        "type": "mc"
    },
    {
        "questionText": "When assessing a client for potential issues related to antihyperlipidemic therapy, the nurse should recognize which cues as important? (Select all that apply.)",
        "options": {
            "A": "Baseline serum cholesterol and triglyceride levels.",
            "B": "Patient's current exercise regimen.",
            "C": "History of liver disorders.",
            "D": "Baseline creatine phosphokinase (CPK) levels.",
            "E": "Patient's preference for fatty foods."
        },
        "correctAnswer": ["A", "C", "D"],
        "rationale": "A. Baseline serum chemistry values (cholesterol, triglycerides) are essential for assessing effectiveness. C. Statin drugs are contraindicated for patients with liver disorders, making a history of liver disorders a critical cue. D. Baseline CPK is important to assess for potential muscle damage, especially with statins. B. While important for nonpharmacologic management, the current exercise regimen is not a direct 'cue' for potential *issues* related to drug therapy. E. Patient's preference for fatty foods is a dietary habit, not a direct clinical cue for drug-related issues, though it impacts adherence and overall lipid management.",
        "type": "sata"
    },
    {
        "questionText": "The nurse notes that the two most frequently prescribed statin drugs in the United States are:",
        "options": {
            "A": "Lovastatin and pravastatin.",
            "B": "Simvastatin and fluvastatin.",
            "C": "Rosuvastatin and atorvastatin.",
            "D": "Pitavastatin and ezetimibe."
        },
        "correctAnswer": "C",
        "rationale": "C. Rosuvastatin and atorvastatin are at the top of the list of most prescribed drugs in the United States. A, B, D. While these are statins or related drugs, they are not identified as the two most prescribed.",
        "type": "mc"
    },
    {
        "questionText": "A client taking cilostazol should be advised to avoid or use caution with which food and herbal interactions? (Select all that apply.)",
        "options": {
            "A": "Grapefruit juice.",
            "B": "Green tea.",
            "C": "Ginger.",
            "D": "St. John's wort.",
            "E": "Licorice."
        },
        "correctAnswer": ["A", "B", "C", "D", "E"],
        "rationale": "A. Grapefruit juice will increase cilostazol levels. B. Green tea will increase cilostazol levels. C. Ginger may prolong bleeding time. D. St. John's wort will decrease the effect of cilostazol. E. Licorice may cause hypokalemia, which can potentiate drug toxicity when taken with cilostazol. All listed options are relevant interactions.",
        "type": "sata"
    },
    {
        "questionText": "A client is prescribed gemfibrozil. The nurse understands that this medication is primarily used to reduce which lipid levels?",
        "options": {
            "A": "LDL and total cholesterol.",
            "B": "Triglycerides and VLDL.",
            "C": "HDL and chylomicrons.",
            "D": "ApoB-100 and cholesterol absorption."
        },
        "correctAnswer": "B",
        "rationale": "B. Gemfibrozil is a fibric acid derivative that is more effective for reducing triglyceride and VLDL levels than for reducing LDL. A. Statins primarily reduce LDL and total cholesterol. C. Gemfibrozil does not primarily target HDL or chylomicrons. D. Ezetimibe targets cholesterol absorption.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is developing a plan of care for a client receiving antihyperlipidemic therapy. Which outcomes indicate effective planning? (Select all that apply.)",
        "options": {
            "A": "The patient's cholesterol level will be less than 200 mg/dL in 6 to 8 weeks.",
            "B": "The patient will demonstrate understanding of high-fat food choices.",
            "C": "The patient will report an increase in muscle pain and weakness.",
            "D": "The patient will choose foods from a list that are low in fat, cholesterol, and complex sugars.",
            "E": "The patient will discontinue medication once lipid levels are normalized."
        },
        "correctAnswer": ["A", "D"],
        "rationale": "A. A desired outcome is for the patient's cholesterol level to be less than 200 mg/dL in 6 to 8 weeks. D. The patient choosing low-fat, low-cholesterol foods demonstrates adherence to dietary modifications. B. The patient should demonstrate understanding of *low-fat* food choices, not high-fat. C. An increase in muscle pain and weakness is an adverse effect, not an effective outcome. E. Discontinuing medication once lipid levels are normalized is dangerous, as antihyperlipidemic therapy is often a lifetime commitment.",
        "type": "sata"
    },
    {
        "questionText": "A client's lipid profile includes an ApoB-100 measurement. The nurse understands that ApoB-100 is a better indicator of risk for coronary artery disease (CAD) than LDL alone because it is a major component of:",
        "options": {
            "A": "HDL.",
            "B": "Chylomicrons.",
            "C": "VLDL and LDL.",
            "D": "Phospholipids."
        },
        "correctAnswer": "C",
        "rationale": "C. ApoB-100 has VLDL as well as LDL and is a better indicator of risk for CAD than LDL alone because it represents the total number of atherogenic particles. A. ApoA-1 is the major component of HDL. B. Chylomicrons are composed mostly of triglycerides. D. Phospholipids are a type of lipid, not a lipoprotein component.",
        "type": "mc"
    },
    {
        "questionText": "A 45-year-old client with hypercholesterolemia is prescribed lovastatin. The nurse emphasizes the importance of taking this medication at a specific time of day. Which instruction is most appropriate?",
        "options": {
            "A": "Take lovastatin in the morning with breakfast.",
            "B": "Take lovastatin with the evening meal.",
            "C": "Take lovastatin on an empty stomach before bedtime.",
            "D": "Take lovastatin any time of day, as long as it's consistent."
        },
        "correctAnswer": "B",
        "rationale": "B. Lovastatin (immediate release) is typically prescribed to be taken with the evening meal to coincide with the peak of cholesterol synthesis, which occurs at night. A, C, D. These instructions are not optimal for lovastatin's effectiveness.",
        "type": "mc"
    },
    {
        "questionText": "A client taking niacin reports significant flushing and itching. Which nursing intervention is most appropriate to help manage these side effects?",
        "options": {
            "A": "Instruct the client to take the niacin on an empty stomach.",
            "B": "Advise the client to increase the niacin dose to build tolerance.",
            "C": "Suggest taking a low-dose aspirin 30 minutes before the niacin.",
            "D": "Recommend discontinuing the niacin immediately."
        },
        "correctAnswer": "C",
        "rationale": "C. Flushing and pruritus are common side effects of niacin. Taking a low-dose aspirin 30 minutes before niacin can help reduce these prostaglandin-mediated effects. A. Taking niacin with meals helps reduce GI upset, not flushing. B. Increasing the dose would likely worsen flushing and other side effects. D. Discontinuing the medication without consulting the provider is inappropriate for manageable side effects.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's medication list and notes the client is taking colestipol. The nurse understands that this medication is effective against which type of hyperlipidemia?",
        "options": {
            "A": "Type I.",
            "B": "Type II.",
            "C": "Type III.",
            "D": "Type IV."
        },
        "correctAnswer": "B",
        "rationale": "B. Colestipol, a bile-acid sequestrant, is similar to cholestyramine, which is effective against hyperlipidemia type II (increased LDL and cholesterol). A, C, D. These types are not primarily targeted by bile-acid sequestrants.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is prescribed ramipril. The nurse explains that this medication improves both PAD symptoms and hypertension through its action as a/an:",
        "options": {
            "A": "Alpha blocker.",
            "B": "Calcium channel blocker.",
            "C": "Angiotensin-converting enzyme (ACE) inhibitor.",
            "D": "Antiplatelet drug."
        },
        "correctAnswer": "C",
        "rationale": "C. Ramipril is an angiotensin-converting enzyme (ACE) inhibitor, which improves both PAD symptoms and hypertension. A. Prazosin is an alpha blocker. B. Nifedipine is a calcium channel blocker. D. Clopidogrel and aspirin are antiplatelet drugs.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is considering complementary therapies. The nurse cautions the client that St. John's wort can have which effect when taken with statins?",
        "options": {
            "A": "Increase the effect and drug levels of statins.",
            "B": "Decrease the effect and drug levels of statins.",
            "C": "Potentiate an increase in liver enzymes.",
            "D": "Increase side effects of statins, such as muscle pain."
        },
        "correctAnswer": "B",
        "rationale": "B. St. John's wort may decrease the effect and drug levels of statins, potentially reducing their therapeutic efficacy. A. This is incorrect. C. Black cohosh may potentiate an increase in liver enzymes. D. Cranberry and green tea may increase side effects of simvastatin and statins, respectively, but St. John's wort decreases the effect.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing education about the importance of fasting before a lipid profile. The nurse accurately states that the client should fast for how long?",
        "options": {
            "A": "4 to 6 hours.",
            "B": "8 to 10 hours.",
            "C": "12 to 14 hours.",
            "D": "No fasting is required for a lipid profile."
        },
        "correctAnswer": "C",
        "rationale": "C. For a lipid-level profile, the patient should fast for 12 to 14 hours to ensure accurate triglyceride and cholesterol measurements. A, B, D. These fasting durations are incorrect for a comprehensive lipid profile.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse emphasizes the importance of an annual eye examination due to the potential for which adverse effect?",
        "options": {
            "A": "Glaucoma.",
            "B": "Retinal detachment.",
            "C": "Cataract formation.",
            "D": "Macular degeneration."
        },
        "correctAnswer": "C",
        "rationale": "C. An annual eye examination is needed for patients taking statins because cataract formation may result. A, B, D. While these are eye conditions, they are not specifically linked to statin use in the provided text.",
        "type": "mc"
    },
    {
        "questionText": "A client asks the nurse about the difference between 'good' and 'bad' cholesterol. The nurse explains that 'good' cholesterol refers to which lipoprotein?",
        "options": {
            "A": "Very-low-density lipoprotein (VLDL).",
            "B": "Low-density lipoprotein (LDL).",
            "C": "High-density lipoprotein (HDL).",
            "D": "Chylomicrons."
        },
        "correctAnswer": "C",
        "rationale": "C. HDL (high-density lipoprotein) is also known as 'friendly' or 'good' lipoprotein because its function is to remove cholesterol from the bloodstream and deliver it to the liver for excretion. A. VLDL carries mostly triglycerides. B. LDL is the 'bad' lipoprotein. D. Chylomicrons transport fatty acids and cholesterol to the liver.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is prescribed cilostazol. The nurse informs the client that the medication is most effective for improving which specific symptom?",
        "options": {
            "A": "Numbness of the extremities.",
            "B": "Coolness of the extremities.",
            "C": "Intermittent claudication.",
            "D": "Leg ulcers."
        },
        "correctAnswer": "C",
        "rationale": "C. Cilostazol is an antiplatelet drug approved by the US Food and Drug Administration (FDA) for treating intermittent claudication. A, B, D. While these are symptoms of PAD, cilostazol's primary indication and effectiveness are specifically for intermittent claudication.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is teaching a client about the importance of reducing dietary cholesterol. The nurse states that total fat intake should be what percentage or less of caloric intake?",
        "options": {
            "A": "10%.",
            "B": "20%.",
            "C": "30%.",
            "D": "40%."
        },
        "correctAnswer": "C",
        "rationale": "C. Total fat intake should be 30% or less of caloric intake, and cholesterol intake should be 300 mg/day or less, as part of nonpharmacologic methods for cholesterol reduction. A, B, D. These percentages are either too low or too high according to the guidelines.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse advises the client that if they experience muscle aches or weakness, they should report it immediately. This is because these symptoms could indicate which life-threatening adverse reaction?",
        "options": {
            "A": "Myositis.",
            "B": "Fibromyalgia.",
            "C": "Rhabdomyolysis.",
            "D": "Muscular dystrophy."
        },
        "correctAnswer": "C",
        "rationale": "C. The patient should report immediately any muscle aches or weakness, which can lead to rhabdomyolysis, a muscle disintegration that can become fatal. A. Myositis is muscle inflammation, but rhabdomyolysis is the more severe and life-threatening concern associated with statins. B, D. Fibromyalgia and muscular dystrophy are distinct conditions not caused by statins.",
        "type": "mc"
    },
    {
        "questionText": "Which lipoprotein contains more protein and less fat than others, and its function is to remove cholesterol from the bloodstream for excretion?",
        "options": {
            "A": "Low-density lipoprotein (LDL).",
            "B": "Very-low-density lipoprotein (VLDL).",
            "C": "High-density lipoprotein (HDL).",
            "D": "Chylomicrons."
        },
        "correctAnswer": "C",
        "rationale": "C. HDL, also known as 'friendly' or 'good' lipoprotein, is the smallest and densest lipoprotein, meaning that it contains more protein and less fat than the others. Its function is to remove cholesterol from the bloodstream and deliver it to the liver for excretion in bile. A. LDL is 'bad' and contains more cholesterol. B. VLDL carries mostly triglycerides. D. Chylomicrons transport fatty acids and cholesterol to the liver.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is taking an HMG-CoA reductase inhibitor (statin) for dyslipidemia. The nurse explains that this medication may also have which beneficial effect on PAD symptoms?",
        "options": {
            "A": "Directly dilate peripheral vessels to increase blood flow.",
            "B": "Decrease blood viscosity and improve erythrocyte flexibility.",
            "C": "Improve intermittent claudication symptoms.",
            "D": "Reduce the risk of peptic ulcers in the extremities."
        },
        "correctAnswer": "C",
        "rationale": "C. Individuals with PAD who are treated with HMG-CoA reductase inhibitors (statins) for dyslipidemia may see an improvement in intermittent claudication symptoms as well as a decrease in serum lipids. A. Statins do not directly dilate peripheral vessels; peripheral vasodilators do. B. This is the action of pentoxifylline. D. Statins do not reduce the risk of peptic ulcers in the extremities.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is preparing to administer cholestyramine. The client reports a history of peptic ulcer disease. The nurse should be aware that cholestyramine can cause which gastrointestinal side effect related to this history?",
        "options": {
            "A": "Diarrhea.",
            "B": "Flatulence.",
            "C": "Peptic ulcer.",
            "D": "Steatorrhea."
        },
        "correctAnswer": "C",
        "rationale": "C. Cholestyramine can cause peptic ulcer as a side effect. Early signs include nausea and abdominal discomfort, followed by abdominal pain and distension. A, B, D. While these are also GI side effects of cholestyramine, peptic ulcer is specifically mentioned as a potential adverse effect that relates to the client's history.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse advises the client that the positive effect of lowering lipids is seen in about 3 to 5 days, but it takes how long to achieve the full therapeutic effect?",
        "options": {
            "A": "1 to 2 hours.",
            "B": "1 to 2 weeks.",
            "C": "2 to 4 weeks.",
            "D": "6 to 8 weeks."
        },
        "correctAnswer": "C",
        "rationale": "C. While the positive effect of lowering lipids with atorvastatin is seen in about 3 to 5 days, it takes 2 to 4 weeks to achieve therapeutic effect. A. 1 to 2 hours is the peak time, not the time to therapeutic effect. B, D. These timeframes are incorrect.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed niacin. The nurse understands that niacin is only recommended in specific clinical situations, such as:",
        "options": {
            "A": "LDL levels greater than 100 mg/dL.",
            "B": "Triglyceride levels over 500 mg/dL.",
            "C": "When the client is already taking a statin.",
            "D": "To increase HDL levels as a primary goal."
        },
        "correctAnswer": "B",
        "rationale": "B. Niacin is only recommended in specific clinical situations such as triglyceride levels over 500 mg/dL or if intolerant to other treatment. A. While niacin reduces LDL, its use is restricted due to side effects. C. Niacin is not typically recommended simply because a client is on a statin; it's for specific severe hypertriglyceridemia or intolerance. D. While niacin does have a desirable effect on the lipid profile, including HDL, its use is limited by side effects and reserved for specific conditions.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's medication history and notes a prescription for simvastatin and ezetimibe. The nurse understands that this combination drug is used for which purpose?",
        "options": {
            "A": "To treat hypertension and hypercholesterolemia.",
            "B": "To decrease blood clotting and improve peripheral blood flow.",
            "C": "To enhance the antihyperlipidemic effect for hypercholesterolemia and hyperlipoproteinemia.",
            "D": "To primarily reduce triglycerides and VLDL."
        },
        "correctAnswer": "C",
        "rationale": "C. Simvastatin and ezetimibe is a combination drug used for hypercholesterolemia and hyperlipoproteinemia, combining the effects of a statin and a cholesterol absorption inhibitor for optimum antihyperlipidemic effect. A. Atorvastatin and amlodipine is a combination for hypertension and hypercholesterolemia. B. This combination does not primarily target blood clotting or peripheral blood flow. D. While both components affect lipids, this combination is not primarily for triglyceride and VLDL reduction; fibrates are more effective for that.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed pentoxifylline. The nurse advises the client to take the medication with food to minimize which common side effects?",
        "options": {
            "A": "Blurred vision and confusion.",
            "B": "Tachycardia and hypotension.",
            "C": "Nausea and vomiting.",
            "D": "Muscle pain and weakness."
        },
        "correctAnswer": "C",
        "rationale": "C. The most common side effects of pentoxifylline are nausea and vomiting, and the drug should be taken with food to help alleviate these GI disturbances. A, B. These are overdose reactions or less common side effects, not the primary reason for taking with food. D. Muscle pain and weakness are associated with statins (rhabdomyolysis), not pentoxifylline.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse emphasizes that dietary modifications and exercise are still crucial because:",
        "options": {
            "A": "Statins are only effective if combined with strict dietary adherence.",
            "B": "Diet and exercise alone can completely cure hyperlipidemia.",
            "C": "Statins are adjuncts to, not substitutes for, lifestyle changes.",
            "D": "The body develops tolerance to statins, requiring lifestyle changes to maintain effects."
        },
        "correctAnswer": "C",
        "rationale": "C. It must be emphasized to the patient that dietary changes need to be made and an exercise program followed, even after drug therapy is initiated, as antihyperlipidemics are adjuncts to, not substitutes for, a low-fat diet and healthy lifestyle. A. While adherence is important, statins have their own mechanism of action. B. Hyperlipidemia is typically a chronic condition requiring ongoing management, not a 'cure.' D. The text does not mention tolerance development to statins.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is teaching a client about the different types of lipoproteins. The nurse explains that VLDL primarily carries which type of lipid?",
        "options": {
            "A": "Cholesterol.",
            "B": "Phospholipids.",
            "C": "Triglycerides.",
            "D": "Fatty acids."
        },
        "correctAnswer": "C",
        "rationale": "C. VLDL (very-low-density lipoprotein) carries mostly triglycerides and less cholesterol. A. LDL carries most cholesterol. B. Phospholipids are a type of lipid. D. Fatty acids are transported by chylomicrons to the liver.",
        "type": "mc"
    },
    {
        "questionText": "A client with a history of hyperlipidemia is advised to choose lean meats. Which types of meat are specifically recommended in the nonpharmacologic management of cholesterol reduction?",
        "options": {
            "A": "Beef and pork.",
            "B": "Lamb and veal.",
            "C": "Chicken and fish.",
            "D": "Processed meats and cold cuts."
        },
        "correctAnswer": "C",
        "rationale": "C. Patients should choose lean meats, especially chicken and fish, as part of nonpharmacologic methods for cholesterol reduction. A, B, D. These options generally contain higher levels of saturated fats and cholesterol, which should be reduced.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed rosuvastatin. The nurse understands that this medication is effective for lowering which lipid levels?",
        "options": {
            "A": "Primarily VLDL and triglycerides.",
            "B": "Mainly HDL and chylomicrons.",
            "C": "LDL, VLDL, and triglycerides, with a slight increase in HDL.",
            "D": "Only dietary cholesterol absorption."
        },
        "correctAnswer": "C",
        "rationale": "C. Rosuvastatin, like other statins, inhibits HMG-CoA reductase, decreasing cholesterol synthesis. This results in decreased cholesterol, decreased LDL, decreased VLDL, and decreased triglycerides, with a slight increase in HDL cholesterol. A. Fibrates primarily target VLDL and triglycerides. B. This is incorrect. D. This is the mechanism of ezetimibe.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is assessing a client for potential signs of inadequate blood flow to the extremities. Which assessment finding would be a primary indicator?",
        "options": {
            "A": "Warm and flushed skin.",
            "B": "Strong pedal pulses.",
            "C": "Pallor and coolness of the extremities.",
            "D": "Absence of pain at rest."
        },
        "correctAnswer": "C",
        "rationale": "C. Pallor and coolness of the extremities are direct signs of inadequate blood flow to the extremities, characteristic of peripheral arterial disease (PAD). A. Warm and flushed skin indicates good blood flow. B. Strong pedal pulses indicate adequate arterial perfusion. D. Absence of pain at rest, while present in claudication, does not directly indicate inadequate blood flow as much as pallor and coolness.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed cholestyramine. The nurse advises the client that early signs of a potential peptic ulcer, a side effect of this medication, include:",
        "options": {
            "A": "Increased appetite and weight gain.",
            "B": "Nausea and abdominal discomfort.",
            "C": "Diarrhea and dehydration.",
            "D": "Headache and dizziness."
        },
        "correctAnswer": "B",
        "rationale": "B. Early signs of peptic ulcer with cholestyramine are nausea and abdominal discomfort, followed later by abdominal pain and distension. A, C, D. These are not specific early signs of peptic ulcer related to cholestyramine.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is teaching a client about the 'bad' lipoprotein. The nurse explains that this lipoprotein is primarily responsible for depositing cholesterol in the arteries, leading to atherosclerosis. Which lipoprotein is the nurse describing?",
        "options": {
            "A": "HDL.",
            "B": "VLDL.",
            "C": "LDL.",
            "D": "Chylomicrons."
        },
        "correctAnswer": "C",
        "rationale": "C. LDL, the 'bad' lipoprotein, contains 50% to 60% of cholesterol in the bloodstream. With an elevated LDL, the risk is greater for developing atherosclerotic plaques and heart disease because it deposits cholesterol in the arteries. A. HDL removes cholesterol. B. VLDL carries triglycerides. D. Chylomicrons transport fatty acids and cholesterol to the liver.",
        "type": "mc"
    },
    {
        "questionText": "A 72-year-old client is diagnosed with hyperlipidemia type IV. The nurse anticipates the healthcare provider will primarily prescribe which medication for this client?",
        "options": {
            "A": "Cholestyramine.",
            "B": "Lovastatin.",
            "C": "Gemfibrozil.",
            "D": "Ezetimibe."
        },
        "correctAnswer": "C",
        "rationale": "C. Gemfibrozil is a fibric acid derivative that is more effective for reducing triglyceride and VLDL levels and is primarily used for hyperlipidemia type IV. A. Cholestyramine is a bile-acid sequestrant effective for hyperlipidemia type II. B. Lovastatin is a statin primarily for lowering LDL (hyperlipidemia type II). D. Ezetimibe is a cholesterol absorption inhibitor used for hypercholesterolemia, often combined with a statin.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is educating a client about the role of high-density lipoprotein (HDL). The nurse explains that HDL is considered 'good' cholesterol because it:",
        "options": {
            "A": "Transports fatty acids and cholesterol to the liver.",
            "B": "Contains 50% to 60% of the cholesterol in the bloodstream.",
            "C": "Removes cholesterol from the bloodstream and delivers it to the liver for excretion.",
            "D": "Is primarily composed of triglycerides."
        },
        "correctAnswer": "C",
        "rationale": "C. The function of HDL is to remove cholesterol from the bloodstream and deliver it to the liver for excretion in bile, hence its 'good' designation. A. Chylomicrons transport fatty acids and cholesterol to the liver. B. LDL contains 50% to 60% of cholesterol in the bloodstream. D. VLDL is primarily composed of triglycerides.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse emphasizes the importance of promptly reporting which symptoms to the healthcare provider due to the potential for serious adverse effects? (Select all that apply.)",
        "options": {
            "A": "Unexplained muscle tenderness.",
            "B": "Malaise.",
            "C": "Fever.",
            "D": "Headache.",
            "E": "Mild dyspepsia."
        },
        "correctAnswer": ["A", "B", "C"],
        "rationale": "A, B, C. Patients should be advised to promptly report to the healthcare provider any unexplained muscle tenderness or weakness, especially if accompanied by fever or malaise, as these can indicate rhabdomyolysis. D. Headache and E. Mild dyspepsia are common early complaints or side effects that typically do not require immediate notification unless severe or persistent.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is reviewing a client's fasting lipid profile. The nurse recognizes that a low-risk LDL level is within which range?",
        "options": {
            "A": "<100 mg/dL.",
            "B": "100-130 mg/dL.",
            "C": "130-159 mg/dL.",
            "D": ">160 mg/dL."
        },
        "correctAnswer": "B",
        "rationale": "B. According to Table 44.1, a low-risk LDL level is 100-130 mg/dL. A. <100 mg/dL is desirable. C. 130-159 mg/dL is moderate risk. D. >160 mg/dL is high risk.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed colesevelam. The nurse recognizes that this medication is a bile acid sequestrant. Which common side effects of older bile acid sequestrants are less likely to occur with colesevelam? (Select all that apply.)",
        "options": {
            "A": "Constipation.",
            "B": "Flatulence.",
            "C": "Cramping.",
            "D": "Headache.",
            "E": "Hypoglycemia."
        },
        "correctAnswer": ["A", "B", "C"],
        "rationale": "A, B, C. Colesevelam is an agent that has fewer side effects (less constipation, flatulence, and cramping) compared to older bile acid sequestrants like cholestyramine and colestipol. D. Headache and E. Hypoglycemia are listed as potential side effects of colesevelam, but not necessarily less likely than with older agents.",
        "type": "sata"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is prescribed cilostazol. The nurse should advise the client that the effectiveness of this medication in increasing blood flow by vasodilation is questionable in the presence of:",
        "options": {
            "A": "Raynaud disease.",
            "B": "Vasospasm.",
            "C": "Arteriosclerosis.",
            "D": "Diabetes mellitus."
        },
        "correctAnswer": "C",
        "rationale": "C. The effectiveness of peripheral vasodilators in increasing blood flow by vasodilation is questionable in the presence of arteriosclerosis. A, B. Peripheral vasodilators are more effective for disorders that result from vasospasm, such as Raynaud disease. D. While diabetes mellitus is a risk factor for PAD, it does not directly question the effectiveness of cilostazol's vasodilatory action in the same way as established arteriosclerosis.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is teaching a client about modifiable risk factors for coronary artery disease (CAD). Which risk factor should the nurse emphasize as directly increasing LDL cholesterol and decreasing HDL?",
        "options": {
            "A": "Sedentary lifestyle.",
            "B": "High dietary saturated fats.",
            "C": "Smoking.",
            "D": "Obesity."
        },
        "correctAnswer": "C",
        "rationale": "C. Smoking is a risk factor that should be eliminated as it increases LDL cholesterol and decreases HDL. A, B, D. While sedentary lifestyle, high dietary saturated fats, and obesity are risk factors for CAD and hyperlipidemia, smoking is specifically noted for its direct impact on LDL and HDL levels as described.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin. The nurse understands that despite its effectiveness in lowering cholesterol, niacin's usefulness is often limited by which factors? (Select all that apply.)",
        "options": {
            "A": "Requires very low doses for therapeutic effect.",
            "B": "Numerous side effects.",
            "C": "Large doses are required.",
            "D": "Only recommended for triglyceride levels below 200 mg/dL.",
            "E": "Poor patient tolerance."
        },
        "correctAnswer": ["B", "C", "E"],
        "rationale": "B, C, E. Niacin has numerous side effects and large doses are required, leading to poor patient tolerance; as few as 20% of patients can initially tolerate it. A. Niacin requires large doses, not very low doses. D. Niacin is only recommended in specific clinical situations such as triglyceride levels over 500 mg/dL, not below 200 mg/dL.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is reviewing a client's medication list. Which medication is classified as a hemorrheologic agent or blood viscosity reducer agent?",
        "options": {
            "A": "Cilostazol.",
            "B": "Atorvastatin.",
            "C": "Pentoxifylline.",
            "D": "Gemfibrozil."
        },
        "correctAnswer": "C",
        "rationale": "C. Pentoxifylline is classified as a hemorrheologic agent or blood viscosity reducer agent, improving microcirculation by decreasing blood viscosity and improving erythrocyte flexibility. A. Cilostazol is a direct-acting vasodilator and antiplatelet. B. Atorvastatin is an HMG-CoA reductase inhibitor (statin). D. Gemfibrozil is a fibric acid derivative.",
        "type": "mc"
    },
    {
        "questionText": "A client is taking lovastatin. The nurse should instruct the client that this medication is typically taken with which meal?",
        "options": {
            "A": "Breakfast.",
            "B": "Lunch.",
            "C": "Evening meal.",
            "D": "Any meal, as long as it's consistent."
        },
        "correctAnswer": "C",
        "rationale": "C. Lovastatin (immediate release) is typically prescribed to be taken with the evening meal. This timing is often chosen for statins to coincide with the peak of cholesterol synthesis, which occurs during the night.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a bile-acid sequestrant. The nurse understands that this drug class works by:",
        "options": {
            "A": "Inhibiting cholesterol synthesis in the liver.",
            "B": "Blocking cholesterol absorption in the small intestine.",
            "C": "Binding with bile acids in the intestine to reduce LDL cholesterol.",
            "D": "Reducing triglyceride and VLDL levels."
        },
        "correctAnswer": "C",
        "rationale": "C. Bile-acid sequestrants like cholestyramine reduce LDL cholesterol (LDL-C) levels by binding with bile acids in the intestine, preventing their reabsorption and increasing their excretion. A. This is the mechanism of statins. B. This is the mechanism of cholesterol absorption inhibitors like ezetimibe. D. This is primarily the action of fibrates.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's laboratory results. A high-sensitivity C-reactive protein (hsCRP) level of 4 mg/L indicates which level of risk for cardiovascular disease?",
        "options": {
            "A": "Low risk.",
            "B": "Moderate risk.",
            "C": "High risk.",
            "D": "No risk."
        },
        "correctAnswer": "C",
        "rationale": "C. According to the provided information, an hsCRP level greater than 3 mg/L indicates high risk for cardiovascular disease. A. Low risk is less than 1 mg/L. B. Moderate risk is 1 to 3 mg/L.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed cilostazol. The nurse should instruct the client to take this medication at which times relative to meals?",
        "options": {
            "A": "With meals.",
            "B": "30 minutes before or 2 hours after morning and evening meals.",
            "C": "On an empty stomach at bedtime.",
            "D": "Anytime, as long as it's consistent."
        },
        "correctAnswer": "B",
        "rationale": "B. Cilostazol is prescribed to be taken 30 minutes before or 2 hours after morning and evening meals with a full glass of water. A, C, D. These instructions are incorrect for cilostazol administration.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is teaching a client about the importance of apolipoproteins. The nurse explains that ApoB-100 is a better indicator of coronary artery disease (CAD) risk than LDL alone because it includes components from:",
        "options": {
            "A": "HDL only.",
            "B": "Chylomicrons only.",
            "C": "VLDL as well as LDL.",
            "D": "Phospholipids and triglycerides."
        },
        "correctAnswer": "C",
        "rationale": "C. ApoB-100 has VLDL as well as LDL and is a better indicator of risk for CAD than LDL alone because it represents the total number of atherogenic particles. A. ApoA-1 is the major component of HDL. B. Chylomicrons are composed mostly of triglycerides. D. Phospholipids are a type of lipid, not a lipoprotein component.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse understands that the reduction of LDL cholesterol may be seen as early as how long after initiating therapy?",
        "options": {
            "A": "Within 24 hours.",
            "B": "As early as 2 weeks.",
            "C": "After 1 to 2 months.",
            "D": "Not until 6 months of therapy."
        },
        "correctAnswer": "B",
        "rationale": "B. Reduction of LDL cholesterol with statins may be seen as early as 2 weeks after initiating therapy. A, C, D. These timeframes are incorrect for the initial reduction of LDL.",
        "type": "mc"
    },
    {
        "questionText": "A client taking pentoxifylline should be advised to avoid which substance due to its vasoconstrictive effects?",
        "options": {
            "A": "Alcohol.",
            "B": "Caffeine.",
            "C": "Nicotine (smoking).",
            "D": "Grapefruit juice."
        },
        "correctAnswer": "C",
        "rationale": "C. The patient should avoid smoking because nicotine increases vasoconstriction, which would counteract the therapeutic effects of pentoxifylline. A. Alcohol with vasodilators may cause hypotensive reactions, but nicotine is specifically mentioned for vasoconstriction. B, D. Caffeine and grapefruit juice are not specifically mentioned as interactions for pentoxifylline in the provided text.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing patient teaching for a client prescribed gemfibrozil. Which statement indicates the client understands the medication's administration instructions?",
        "options": {
            "A": "I should take this medication with my largest meal of the day.",
            "B": "I need to take this medication 30 minutes before my morning and evening meals.",
            "C": "I can take this medication anytime, as long as it's consistent.",
            "D": "I should take this medication on an empty stomach at bedtime."
        },
        "correctAnswer": "B",
        "rationale": "B. Gemfibrozil is prescribed as 600 mg twice daily 30 minutes before morning and evening meals. A, C, D. These instructions are incorrect for gemfibrozil administration.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed atorvastatin. The nurse understands that this medication is highly protein bound at what percentage?",
        "options": {
            "A": "50%.",
            "B": "75%.",
            "C": "90%.",
            "D": "98%."
        },
        "correctAnswer": "D",
        "rationale": "D. Atorvastatin is highly protein bound at 98%, which contributes to its once-daily dosing. A, B, C. These percentages are incorrect for atorvastatin's protein binding.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is educating a client about nonpharmacologic methods of cholesterol reduction. Which dietary recommendations should the nurse include? (Select all that apply.)",
        "options": {
            "A": "Limit total fat intake to 30% or less of caloric intake.",
            "B": "Reduce saturated fats and cholesterol in the diet.",
            "C": "Increase cholesterol intake to 500 mg/day.",
            "D": "Read labels on containers and buy appropriate foods.",
            "E": "Choose lean meats, especially chicken and fish."
        },
        "correctAnswer": ["A", "B", "D", "E"],
        "rationale": "A. Total fat intake should be 30% or less of caloric intake. B. Saturated fats and cholesterol in the diet should be reduced. D. Patients should be advised to read labels on containers and buy appropriate foods. E. Patients should choose lean meats, especially chicken and fish. C. Cholesterol intake should be 300 mg/day or less, not increased to 500 mg/day.",
        "type": "sata"
    },
    {
        "questionText": "A client asks the nurse about the mechanism of action of statin drugs. The nurse explains that statins work by:",
        "options": {
            "A": "Binding with bile acids in the intestine.",
            "B": "Inhibiting the enzyme HMG-CoA reductase in cholesterol biosynthesis.",
            "C": "Inhibiting cholesterol absorption in the small intestine.",
            "D": "Decreasing blood viscosity and improving erythrocyte flexibility."
        },
        "correctAnswer": "B",
        "rationale": "B. The statin drugs inhibit the enzyme HMG-CoA reductase in cholesterol biosynthesis, thus decreasing the concentration of cholesterol in the liver. A. This is the mechanism of bile-acid sequestrants. C. This is the mechanism of cholesterol absorption inhibitors like ezetimibe. D. This is the mechanism of pentoxifylline.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is prescribed clopidogrel. The nurse understands that this medication is used to:",
        "options": {
            "A": "Dilate peripheral vessels directly.",
            "B": "Decrease blood viscosity.",
            "C": "Decrease PAD symptoms by its antiplatelet effect.",
            "D": "Reduce cholesterol synthesis."
        },
        "correctAnswer": "C",
        "rationale": "C. The antiplatelet drugs clopidogrel and aspirin have been used to decrease PAD symptoms. A. Direct vasodilation is the action of drugs like cilostazol. B. Decreasing blood viscosity is the action of pentoxifylline. D. Reducing cholesterol synthesis is the action of statins.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin. The nurse should advise the client that which side effects are common with this medication? (Select all that apply.)",
        "options": {
            "A": "Flushing of the skin.",
            "B": "Abnormal liver function (elevated serum liver enzymes).",
            "C": "Hyperglycemia.",
            "D": "Hypotension.",
            "E": "Hyperuricemia."
        },
        "correctAnswer": ["A", "B", "C", "D", "E"],
        "rationale": "A, B, C, D, E. The many side effects of niacin include GI disturbances (nausea, vomiting, diarrhea), flushing of the skin, abnormal liver function (elevated serum liver enzymes), hyperglycemia, hyperuricemia, and hypotension (with large doses). All options are listed side effects.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is reviewing a client's medical history. The nurse recognizes that which condition is a contraindication for statin drugs?",
        "options": {
            "A": "History of well-controlled diabetes mellitus.",
            "B": "Chronic stable angina.",
            "C": "Acute hepatic disorders.",
            "D": "Mild hypertension."
        },
        "correctAnswer": "C",
        "rationale": "C. Patients with acute hepatic disorders should not take a statin drug. A, B, D. These conditions are not contraindications for statin use; statins may even be beneficial for cardiovascular risk reduction in these populations.",
        "type": "mc"
    },
    {
        "questionText": "A client with intermittent claudication is considering taking Ginkgo biloba. The nurse should caution the client about taking this herbal supplement with which class of medications due to potential interactions?",
        "options": {
            "A": "Statins.",
            "B": "Antiplatelet drugs.",
            "C": "Bile-acid sequestrants.",
            "D": "Fibrates."
        },
        "correctAnswer": "B",
        "rationale": "B. Ginkgo biloba, taken with an antiplatelet drug, has been used to treat intermittent claudication, but it can prolong bleeding time. Therefore, caution is needed when combined with antiplatelet drugs. A. Ginkgo biloba may increase drug levels of statins, which is also an interaction, but the question specifically asks about its use for intermittent claudication with antiplatelets. C, D. No specific interactions with bile-acid sequestrants or fibrates are mentioned for Ginkgo biloba in this context.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed cholestyramine. The nurse should instruct the client that constipation, a common side effect, can be alleviated by:",
        "options": {
            "A": "Taking the medication on an empty stomach.",
            "B": "Increasing intake of fluids and foods high in fiber.",
            "C": "Limiting fluid intake to reduce stool bulk.",
            "D": "Taking a stool softener daily without consulting the provider."
        },
        "correctAnswer": "B",
        "rationale": "B. Constipation, a common side effect of cholestyramine, can be decreased or alleviated by increasing intake of fluids and foods high in fiber. A. Taking on an empty stomach might worsen GI discomfort. C. Limiting fluid intake would worsen constipation. D. While stool softeners might be used, the primary non-pharmacological interventions are fluid and fiber, and a client should consult their provider before adding new medications.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is explaining the difference between LDL and VLDL. The nurse correctly states that VLDL primarily carries:",
        "options": {
            "A": "Cholesterol.",
            "B": "Triglycerides.",
            "C": "Phospholipids.",
            "D": "Apolipoproteins."
        },
        "correctAnswer": "B",
        "rationale": "B. VLDL (very-low-density lipoprotein) carries mostly triglycerides and less cholesterol. A. LDL carries 50% to 60% of cholesterol. C. Phospholipids are a type of lipid. D. Apolipoproteins are within the lipoprotein shell.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse understands that this medication has a half-life of approximately:",
        "options": {
            "A": "1-2 hours.",
            "B": "14 hours.",
            "C": "22 hours.",
            "D": "30-50 hours."
        },
        "correctAnswer": "B",
        "rationale": "B. Atorvastatin has a half-life of 14 hours. A. 1-2 hours is the peak time. C. Ezetimibe has a half-life of 22 hours. D. Amlodipine has a half-life of 30-50 hours.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing discharge teaching to a client with hyperlipidemia. The nurse emphasizes that antihyperlipidemic therapy is often a lifetime commitment because:",
        "options": {
            "A": "The body develops a tolerance to the medication over time.",
            "B": "Abruptly stopping statin drugs can cause a serious rebound effect leading to AMI.",
            "C": "Dietary and exercise changes are ineffective without continuous medication.",
            "D": "The medication cures the underlying hyperlipidemia."
        },
        "correctAnswer": "B",
        "rationale": "B. Abruptly stopping the statin drug could cause a threefold rebound effect that may cause death from acute myocardial infarction (AMI), making it a lifetime commitment for maintaining a decrease in serum lipid levels. A. The text does not support the development of tolerance. C. Dietary and exercise changes are crucial adjuncts to medication, not ineffective without it. D. The medication manages, but does not cure, hyperlipidemia.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed ezetimibe in combination with simvastatin. The nurse explains that this combination aims to:",
        "options": {
            "A": "Reduce blood pressure and cholesterol.",
            "B": "Increase HDL and decrease triglycerides.",
            "C": "Optimize the antihyperlipidemic effect by inhibiting both cholesterol synthesis and absorption.",
            "D": "Improve peripheral blood flow and reduce platelet aggregation."
        },
        "correctAnswer": "C",
        "rationale": "C. Ezetimibe is a cholesterol absorption inhibitor, and simvastatin is a statin (HMG-CoA reductase inhibitor). Combining them provides an optimum antihyperlipidemic effect by inhibiting both cholesterol absorption from the intestine and cholesterol synthesis in the liver. A. This describes atorvastatin and amlodipine. B. While these drugs affect HDL and triglycerides, the primary benefit of this combination is comprehensive cholesterol reduction. D. This describes cilostazol.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's laboratory results. Which serum lipid value indicates a desirable level of HDL?",
        "options": {
            "A": "<35 mg/dL.",
            "B": "35-50 mg/dL.",
            "C": "50-60 mg/dL.",
            "D": ">60 mg/dL."
        },
        "correctAnswer": "D",
        "rationale": "D. According to Table 44.1, a desirable HDL level is >60 mg/dL. A. <35 mg/dL is high risk. B. 35-50 mg/dL is moderate risk. C. 50-60 mg/dL is low risk.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) asks the nurse about the primary cause of their condition. The nurse explains that PAD is primarily caused by:",
        "options": {
            "A": "Venous insufficiency.",
            "B": "Vasospasm.",
            "C": "Arteriosclerosis and hyperlipidemia leading to atherosclerosis.",
            "D": "Deep vein thrombosis."
        },
        "correctAnswer": "C",
        "rationale": "C. The primary cause of peripheral arterial disease (PAD) is arteriosclerosis and hyperlipidemia, resulting in atherosclerosis, after which the arteries become occluded. A. Venous insufficiency affects veins, not arteries. B. Vasospasm is a cause of conditions like Raynaud disease, but arteriosclerosis is the primary cause of PAD. D. Deep vein thrombosis affects veins.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin. The nurse advises the client that the flushing experienced with this medication should:",
        "options": {
            "A": "Worsen over time.",
            "B": "Decrease with continued use of the drug.",
            "C": "Require immediate discontinuation of the medication.",
            "D": "Indicate a severe allergic reaction."
        },
        "correctAnswer": "B",
        "rationale": "B. Flushing is common with niacin but should decrease with continued use of the drug, especially when started at a low dose and titrated carefully. A. Flushing should not worsen. C, D. Flushing is a common side effect, not typically an indication for immediate discontinuation or a severe allergic reaction.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is preparing to administer cholestyramine powder. To avoid gastrointestinal discomfort, the nurse should ensure the drug is taken:",
        "options": {
            "A": "On an empty stomach.",
            "B": "With a small amount of water only.",
            "C": "With and followed by sufficient fluids.",
            "D": "Mixed with carbonated beverages."
        },
        "correctAnswer": "C",
        "rationale": "C. To avoid GI discomfort, cholestyramine must be taken with and followed by sufficient fluids. A. Taking on an empty stomach might increase discomfort. B. A small amount of water may not be sufficient. D. Carbonated beverages are not recommended for mixing.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse emphasizes the importance of monitoring for a slight transient increase in which laboratory values, which may be within normal range but require rechecking?",
        "options": {
            "A": "Blood glucose levels.",
            "B": "Serum liver enzyme levels.",
            "C": "Serum creatinine levels.",
            "D": "Homocysteine levels."
        },
        "correctAnswer": "B",
        "rationale": "B. A slight transient increase in serum liver enzyme levels (ALP, ALT, GGT) may be within normal range for the patient, but it should be rechecked in 1 week or so. A. Blood glucose can be affected by some antihyperlipidemics (e.g., niacin), but liver enzymes are specifically mentioned for statins. C, D. These are not specifically mentioned as 'slight transient increases' that are rechecked in this context for statins.",
        "type": "mc"
    },
    {
        "questionText": "A client with intermittent claudication is prescribed pentoxifylline. The nurse explains that this medication improves microcirculation and tissue perfusion by:",
        "options": {
            "A": "Directly dilating peripheral arteries.",
            "B": "Inhibiting platelet aggregation.",
            "C": "Decreasing blood viscosity and improving erythrocyte flexibility.",
            "D": "Reducing cholesterol synthesis in the liver."
        },
        "correctAnswer": "C",
        "rationale": "C. Pentoxifylline improves microcirculation and tissue perfusion by decreasing blood viscosity and improving the flexibility of erythrocytes, thus increasing tissue oxygenation. A. This is the action of direct-acting vasodilators. B. This is an action of cilostazol. D. This is the action of statins.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing patient teaching about peripheral vasodilators. The nurse includes information that these drugs are more effective for disorders that result from vasospasm, such as:",
        "options": {
            "A": "Arteriosclerosis obliterans.",
            "B": "Thromboangiitis obliterans (Buerger disease).",
            "C": "Raynaud disease.",
            "D": "Severe arterial occlusions."
        },
        "correctAnswer": "C",
        "rationale": "C. Peripheral vasodilators are more effective for disorders that result from vasospasm (Raynaud disease) than from vessel occlusion or arteriosclerosis. A, B, D. These conditions involve vessel occlusion or arteriosclerosis, where vasodilators have limited effectiveness.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed fenofibrate. The nurse understands that this medication is highly protein bound. Therefore, the nurse should be vigilant for interactions if the client is also taking:",
        "options": {
            "A": "Digoxin.",
            "B": "Warfarin.",
            "C": "Phenytoin.",
            "D": "Propranolol."
        },
        "correctAnswer": "B",
        "rationale": "B. Fenofibrate is highly protein bound. If taken with warfarin, bleeding might occur because they compete for protein binding sites, increasing the effect of warfarin. A, C, D. While other drug interactions exist for statins, warfarin is specifically mentioned for fenofibrate due to protein binding competition.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. Which finding would indicate a high risk for coronary artery disease (CAD)?",
        "options": {
            "A": "Total cholesterol of 180 mg/dL.",
            "B": "LDL of 90 mg/dL.",
            "C": "HDL of 65 mg/dL.",
            "D": "Triglycerides of 210 mg/dL."
        },
        "correctAnswer": "D",
        "rationale": "D. According to Table 44.1, a triglyceride level >190 mg/dL indicates high risk for CAD. A. Total cholesterol of 180 mg/dL is desirable. B. LDL of 90 mg/dL is desirable. C. HDL of 65 mg/dL is desirable.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed atorvastatin. The nurse advises the client that this medication may be taken:",
        "options": {
            "A": "Only with food.",
            "B": "Only on an empty stomach.",
            "C": "Without regard to meals.",
            "D": "Only at bedtime."
        },
        "correctAnswer": "C",
        "rationale": "C. Atorvastatin may be taken without regard to meals. A, B, D. These instructions are incorrect for atorvastatin administration.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is teaching a client about the importance of exercise in cholesterol reduction. The nurse emphasizes that for older adults, appropriate exercise can include: (Select all that apply.)",
        "options": {
            "A": "High-intensity interval training.",
            "B": "Walking.",
            "C": "Bicycling.",
            "D": "Heavy weightlifting.",
            "E": "Competitive sports."
        },
        "correctAnswer": ["B", "C"],
        "rationale": "B, C. For the older adult, exercise can be walking and bicycling. A, D, E. High-intensity interval training, heavy weightlifting, and competitive sports may not be appropriate or safe for all older adults, especially those with pre-existing conditions.",
        "type": "sata"
    },
    {
        "questionText": "A client is prescribed colestipol. The nurse understands that this medication is a bile acid sequestrant similar to cholestyramine. Which adverse effects are common with this drug? (Select all that apply.)",
        "options": {
            "A": "Nausea.",
            "B": "Vomiting.",
            "C": "Diarrhea.",
            "D": "Constipation.",
            "E": "Peptic ulcer."
        },
        "correctAnswer": ["A", "B", "C", "D", "E"],
        "rationale": "A, B, C, D, E. Colestipol may cause nausea, vomiting, diarrhea, constipation, cholelithiasis, peptic ulcer, and GI bleeding. All options are listed as common adverse effects.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is reviewing the function of different lipoproteins. Which lipoprotein is described as the 'bad' lipoprotein, containing 50% to 60% of cholesterol in the bloodstream, and associated with increased risk for atherosclerotic plaques?",
        "options": {
            "A": "High-density lipoprotein (HDL).",
            "B": "Very-low-density lipoprotein (VLDL).",
            "C": "Low-density lipoprotein (LDL).",
            "D": "Chylomicrons."
        },
        "correctAnswer": "C",
        "rationale": "C. LDL, the 'bad' lipoprotein, contains 50% to 60% of cholesterol in the bloodstream. With an elevated LDL, the risk is greater for developing atherosclerotic plaques and heart disease. A. HDL is 'good.' B. VLDL carries triglycerides. D. Chylomicrons transport fatty acids and cholesterol.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed cilostazol. The nurse understands that this medication has a dual purpose of inhibiting platelet aggregation and causing:",
        "options": {
            "A": "Vasoconstriction.",
            "B": "Vasodilation.",
            "C": "Increased blood viscosity.",
            "D": "Increased cholesterol synthesis."
        },
        "correctAnswer": "B",
        "rationale": "B. Cilostazol is an antiplatelet drug that has a dual purpose of inhibiting platelet aggregation as well as causing vasodilation to treat intermittent claudication. A. Vasoconstriction is the opposite of its action. C. It does not increase blood viscosity. D. It does not affect cholesterol synthesis.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that this drug class has been useful in decreasing coronary artery disease (CAD) and reducing:",
        "options": {
            "A": "Blood pressure.",
            "B": "Blood clotting time.",
            "C": "Mortality rates.",
            "D": "The need for dietary modifications."
        },
        "correctAnswer": "C",
        "rationale": "C. The statin group has been useful in decreasing CAD and reducing mortality rates. A. While some statin combinations can affect blood pressure, it's not a primary direct effect of statins alone. B. Statins do not primarily affect blood clotting time. D. Dietary modifications are still necessary adjuncts to statin therapy.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the mechanism of action of pentoxifylline. The nurse understands that this drug works by improving the flexibility of which blood cells?",
        "options": {
            "A": "Leukocytes.",
            "B": "Platelets.",
            "C": "Erythrocytes.",
            "D": "Lymphocytes."
        },
        "correctAnswer": "C",
        "rationale": "C. Pentoxifylline improves microcirculation and tissue perfusion by decreasing blood viscosity and improving the flexibility of erythrocytes (red blood cells). A, B, D. Leukocytes, platelets, and lymphocytes are other blood components, but not the primary ones whose flexibility is improved by pentoxifylline.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse advises the client that complementary therapies such as black cohosh may have which interaction?",
        "options": {
            "A": "Decrease drug levels of statins.",
            "B": "Potentiate an increase in liver enzymes.",
            "C": "Increase drug levels of statins.",
            "D": "Increase side effects of statins."
        },
        "correctAnswer": "B",
        "rationale": "B. Black cohosh may potentiate an increase in liver enzymes when taken with statins. A. St. John's wort decreases drug levels. C. Chinese skullcap and Ginkgo biloba may increase drug levels. D. Cranberry and green tea may increase side effects.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. A desirable triglyceride level is within which range?",
        "options": {
            "A": "<40 mg/dL.",
            "B": "40-150 mg/dL.",
            "C": "150-190 mg/dL.",
            "D": ">190 mg/dL."
        },
        "correctAnswer": "B",
        "rationale": "B. According to Table 44.1, a desirable triglyceride level is 40-150 mg/dL. A. This is too low. C. This is a higher range. D. >190 mg/dL is considered high risk.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is prescribed an antiplatelet drug. The nurse understands that which antiplatelet drug has been approved by the FDA specifically for treating intermittent claudication?",
        "options": {
            "A": "Aspirin.",
            "B": "Clopidogrel.",
            "C": "Cilostazol.",
            "D": "Warfarin."
        },
        "correctAnswer": "C",
        "rationale": "C. Cilostazol is an antiplatelet drug that has been approved by the US Food and Drug Administration (FDA) for treating intermittent claudication. A, B. Aspirin and clopidogrel are antiplatelet drugs used to decrease PAD symptoms, but cilostazol is specifically mentioned as FDA-approved for intermittent claudication. D. Warfarin is an anticoagulant, not an antiplatelet.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin. The nurse should advise the client that large doses of niacin can cause which cardiovascular side effect?",
        "options": {
            "A": "Bradycardia.",
            "B": "Hypertension.",
            "C": "Vasodilation leading to dizziness and faintness.",
            "D": "Myocardial infarction."
        },
        "correctAnswer": "C",
        "rationale": "C. Large doses of niacin can cause vasodilation and produce dizziness and faintness (syncope). A, B. Bradycardia and hypertension are not typical cardiovascular side effects of niacin. D. Myocardial infarction is not a direct side effect of niacin, though rebound AMI can occur if statins are abruptly stopped.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the major categories of lipoproteins. Which category is described as containing more protein and less fat, and removes cholesterol from the bloodstream?",
        "options": {
            "A": "LDL.",
            "B": "VLDL.",
            "C": "HDL.",
            "D": "Chylomicrons."
        },
        "correctAnswer": "C",
        "rationale": "C. HDL, also known as 'friendly' or 'good' lipoprotein, is the smallest and densest lipoprotein, meaning that it contains more protein and less fat than the others. Its function is to remove cholesterol from the bloodstream and deliver it to the liver for excretion in bile.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed colesevelam. The nurse understands that this medication has less effect on the absorption of which type of vitamins compared to older bile-acid sequestrants?",
        "options": {
            "A": "Water-soluble vitamins.",
            "B": "Fat-soluble vitamins.",
            "C": "B vitamins.",
            "D": "Vitamin C."
        },
        "correctAnswer": "B",
        "rationale": "B. Colesevelam has less effect on the absorption of fat-soluble vitamins than the older agents (cholestyramine, colestipol). A, C, D. These are incorrect.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing education to a client about hyperlipidemia. The nurse explains that when there is an excess of one or more lipids in the blood, the condition is known as:",
        "options": {
            "A": "Hypolipidemia.",
            "B": "Normolipidemia.",
            "C": "Hyperlipidemia or hyperlipoproteinemia.",
            "D": "Alipidemia."
        },
        "correctAnswer": "C",
        "rationale": "C. When there is an excess of one or more lipids in the blood, the condition is known as hyperlipidemia or hyperlipoproteinemia. A, B, D. These terms describe low, normal, or absence of lipids, respectively.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse should advise the client that the full therapeutic effect of this medication is typically achieved in:",
        "options": {
            "A": "3 to 5 days.",
            "B": "1 to 2 weeks.",
            "C": "2 to 4 weeks.",
            "D": "6 to 8 weeks."
        },
        "correctAnswer": "C",
        "rationale": "C. It takes 2 to 4 weeks to achieve the full therapeutic effect of atorvastatin, although positive lipid-lowering effects may be seen in 3 to 5 days. A, B, D. These timeframes are incorrect for the full therapeutic effect.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the reference values for homocysteine. A fasting homocysteine level of 20 mmol/L would indicate:",
        "options": {
            "A": "A desirable level.",
            "B": "A low risk for cardiovascular disease.",
            "C": "A high level linked to cardiovascular disease.",
            "D": "No clinical significance."
        },
        "correctAnswer": "C",
        "rationale": "C. Reference values for homocysteine are 4 to 17 mmol/L (fasting). A level of 20 mmol/L is high and has been linked to cardiovascular disease, stroke, and Alzheimer disease. A, B, D. These options are incorrect for a level of 20 mmol/L.",
        "type": "mc"
    },
    {
        "questionText": "A client with hypercholesterolemia is prescribed simvastatin. The nurse understands that this medication is typically taken at which time of day?",
        "options": {
            "A": "In the morning with breakfast.",
            "B": "At lunchtime.",
            "C": "In the evening (at hs).",
            "D": "Anytime, as long as it's consistent."
        },
        "correctAnswer": "C",
        "rationale": "C. Simvastatin is typically prescribed to be taken in the evening (at hs) to align with the body's natural cholesterol synthesis cycle. A, B, D. These times are not optimal for simvastatin administration.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing education on the importance of regular exercise for cholesterol reduction. The nurse explains that exercise is important because it can:",
        "options": {
            "A": "Increase LDL cholesterol.",
            "B": "Decrease HDL cholesterol.",
            "C": "Reduce cholesterol and increase HDL.",
            "D": "Directly lower endogenous cholesterol production."
        },
        "correctAnswer": "C",
        "rationale": "C. Exercise is an important aspect of the nonpharmacologic method to reduce cholesterol and increase HDL. A, B. Exercise has the opposite effect on LDL and HDL. D. While exercise contributes to overall lipid health, it doesn't directly lower endogenous cholesterol production in the same way statins do.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed cholestyramine. The nurse should be aware of which potential gastrointestinal side effects? (Select all that apply.)",
        "options": {
            "A": "Anorexia.",
            "B": "Nausea.",
            "C": "Vomiting.",
            "D": "Diarrhea.",
            "E": "Constipation."
        },
        "correctAnswer": ["A", "B", "C", "D", "E"],
        "rationale": "A, B, C, D, E. Cholestyramine may cause anorexia, nausea, vomiting, diarrhea, constipation, steatorrhea, abdominal pain, eructation, flatulence, osteoporosis, peptic ulcer, and GI bleeding. All listed options are common GI side effects.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is reviewing a client's medication list for peripheral arterial disease (PAD). Which medication is classified as an angiotensin-converting enzyme (ACE) inhibitor that can improve both PAD symptoms and hypertension?",
        "options": {
            "A": "Prazosin.",
            "B": "Nifedipine.",
            "C": "Ramipril.",
            "D": "Cilostazol."
        },
        "correctAnswer": "C",
        "rationale": "C. Patients with PAD who are hypertensive see improvement for both conditions when taking the antihypertensive drug ramipril, an angiotensin-converting enzyme (ACE) inhibitor. A. Prazosin is an alpha blocker. B. Nifedipine is a calcium channel blocker. D. Cilostazol is an antiplatelet and vasodilator.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse advises the client that complementary therapies such as Chinese skullcap may have which interaction?",
        "options": {
            "A": "Decrease drug levels of statins.",
            "B": "Potentiate an increase in liver enzymes.",
            "C": "Increase drug levels of rosuvastatin.",
            "D": "Increase side effects of statins."
        },
        "correctAnswer": "C",
        "rationale": "C. Chinese skullcap may increase drug levels of rosuvastatin. A. St. John's wort decreases drug levels. B. Black cohosh may potentiate an increase in liver enzymes. D. Cranberry and green tea may increase side effects.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. Which LDL level is considered desirable?",
        "options": {
            "A": "<100 mg/dL.",
            "B": "100-130 mg/dL.",
            "C": "130-159 mg/dL.",
            "D": ">160 mg/dL."
        },
        "correctAnswer": "A",
        "rationale": "A. According to Table 44.1, a desirable LDL level is <100 mg/dL. B. 100-130 mg/dL is low risk. C. 130-159 mg/dL is moderate risk. D. >160 mg/dL is high risk.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is prescribed pentoxifylline. The nurse explains that this medication inhibits aggregation of platelets and red blood cells, and because it decreases blood viscosity, it helps increase flow through:",
        "options": {
            "A": "Large arteries.",
            "B": "Peripheral vessels.",
            "C": "Veins only.",
            "D": "Coronary arteries only."
        },
        "correctAnswer": "B",
        "rationale": "B. Pentoxifylline inhibits aggregation of platelets and red blood cells, and because it decreases blood viscosity, it helps increase flow through peripheral vessels. A, C, D. While it affects circulation generally, its specific benefit is highlighted for peripheral vessels.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing education to a client about the importance of reading food labels for cholesterol reduction. The nurse advises that cholesterol intake should be what amount per day or less?",
        "options": {
            "A": "100 mg.",
            "B": "200 mg.",
            "C": "300 mg.",
            "D": "400 mg."
        },
        "correctAnswer": "C",
        "rationale": "C. Cholesterol intake should be 300 mg/day or less as part of nonpharmacologic methods of cholesterol reduction. A, B, D. These amounts are incorrect according to the guidelines.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that the primary mechanism of action of statins is to:",
        "options": {
            "A": "Increase the excretion of bile acids.",
            "B": "Inhibit cholesterol synthesis in the liver.",
            "C": "Block cholesterol absorption in the small intestine.",
            "D": "Increase the breakdown of triglycerides."
        },
        "correctAnswer": "B",
        "rationale": "B. The statin drugs inhibit the enzyme HMG-CoA reductase in cholesterol biosynthesis, thereby inhibiting cholesterol synthesis in the liver. A. This is the mechanism of bile-acid sequestrants. C. This is the mechanism of ezetimibe. D. While statins affect triglycerides, their primary mechanism is cholesterol synthesis inhibition.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed cilostazol. The nurse should caution the client about taking which herbal supplement, as it may prolong bleeding time?",
        "options": {
            "A": "St. John's wort.",
            "B": "Black cohosh.",
            "C": "Ginger.",
            "D": "Licorice."
        },
        "correctAnswer": "C",
        "rationale": "C. Ginger may prolong bleeding time when taken with cilostazol. A. St. John's wort decreases cilostazol effect. B. Black cohosh is not listed as an interaction for cilostazol. D. Licorice may cause hypokalemia.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's medical history for risk factors of peripheral arterial disease (PAD). Which condition increases a client's likelihood of having PAD by two to four times the usual rate?",
        "options": {
            "A": "Hypertension.",
            "B": "Hyperlipidemia.",
            "C": "Diabetes mellitus.",
            "D": "Smoking."
        },
        "correctAnswer": "C",
        "rationale": "C. Patients with diabetes mellitus are more likely to have PAD by two to four times the usual rate and are at risk of intermittent claudication. A, B, D. While hypertension, hyperlipidemia, and smoking are risk factors for PAD, diabetes mellitus is specifically noted for increasing the likelihood by this magnitude.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed colesevelam. The nurse understands that this medication is usually the first-choice bile-acid sequestrant drug due to:",
        "options": {
            "A": "Its superior efficacy in lowering VLDL.",
            "B": "Fewer side effects and less impact on fat-soluble vitamin absorption.",
            "C": "Its ability to be taken without regard to meals.",
            "D": "Its effectiveness against hyperlipidemia type IV."
        },
        "correctAnswer": "B",
        "rationale": "B. Colesevelam is usually the first-choice bile-acid sequestrant drug because it has fewer side effects (less constipation, flatulence, and cramping) and less effect on the absorption of fat-soluble vitamins than the older agents. A. Fibrates are more effective for VLDL. C. The text does not specify meal timing as a primary advantage. D. Bile-acid sequestrants are effective for type II, not type IV.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's medication list. Which medication is a combination of an antihypertensive and an antihyperlipidemic?",
        "options": {
            "A": "Ezetimibe and simvastatin.",
            "B": "Amlodipine and atorvastatin.",
            "C": "Fenofibrate and warfarin.",
            "D": "Niacin and aspirin."
        },
        "correctAnswer": "B",
        "rationale": "B. Amlodipine and atorvastatin is a combination drug that includes amlodipine (an antihypertensive) and atorvastatin (an antihyperlipidemic). A. Ezetimibe and simvastatin is a combination of two antihyperlipidemics. C. Fenofibrate and warfarin are two separate drugs with a known interaction. D. Niacin and aspirin are two separate drugs, with aspirin used to manage niacin side effects.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse advises the client that complementary therapies such as cranberry may have which interaction?",
        "options": {
            "A": "Decrease drug levels of statins.",
            "B": "Potentiate an increase in liver enzymes.",
            "C": "Increase drug levels of statins.",
            "D": "Increase side effects of simvastatin."
        },
        "correctAnswer": "D",
        "rationale": "D. Cranberry may increase side effects of simvastatin. A. St. John's wort decreases drug levels. B. Black cohosh may potentiate an increase in liver enzymes. C. Chinese skullcap and Ginkgo biloba may increase drug levels.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's laboratory results. A high-sensitivity C-reactive protein (hsCRP) level of 2 mg/L indicates which level of risk for cardiovascular disease?",
        "options": {
            "A": "Low risk.",
            "B": "Moderate risk.",
            "C": "High risk.",
            "D": "No risk."
        },
        "correctAnswer": "B",
        "rationale": "B. According to the provided information, an hsCRP level of 1 to 3 mg/L indicates moderate risk for cardiovascular disease. A. Low risk is less than 1 mg/L. C. High risk is greater than 3 mg/L.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed pentoxifylline. The nurse should advise the client that if they are also taking an antihypertensive drug, their dosage may need to be adjusted to avoid:",
        "options": {
            "A": "Hypertensive crisis.",
            "B": "Hypotensive reactions.",
            "C": "Increased blood viscosity.",
            "D": "Decreased erythrocyte flexibility."
        },
        "correctAnswer": "B",
        "rationale": "B. Patients taking an antihypertensive drug along with pentoxifylline may need to have the antihypertensive dosage decreased to avoid side effects, specifically hypotensive reactions. A. It would lead to hypotension, not hypertension. C, D. These are related to the mechanism of pentoxifylline, not a drug interaction with antihypertensives.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is explaining the difference between lipids. The nurse correctly states that cholesterol, triglycerides, and phospholipids are bound in the inner shell of which carrier that transports lipids in the bloodstream?",
        "options": {
            "A": "Albumin.",
            "B": "Globulin.",
            "C": "Protein.",
            "D": "Hemoglobin."
        },
        "correctAnswer": "C",
        "rationale": "C. Lipidscholesterol, triglycerides, and phospholipidsare bound in the inner shell of protein, a carrier that transports lipids in the bloodstream. A, B, D. While these are proteins or blood components, 'protein' is the general term used in the text for the carrier.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse should caution the client that which food should be avoided as it could cause an increase in drug concentration?",
        "options": {
            "A": "Orange juice.",
            "B": "Apple juice.",
            "C": "Grapefruit juice.",
            "D": "Cranberry juice."
        },
        "correctAnswer": "C",
        "rationale": "C. Grapefruit juice should be avoided when taking atorvastatin as it could cause an increase in drug concentration. A, B, D. These juices are not specifically mentioned as interacting with atorvastatin.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. A desirable total cholesterol level is:",
        "options": {
            "A": "Less than 100 mg/dL.",
            "B": "150-200 mg/dL.",
            "C": "200-240 mg/dL.",
            "D": "Greater than 240 mg/dL."
        },
        "correctAnswer": "B",
        "rationale": "B. According to Table 44.1, a desirable total cholesterol level is 150-200 mg/dL. A. Less than 100 mg/dL is desirable for LDL. C. 200-240 mg/dL is moderate risk. D. Greater than 240 mg/dL is high risk.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that if antihyperlipidemic therapy is withdrawn, cholesterol and LDL levels will:",
        "options": {
            "A": "Remain at the desired levels.",
            "B": "Return to pretreatment levels.",
            "C": "Decrease further.",
            "D": "Be unaffected."
        },
        "correctAnswer": "B",
        "rationale": "B. If antihyperlipidemic therapy is withdrawn, cholesterol and LDL levels return to pretreatment levels. A, C, D. These are incorrect outcomes.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is assessing a client for peripheral arterial disease (PAD). Which symptom is characterized by pain and weakness of a limb when walking but no symptoms at rest?",
        "options": {
            "A": "Paresthesia.",
            "B": "Claudication.",
            "C": "Rest pain.",
            "D": "Peripheral neuropathy."
        },
        "correctAnswer": "B",
        "rationale": "B. Claudication is characterized by pain and weakness of a limb when walking but no symptoms at rest. A. Paresthesia is a sensation of tingling or numbness. C. Rest pain is pain that occurs even at rest, indicating more severe PAD. D. Peripheral neuropathy is nerve damage.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin. The nurse should advise the client that which gastrointestinal side effects are common? (Select all that apply.)",
        "options": {
            "A": "Nausea.",
            "B": "Vomiting.",
            "C": "Diarrhea.",
            "D": "Constipation.",
            "E": "Abdominal pain."
        },
        "correctAnswer": ["A", "B", "C"],
        "rationale": "A, B, C. Niacin can cause GI disturbances including nausea, vomiting, and diarrhea. D. Constipation is more common with bile-acid sequestrants. E. Abdominal pain is a general GI symptom but not specifically highlighted as a primary common side effect of niacin in the same way as nausea, vomiting, and diarrhea.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is reviewing the major component of ApoA-1. The nurse understands that ApoA-1 is the major component of which lipoprotein?",
        "options": {
            "A": "LDL.",
            "B": "VLDL.",
            "C": "HDL.",
            "D": "Chylomicrons."
        },
        "correctAnswer": "C",
        "rationale": "C. The major component of apoA-1 is HDL. A, B, D. ApoB is the major component of LDL and VLDL; chylomicrons are mostly triglycerides.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse advises the client that complementary therapies such as Ginkgo biloba may have which interaction?",
        "options": {
            "A": "Decrease drug levels of statins.",
            "B": "Potentiate an increase in liver enzymes.",
            "C": "Increase drug levels of statins.",
            "D": "Increase side effects of statins."
        },
        "correctAnswer": "C",
        "rationale": "C. Ginkgo biloba may increase drug levels of statins. A. St. John's wort decreases drug levels. B. Black cohosh may potentiate an increase in liver enzymes. D. Cranberry and green tea may increase side effects.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. A total cholesterol level of 220 mg/dL is considered:",
        "options": {
            "A": "Desirable.",
            "B": "Low risk.",
            "C": "Moderate risk.",
            "D": "High risk."
        },
        "correctAnswer": "C",
        "rationale": "C. According to Table 44.1, a total cholesterol level of 200-240 mg/dL is considered moderate risk. A. Desirable is 150-200 mg/dL. B. Low risk is <200 mg/dL. D. High risk is >240 mg/dL.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed pentoxifylline. The nurse should advise the client that this medication is typically taken:",
        "options": {
            "A": "On an empty stomach.",
            "B": "With meals.",
            "C": "At bedtime.",
            "D": "Once daily."
        },
        "correctAnswer": "B",
        "rationale": "B. Pentoxifylline should be taken with food (400 mg tid with meals) to minimize gastrointestinal side effects like nausea and vomiting. A, C, D. These instructions are incorrect for pentoxifylline administration.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is explaining the difference between lipids and lipoproteins. The nurse correctly states that lipids are transported in the bloodstream bound to:",
        "options": {
            "A": "Water molecules.",
            "B": "Glucose.",
            "C": "Protein carriers.",
            "D": "Red blood cells."
        },
        "correctAnswer": "C",
        "rationale": "C. Lipidscholesterol, triglycerides, and phospholipidsare bound in the inner shell of protein, a carrier that transports lipids in the bloodstream. A, B, D. These are incorrect carriers.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse understands that this medication is effective for lowering which lipid levels? (Select all that apply.)",
        "options": {
            "A": "LDL.",
            "B": "Total cholesterol.",
            "C": "VLDL.",
            "D": "Triglycerides.",
            "E": "Slightly increasing HDL."
        },
        "correctAnswer": ["A", "B", "C", "D", "E"],
        "rationale": "A, B, C, D, E. Atorvastatin decreases LDL, total cholesterol, VLDL, and triglycerides, and slightly increases HDL cholesterol. All options are correct effects of atorvastatin.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. An HDL level of 40 mg/dL is considered:",
        "options": {
            "A": "Desirable.",
            "B": "Low risk.",
            "C": "Moderate risk.",
            "D": "High risk."
        },
        "correctAnswer": "C",
        "rationale": "C. According to Table 44.1, an HDL level of 35-50 mg/dL is considered moderate risk. A. Desirable is >60 mg/dL. B. Low risk is 50-60 mg/dL. D. High risk is <35 mg/dL.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is prescribed cilostazol. The nurse should advise the client that a desired therapeutic response may take how long?",
        "options": {
            "A": "A few days.",
            "B": "1 to 2 weeks.",
            "C": "1.5 to 3 months.",
            "D": "6 months to a year."
        },
        "correctAnswer": "C",
        "rationale": "C. Inform patients that a desired therapeutic response to cilostazol may take 1.5 to 3 months. A, B, D. These timeframes are incorrect for the desired therapeutic response.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing education about nonpharmacologic methods of cholesterol reduction. The nurse emphasizes that dietary modification alone typically lowers total cholesterol levels by only:",
        "options": {
            "A": "Less than 10%.",
            "B": "10% to 30%.",
            "C": "30% to 50%.",
            "D": "More than 50%."
        },
        "correctAnswer": "B",
        "rationale": "B. Dietary modification alone will typically lower total cholesterol levels by only 10% to 30% because 75% to 85% of serum cholesterol is endogenously derived. A, C, D. These percentages are incorrect.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed cholestyramine. The nurse should advise the client that early signs of peptic ulcer include nausea and abdominal discomfort, followed later by:",
        "options": {
            "A": "Increased appetite and weight gain.",
            "B": "Abdominal pain and distension.",
            "C": "Diarrhea and dehydration.",
            "D": "Headache and dizziness."
        },
        "correctAnswer": "B",
        "rationale": "B. Early signs of peptic ulcer with cholestyramine are nausea and abdominal discomfort, followed later by abdominal pain and distension. A, C, D. These are not specific later signs of peptic ulcer related to cholestyramine.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the different types of hyperlipidemia. Which type is described as being very common and characterized by increased VLDL, increased LDL, increased cholesterol, and triglycerides?",
        "options": {
            "A": "Type I.",
            "B": "Type IIA.",
            "C": "Type IIB.",
            "D": "Type IV."
        },
        "correctAnswer": "C",
        "rationale": "C. Hyperlipidemia Type IIB is described as very common and characterized by increased VLDL, increased LDL, increased cholesterol, and triglycerides. A. Type I is uncommon with increased chylomicrons and triglycerides. B. Type IIA is common with increased LDL and cholesterol. D. Type IV is very common with increased VLDL and markedly increased triglycerides.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse understands that this medication has a peak time after a dose of approximately:",
        "options": {
            "A": "Less than 1 hour.",
            "B": "1 to 2 hours.",
            "C": "3 to 5 days.",
            "D": "14 hours."
        },
        "correctAnswer": "B",
        "rationale": "B. The peak time after a dose of atorvastatin is 1 to 2 hours. A, C, D. These timeframes are incorrect for the peak time.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the reference values for high-sensitivity C-reactive protein (hsCRP). A low risk level is considered:",
        "options": {
            "A": "Less than 1 mg/L.",
            "B": "1 to 3 mg/L.",
            "C": "Greater than 3 mg/L.",
            "D": "Any level below 5 mg/L."
        },
        "correctAnswer": "A",
        "rationale": "A. High-sensitivity C-reactive protein (hsCRP) low risk is less than 1 mg/L. B. 1 to 3 mg/L is moderate risk. C. Greater than 3 mg/L is high risk.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed pentoxifylline. The nurse should advise the client that the most common side effects of this medication are:",
        "options": {
            "A": "Headache and dizziness.",
            "B": "Nausea and vomiting.",
            "C": "Muscle pain and weakness.",
            "D": "Flushing and itching."
        },
        "correctAnswer": "B",
        "rationale": "B. The most common side effects of pentoxifylline are nausea and vomiting. A. Headache and dizziness are common with cilostazol. C. Muscle pain and weakness are associated with statins. D. Flushing and itching are associated with niacin.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing patient teaching for a client taking cilostazol. The nurse advises the client to change position slowly but frequently to avoid which side effect?",
        "options": {
            "A": "Tachycardia.",
            "B": "Orthostatic hypotension.",
            "C": "Angina.",
            "D": "Peripheral edema."
        },
        "correctAnswer": "B",
        "rationale": "B. Encourage patients to change position slowly but frequently to avoid orthostatic hypotension, which is common when taking high doses of a vasodilator like cilostazol. A. Tachycardia is a side effect but not directly managed by slow position changes. C, D. Angina and peripheral edema are adverse effects but not directly related to orthostatic changes.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that statins are also known as:",
        "options": {
            "A": "Bile-acid sequestrants.",
            "B": "Fibrates.",
            "C": "HMG-CoA reductase inhibitors.",
            "D": "Cholesterol absorption inhibitors."
        },
        "correctAnswer": "C",
        "rationale": "C. Statins inhibit the enzyme HMG-CoA reductase in cholesterol biosynthesis; thus statins are called HMG-CoA reductase inhibitors. A. Cholestyramine is a bile-acid sequestrant. B. Gemfibrozil is a fibrate. D. Ezetimibe is a cholesterol absorption inhibitor.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the major component of ApoB. The nurse understands that ApoB is the major component of which lipoproteins? (Select all that apply.)",
        "options": {
            "A": "HDL.",
            "B": "LDL.",
            "C": "VLDL.",
            "D": "Chylomicrons.",
            "E": "Exists in two forms, apoB-100 and apoB-48."
        },
        "correctAnswer": ["B", "C", "E"],
        "rationale": "B, C, E. The major component of apoB is LDL, which exists in two forms, apoB-100 and apoB-48. ApoB-100 also has VLDL as well as LDL. A. ApoA-1 is the major component of HDL. D. Chylomicrons are mostly triglycerides.",
        "type": "sata"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that this medication primarily works by inhibiting cholesterol synthesis in which organ?",
        "options": {
            "A": "Small intestine.",
            "B": "Kidneys.",
            "C": "Liver.",
            "D": "Pancreas."
        },
        "correctAnswer": "C",
        "rationale": "C. Statins inhibit cholesterol synthesis in the liver by inhibiting the enzyme HMG-CoA reductase. A. Cholesterol absorption occurs in the small intestine. B, D. Kidneys and pancreas are not primary sites of cholesterol synthesis inhibition by statins.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is advised not to smoke. The nurse explains that smoking worsens PAD by:",
        "options": {
            "A": "Increasing HDL cholesterol.",
            "B": "Decreasing LDL cholesterol.",
            "C": "Increasing vasospasm.",
            "D": "Improving blood viscosity."
        },
        "correctAnswer": "C",
        "rationale": "C. Advise patients not to smoke because smoking increases vasospasm, which would worsen PAD symptoms. A, B. Smoking increases LDL and decreases HDL. D. Smoking does not improve blood viscosity; it generally has negative effects on blood flow.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's medication list. Which medication is a fibric acid derivative that is more effective for reducing triglyceride and VLDL levels?",
        "options": {
            "A": "Atorvastatin.",
            "B": "Cholestyramine.",
            "C": "Gemfibrozil.",
            "D": "Ezetimibe."
        },
        "correctAnswer": "C",
        "rationale": "C. Gemfibrozil is a fibric acid derivative that is more effective for reducing triglyceride and VLDL levels than for reducing LDL. A. Atorvastatin is a statin. B. Cholestyramine is a bile-acid sequestrant. D. Ezetimibe is a cholesterol absorption inhibitor.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin. The nurse understands that to increase patient tolerance and reduce side effects, which interventions can be implemented? (Select all that apply.)",
        "options": {
            "A": "Careful drug titration.",
            "B": "Concomitant use of aspirin.",
            "C": "Administering very high initial doses.",
            "D": "Taking the medication on an empty stomach.",
            "E": "Providing proper counseling."
        },
        "correctAnswer": ["A", "B", "E"],
        "rationale": "A, B, E. With proper counseling, careful drug titration, and concomitant use of aspirin, the number of patients who can tolerate niacin can be increased. C. Administering large doses initially contributes to poor tolerance. D. Niacin should be taken with meals to decrease GI discomfort.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is reviewing the different types of hyperlipidemia. Which type is described as being very common and characterized by increased VLDL and markedly increased triglycerides?",
        "options": {
            "A": "Type I.",
            "B": "Type IIA.",
            "C": "Type IIB.",
            "D": "Type IV."
        },
        "correctAnswer": "D",
        "rationale": "D. Hyperlipidemia Type IV is described as very common and characterized by increased VLDL and markedly increased triglycerides. A. Type I is uncommon with increased chylomicrons and triglycerides. B. Type IIA is common with increased LDL and cholesterol. C. Type IIB is very common with increased VLDL, LDL, cholesterol, and triglycerides.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that this medication decreases the concentration of cholesterol, decreases LDL, and slightly increases:",
        "options": {
            "A": "VLDL.",
            "B": "Triglycerides.",
            "C": "HDL.",
            "D": "Chylomicrons."
        },
        "correctAnswer": "C",
        "rationale": "C. By inhibiting cholesterol synthesis in the liver, statins decrease the concentration of cholesterol, decrease LDL, and slightly increase HDL cholesterol. A, B, D. Statins typically decrease VLDL and triglycerides, and do not directly increase chylomicrons.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's medication list. Which medication is a cholesterol absorption inhibitor that acts on cells in the small intestine?",
        "options": {
            "A": "Atorvastatin.",
            "B": "Cholestyramine.",
            "C": "Gemfibrozil.",
            "D": "Ezetimibe."
        },
        "correctAnswer": "D",
        "rationale": "D. Ezetimibe is a cholesterol absorption inhibitor that acts on the cells in the small intestine to inhibit cholesterol absorption. A. Atorvastatin is a statin. B. Cholestyramine is a bile-acid sequestrant. C. Gemfibrozil is a fibrate.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed cilostazol for intermittent claudication. The nurse advises the client that the medication should not be administered with which food or beverage?",
        "options": {
            "A": "Orange juice.",
            "B": "Milk.",
            "C": "Grapefruit juice.",
            "D": "Water."
        },
        "correctAnswer": "C",
        "rationale": "C. Cilostazol should not be administered with grapefruit juice, as it will increase drug levels. A, B, D. These are generally acceptable for administration.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. A triglyceride level of 160 mg/dL is considered:",
        "options": {
            "A": "Desirable.",
            "B": "Low risk.",
            "C": "Moderate risk.",
            "D": "High risk."
        },
        "correctAnswer": "C",
        "rationale": "C. According to Table 44.1, a triglyceride level >150 mg/dL (but not >190 mg/dL) would fall into the moderate risk category, as 'values vary with age' for moderate risk, but 160 mg/dL is above desirable and below high risk. A. Desirable is 40-150 mg/dL. D. High risk is >190 mg/dL.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that the beneficial effects of statins include decreasing CAD and reducing:",
        "options": {
            "A": "Blood pressure.",
            "B": "Mortality rates.",
            "C": "The need for exercise.",
            "D": "Dietary fat intake."
        },
        "correctAnswer": "B",
        "rationale": "B. The statin group has been useful in decreasing CAD and reducing mortality rates. A. While statins can be combined with antihypertensives, they don't directly reduce blood pressure as a primary action. C, D. Exercise and dietary fat intake remain crucial even with statin therapy.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the reference values for high-sensitivity C-reactive protein (hsCRP). A high risk level is considered:",
        "options": {
            "A": "Less than 1 mg/L.",
            "B": "1 to 3 mg/L.",
            "C": "Greater than 3 mg/L.",
            "D": "Any level above 1 mg/L."
        },
        "correctAnswer": "C",
        "rationale": "C. High-sensitivity C-reactive protein (hsCRP) high risk is greater than 3 mg/L. A. Less than 1 mg/L is low risk. B. 1 to 3 mg/L is moderate risk.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is prescribed pentoxifylline. The nurse explains that this medication is classified as a:",
        "options": {
            "A": "Direct-acting vasodilator.",
            "B": "Antiplatelet drug.",
            "C": "Hemorrheologic agent.",
            "D": "HMG-CoA reductase inhibitor."
        },
        "correctAnswer": "C",
        "rationale": "C. Pentoxifylline is classified as a hemorrheologic agent or blood viscosity reducer agent. A. Cilostazol is a direct-acting vasodilator. B. Cilostazol, aspirin, and clopidogrel are antiplatelet drugs. D. Statins are HMG-CoA reductase inhibitors.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing education about nonpharmacologic methods of cholesterol reduction. The nurse emphasizes that adherence to dietary restrictions is often short-lived, which explains why:",
        "options": {
            "A": "Dietary modification is not recommended.",
            "B": "Many patients do not respond to diet modification alone.",
            "C": "Pharmacologic therapy is always the first-line treatment.",
            "D": "Exercise is not an important aspect."
        },
        "correctAnswer": "B",
        "rationale": "B. Adherence to dietary restrictions is often short-lived, which explains why many patients do not respond to diet modification alone. A. Dietary modification is recommended as a first step. C. Nondrug therapy should be initiated before drugs are prescribed. D. Exercise is an important aspect of nonpharmacologic methods.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse understands that this medication is primarily excreted through which route?",
        "options": {
            "A": "Kidneys.",
            "B": "Lungs.",
            "C": "Primarily in feces.",
            "D": "Skin."
        },
        "correctAnswer": "C",
        "rationale": "C. Atorvastatin is primarily excreted in feces. A, B, D. These are incorrect excretion routes for atorvastatin.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. An LDL level of 145 mg/dL is considered:",
        "options": {
            "A": "Desirable.",
            "B": "Low risk.",
            "C": "Moderate risk.",
            "D": "High risk."
        },
        "correctAnswer": "C",
        "rationale": "C. According to Table 44.1, an LDL level of 130-159 mg/dL is considered moderate risk. A. Desirable is <100 mg/dL. B. Low risk is 100-130 mg/dL. D. High risk is >160 mg/dL.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed cilostazol. The nurse should advise the client to report which side effects? (Select all that apply.)",
        "options": {
            "A": "Flushing.",
            "B": "Headaches.",
            "C": "Dizziness.",
            "D": "Weight gain.",
            "E": "Increased appetite."
        },
        "correctAnswer": ["A", "B", "C"],
        "rationale": "A, B, C. Instruct patients to report side effects of cilostazol, such as flushing, headaches, and dizziness. D, E. Weight gain and increased appetite are not listed as common side effects of cilostazol.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is reviewing a client's medication list. Which medication is a direct-acting vasodilator that inhibits platelet aggregation?",
        "options": {
            "A": "Pentoxifylline.",
            "B": "Atorvastatin.",
            "C": "Cilostazol.",
            "D": "Gemfibrozil."
        },
        "correctAnswer": "C",
        "rationale": "C. Cilostazol is a direct-acting vasodilator that inhibits platelet aggregation. A. Pentoxifylline is a hemorrheologic agent. B. Atorvastatin is a statin. D. Gemfibrozil is a fibrate.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that this medication is effective for lowering LDL (hyperlipidemia type II) within several weeks. Which statin was the first one used for this purpose?",
        "options": {
            "A": "Atorvastatin.",
            "B": "Rosuvastatin.",
            "C": "Simvastatin.",
            "D": "Lovastatin."
        },
        "correctAnswer": "D",
        "rationale": "D. Lovastatin was the first statin used to decrease cholesterol and is effective for lowering LDL (hyperlipidemia type II) within several weeks. A, B, C. These are other statins, but not the first one introduced.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the different types of hyperlipidemia. Which type is described as being uncommon and characterized by increased chylomicrons and increased triglycerides?",
        "options": {
            "A": "Type I.",
            "B": "Type IIA.",
            "C": "Type IIB.",
            "D": "Type IV."
        },
        "correctAnswer": "A",
        "rationale": "A. Hyperlipidemia Type I is described as uncommon and characterized by increased chylomicrons and increased triglycerides. B. Type IIA is common. C. Type IIB is very common. D. Type IV is very common.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed ezetimibe. The nurse explains that this medication causes only a small increase in which lipoprotein?",
        "options": {
            "A": "LDL.",
            "B": "VLDL.",
            "C": "HDL.",
            "D": "Chylomicrons."
        },
        "correctAnswer": "C",
        "rationale": "C. Ezetimibe causes only a small increase in HDL. A, B, D. Ezetimibe decreases LDL, triglycerides, and apoB levels, but does not increase VLDL or chylomicrons.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing education to a client about peripheral arterial disease (PAD). The nurse explains that PAD is also called:",
        "options": {
            "A": "Coronary artery disease (CAD).",
            "B": "Peripheral vascular disease (PVD).",
            "C": "Deep vein thrombosis (DVT).",
            "D": "Raynaud disease."
        },
        "correctAnswer": "B",
        "rationale": "B. Peripheral arterial disease (PAD) is also called peripheral vascular disease (PVD). A. CAD affects coronary arteries. C. DVT affects veins. D. Raynaud disease is a specific vasospastic disorder.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that a serious skeletal muscle adverse effect, although rare, is:",
        "options": {
            "A": "Myasthenia gravis.",
            "B": "Muscular dystrophy.",
            "C": "Rhabdomyolysis.",
            "D": "Fibromyalgia."
        },
        "correctAnswer": "C",
        "rationale": "C. The serious skeletal muscle adverse effect, rhabdomyolysis, has been reported with use of the statin drug class, although it is rare. A, B, D. These are other muscle disorders not directly caused by statins.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the definition of hyperlipidemia. The nurse understands that this condition occurs when there is an excess of one or more of which substances in the blood? (Select all that apply.)",
        "options": {
            "A": "Cholesterol.",
            "B": "Triglycerides.",
            "C": "Phospholipids.",
            "D": "Glucose.",
            "E": "Proteins."
        },
        "correctAnswer": ["A", "B", "C"],
        "rationale": "A, B, C. Lipidscholesterol, triglycerides, and phospholipidsare bound in the inner shell of protein. When there is an excess of one or more lipids in the blood, the condition is known as hyperlipidemia or hyperlipoproteinemia. D, E. Glucose and proteins are not the lipids that, when in excess, define hyperlipidemia.",
        "type": "sata"
    },
    {
        "questionText": "A client is prescribed cilostazol. The nurse should instruct the client that this medication is highly protein bound at what percentage?",
        "options": {
            "A": "50%.",
            "B": "75%.",
            "C": "90%.",
            "D": "95% to 98%."
        },
        "correctAnswer": "D",
        "rationale": "D. Cilostazol is highly protein bound at 95% to 98%. A, B, C. These percentages are incorrect for cilostazol's protein binding.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the different types of hyperlipidemia. Which type is described as being common and characterized by increased low-density lipoprotein (LDL) and increased cholesterol?",
        "options": {
            "A": "Type I.",
            "B": "Type IIA.",
            "C": "Type IIB.",
            "D": "Type IV."
        },
        "correctAnswer": "B",
        "rationale": "B. Hyperlipidemia Type IIA is described as common and characterized by increased low-density lipoprotein (LDL) and increased cholesterol. A. Type I is uncommon. C. Type IIB is very common and includes VLDL. D. Type IV is very common and includes markedly increased triglycerides.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that the full therapeutic effect of statins may take how long to achieve?",
        "options": {
            "A": "As early as 2 weeks.",
            "B": "2 to 4 weeks.",
            "C": "6 to 8 weeks.",
            "D": "Several months."
        },
        "correctAnswer": "B",
        "rationale": "B. It takes 2 to 4 weeks to achieve the full therapeutic effect of statins, although reduction of LDL cholesterol may be seen as early as 2 weeks. A. This is when reduction may be seen, not full therapeutic effect. C, D. These timeframes are generally longer than the typical full therapeutic effect onset.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is explaining the difference between peripheral vasodilators and blood viscosity reducer agents. The nurse states that blood viscosity reducer agents primarily:",
        "options": {
            "A": "Dilate vessels that have been narrowed by vasospasm.",
            "B": "Decrease viscosity of blood and increase erythrocyte flexibility.",
            "C": "Inhibit platelet aggregation.",
            "D": "Lower blood lipid concentrations."
        },
        "correctAnswer": "B",
        "rationale": "B. Blood viscosity reducer agents, such as pentoxifylline, decrease viscosity of blood and increase erythrocyte flexibility. A. This describes peripheral vasodilators. C. This is an action of antiplatelet drugs like cilostazol. D. This describes antihyperlipidemics.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin. The nurse understands that this medication is actually very effective at lowering cholesterol levels, and its effect on the lipid profile is highly desirable, but its use is limited due to:",
        "options": {
            "A": "Its high cost.",
            "B": "Its short half-life requiring frequent dosing.",
            "C": "Numerous side effects and large doses required.",
            "D": "Its inability to affect LDL cholesterol."
        },
        "correctAnswer": "C",
        "rationale": "C. Niacin is very effective at lowering cholesterol, and its effect on the lipid profile is highly desirable. However, because it has numerous side effects and large doses are required, its usefulness is limited. A, B, D. These are not the primary reasons for its limited use as stated in the text.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. A desirable HDL level is:",
        "options": {
            "A": "Less than 35 mg/dL.",
            "B": "35-50 mg/dL.",
            "C": "50-60 mg/dL.",
            "D": "Greater than 60 mg/dL."
        },
        "correctAnswer": "D",
        "rationale": "D. According to Table 44.1, a desirable HDL level is >60 mg/dL. A. Less than 35 mg/dL is high risk. B. 35-50 mg/dL is moderate risk. C. 50-60 mg/dL is low risk.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse advises the client that complementary therapies such as green tea may have which interaction?",
        "options": {
            "A": "Decrease drug levels of statins.",
            "B": "Potentiate an increase in liver enzymes.",
            "C": "Increase drug levels of statins.",
            "D": "Increase side effects of statins."
        },
        "correctAnswer": "D",
        "rationale": "D. Green tea may increase side effects of statins. A. St. John's wort decreases drug levels. B. Black cohosh may potentiate an increase in liver enzymes. C. Chinese skullcap and Ginkgo biloba may increase drug levels.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. A total cholesterol level of 250 mg/dL is considered:",
        "options": {
            "A": "Desirable.",
            "B": "Low risk.",
            "C": "Moderate risk.",
            "D": "High risk."
        },
        "correctAnswer": "D",
        "rationale": "D. According to Table 44.1, a total cholesterol level >240 mg/dL is considered high risk. A. Desirable is 150-200 mg/dL. B. Low risk is <200 mg/dL. C. Moderate risk is 200-240 mg/dL.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is prescribed pentoxifylline. The nurse explains that this medication has been approved by the FDA for patients with:",
        "options": {
            "A": "Raynaud disease.",
            "B": "Buerger disease.",
            "C": "Intermittent claudication.",
            "D": "Arteriosclerosis obliterans."
        },
        "correctAnswer": "C",
        "rationale": "C. Pentoxifylline has been approved by the FDA for patients with intermittent claudication. B. It has also been prescribed for Buerger disease, but intermittent claudication is the primary FDA approval mentioned. A, D. While it affects peripheral circulation, these are not its specific FDA-approved indications mentioned.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is explaining the concept of apolipoproteins. The nurse states that apolipoproteins are found:",
        "options": {
            "A": "In the bloodstream as free proteins.",
            "B": "Within the lipoprotein shell.",
            "C": "Only in the liver.",
            "D": "Only in dietary fats."
        },
        "correctAnswer": "B",
        "rationale": "B. Apolipoproteins are within the lipoprotein shell and contain apolipoprotein (apo) A-1, B, and E. A, C, D. These are incorrect locations for apolipoproteins.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse understands that this medication is effective for lowering LDL (hyperlipidemia type II) within:",
        "options": {
            "A": "Several days.",
            "B": "Several weeks.",
            "C": "Several months.",
            "D": "A year."
        },
        "correctAnswer": "B",
        "rationale": "B. Lovastatin (a statin like atorvastatin) is effective for lowering LDL (hyperlipidemia type II) within several weeks. A, C, D. These timeframes are incorrect for the initial LDL lowering effect.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. An LDL level of 170 mg/dL is considered:",
        "options": {
            "A": "Desirable.",
            "B": "Low risk.",
            "C": "Moderate risk.",
            "D": "High risk."
        },
        "correctAnswer": "D",
        "rationale": "D. According to Table 44.1, an LDL level >160 mg/dL is considered high risk. A. Desirable is <100 mg/dL. B. Low risk is 100-130 mg/dL. C. Moderate risk is 130-159 mg/dL.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is prescribed cilostazol. The nurse explains that this medication decreases:",
        "options": {
            "A": "Arterial thrombi.",
            "B": "Venous thrombi.",
            "C": "Blood viscosity.",
            "D": "Cholesterol absorption."
        },
        "correctAnswer": "A",
        "rationale": "A. Cilostazol is an antiplatelet drug that decreases arterial thrombi. B. It does not primarily affect venous thrombi. C. Pentoxifylline decreases blood viscosity. D. Ezetimibe decreases cholesterol absorption.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is explaining the importance of a 12- to 14-hour fasting lipid profile. The nurse states that this test is ordered when:",
        "options": {
            "A": "Only cholesterol levels are high.",
            "B": "Triglyceride levels are high.",
            "C": "Cholesterol, triglycerides, and LDL are elevated.",
            "D": "HDL levels are low."
        },
        "correctAnswer": "C",
        "rationale": "C. If the levels are high (referring to cholesterol and triglycerides), a 12- to 14-hour fasting lipid profile may be ordered. When cholesterol, triglycerides, and LDL are elevated, the patient is at increased risk for CAD. A, B, D. While these individual findings are important, the fasting lipid profile is typically ordered for a comprehensive assessment when multiple lipid components are elevated or to confirm initial high readings.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin. The nurse understands that niacin is a form of which vitamin?",
        "options": {
            "A": "Vitamin B1.",
            "B": "Vitamin B2.",
            "C": "Vitamin B3.",
            "D": "Vitamin B6."
        },
        "correctAnswer": "C",
        "rationale": "C. Niacin is also known as vitamin B3. A, B, D. These are other B vitamins.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the different types of hyperlipidemia. Which two types are commonly associated with coronary artery disease (CAD)? (Select all that apply.)",
        "options": {
            "A": "Type I.",
            "B": "Type II.",
            "C": "Type III.",
            "D": "Type IV.",
            "E": "Type V."
        },
        "correctAnswer": ["B", "D"],
        "rationale": "B, D. Types II and IV hyperlipidemia are commonly associated with coronary artery disease. A, C, E. These types are less commonly associated with CAD according to the text.",
        "type": "sata"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse understands that this medication is contraindicated in which conditions? (Select all that apply.)",
        "options": {
            "A": "Hepatic disease.",
            "B": "Cholestasis.",
            "C": "Pregnancy.",
            "D": "Breastfeeding.",
            "E": "Alcohol use disorder."
        },
        "correctAnswer": ["A", "B", "C", "D"],
        "rationale": "A, B, C, D. Atorvastatin is contraindicated in hepatic disease/encephalopathy, cholestasis, pregnancy, and breastfeeding. E. Alcohol use disorder is a caution, not a contraindication.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is providing patient teaching for a client with hyperlipidemia. The nurse states that before drugs are prescribed, which type of therapy should be initiated?",
        "options": {
            "A": "Combination drug therapy.",
            "B": "High-dose statin therapy.",
            "C": "Nondrug therapy.",
            "D": "Surgical intervention."
        },
        "correctAnswer": "C",
        "rationale": "C. Before drugs to lower LDL and raise HDL are prescribed, nondrug therapy should be initiated to decrease cholesterol. A, B, D. These are not initial interventions.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) reports numbness and coolness of the extremities. The nurse understands that these symptoms are characteristic of:",
        "options": {
            "A": "Venous insufficiency.",
            "B": "Adequate blood flow.",
            "C": "Inadequate blood flow.",
            "D": "Neuropathic pain."
        },
        "correctAnswer": "C",
        "rationale": "C. Numbness and coolness of the extremities are characteristic of peripheral arterial disease (PAD), indicating inadequate blood flow. A. Venous insufficiency typically presents with warmth, edema, and hyperpigmentation. B. Adequate blood flow would result in warm, pink extremities. D. Neuropathic pain is a type of pain, not a direct indicator of blood flow.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's medication list. Which medication is a bile-acid sequestrant that comes in a gritty powder?",
        "options": {
            "A": "Colesevelam.",
            "B": "Colestipol.",
            "C": "Cholestyramine.",
            "D": "Ezetimibe."
        },
        "correctAnswer": "C",
        "rationale": "C. Cholestyramine is a bile-acid sequestrant that comes in a gritty powder that is mixed thoroughly in water or juice. A, B. Colesevelam and colestipol are also bile-acid sequestrants, but cholestyramine is specifically mentioned as a gritty powder. D. Ezetimibe is a tablet.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse understands that this medication can cause which early complaints? (Select all that apply.)",
        "options": {
            "A": "Gastrointestinal disturbances.",
            "B": "Headaches.",
            "C": "Muscle cramps.",
            "D": "Fatigue.",
            "E": "Rhabdomyolysis."
        },
        "correctAnswer": ["A", "B", "C", "D"],
        "rationale": "A, B, C, D. Gastrointestinal (GI) disturbances, headaches, muscle cramps, and fatigue are early complaints with statins. E. Rhabdomyolysis is a serious adverse reaction, not typically an 'early complaint' in the same category as the others, but a severe progression of muscle symptoms.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is explaining the purpose of a 12- to 14-hour fasting lipid profile. The nurse states that this test measures:",
        "options": {
            "A": "Blood glucose and hemoglobin A1C.",
            "B": "Serum cholesterol and triglyceride levels.",
            "C": "Blood pressure and heart rate.",
            "D": "Complete blood count and electrolytes."
        },
        "correctAnswer": "B",
        "rationale": "B. A 12- to 14-hour fasting lipid profile measures serum cholesterol and triglyceride levels, along with LDL and HDL. A, C, D. These are other diagnostic tests, not components of a fasting lipid profile.",
        "type": "mc"
    },
     {
        "questionText": "A 60-year-old client with a history of myocardial infarction is prescribed rosuvastatin. The nurse understands that this medication is highly effective at lowering which lipid levels? (Select all that apply.)",
        "options": {
            "A": "LDL cholesterol.",
            "B": "VLDL.",
            "C": "Triglycerides.",
            "D": "Slightly increasing HDL.",
            "E": "Chylomicrons."
        },
        "correctAnswer": ["A", "B", "C", "D"],
        "rationale": "A, B, C, D. Rosuvastatin is a statin that effectively lowers LDL, VLDL, and triglycerides, and slightly elevates HDL. E. While statins indirectly affect chylomicron metabolism by reducing VLDL, their primary direct effects are on LDL, VLDL, triglycerides, and HDL.",
        "type": "sata"
    },
    {
        "questionText": "A client is prescribed ezetimibe. The nurse explains that for optimum effect, this medication must be combined with a:",
        "options": {
            "A": "Fibrate.",
            "B": "Bile-acid sequestrant.",
            "C": "Statin.",
            "D": "Niacin preparation."
        },
        "correctAnswer": "C",
        "rationale": "C. Ezetimibe, a cholesterol absorption inhibitor, must be combined with a statin (e.g., simvastatin) for optimum effect. A, B, D. While other antihyperlipidemics, they are not the primary class recommended for combination with ezetimibe for optimal effect.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is preparing to administer cholestyramine. The client asks why it needs to be mixed well in fluid. The nurse explains that this is to prevent:",
        "options": {
            "A": "Increased absorption.",
            "B": "Gastrointestinal discomfort.",
            "C": "Rapid onset of action.",
            "D": "Drug precipitation in the bloodstream."
        },
        "correctAnswer": "B",
        "rationale": "B. Cholestyramine comes in a gritty powder that must be mixed thoroughly in water or juice to avoid GI discomfort. A. Mixing does not primarily increase absorption. C. It does not affect the onset of action in this way. D. Drug precipitation in the bloodstream is not a concern for an orally administered powder.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is experiencing claudication. The nurse understands that this symptom is characterized by:",
        "options": {
            "A": "Constant pain in the limb, even at rest.",
            "B": "Numbness and tingling sensations in the extremities.",
            "C": "Pain and weakness of a limb when walking, but no symptoms at rest.",
            "D": "Severe swelling and warmth in the affected limb."
        },
        "correctAnswer": "C",
        "rationale": "C. Claudication is characterized by pain and weakness of a limb when walking but no symptoms at rest. A. Constant pain at rest indicates a more severe stage of PAD. B. Numbness and tingling are paresthesias, which can occur but are not the definition of claudication. D. Swelling and warmth are more indicative of venous issues or inflammation, not typical claudication.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin. The nurse advises the client that taking this medication with meals can help to decrease which common side effect?",
        "options": {
            "A": "Flushing.",
            "B": "Hyperglycemia.",
            "C": "Gastrointestinal discomfort.",
            "D": "Hyperuricemia."
        },
        "correctAnswer": "C",
        "rationale": "C. Instruct patients to take nicotinic acid (niacin) with meals to decrease GI discomfort. A. Flushing can be reduced by aspirin, not by taking with meals. B, D. Hyperglycemia and hyperuricemia are metabolic side effects not directly alleviated by taking with meals.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's medication list and notes a prescription for simvastatin and ezetimibe. The nurse understands that this combination drug is used for:",
        "options": {
            "A": "Treating hypertension.",
            "B": "Reducing triglyceride levels only.",
            "C": "Hypercholesterolemia and hyperlipoproteinemia.",
            "D": "Improving blood viscosity."
        },
        "correctAnswer": "C",
        "rationale": "C. Ezetimibe and simvastatin is a combination drug used for hypercholesterolemia and hyperlipoproteinemia, combining a cholesterol absorption inhibitor and a statin for comprehensive lipid lowering. A. This combination does not primarily treat hypertension. B. While it affects triglycerides, its primary target is cholesterol and lipoproteins. D. Improving blood viscosity is the action of pentoxifylline.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is advised to reduce saturated fats in their diet. The nurse explains that saturated fats and cholesterol intake should be what amount per day or less?",
        "options": {
            "A": "100 mg.",
            "B": "200 mg.",
            "C": "300 mg.",
            "D": "400 mg."
        },
        "correctAnswer": "C",
        "rationale": "C. Cholesterol intake should be 300 mg/day or less, and saturated fats should be reduced as part of nonpharmacologic methods of cholesterol reduction. A, B, D. These amounts are incorrect according to the guidelines.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is explaining the role of very-low-density lipoprotein (VLDL) to a client. The nurse states that VLDL primarily carries:",
        "options": {
            "A": "Cholesterol.",
            "B": "Phospholipids.",
            "C": "Triglycerides.",
            "D": "Fatty acids."
        },
        "correctAnswer": "C",
        "rationale": "C. VLDL carries mostly triglycerides and less cholesterol. A. LDL carries most cholesterol. B. Phospholipids are a type of lipid. D. Fatty acids are transported by chylomicrons to the liver.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed cilostazol. The nurse should advise the client that the onset of action for this medication is typically observed within:",
        "options": {
            "A": "A few hours.",
            "B": "2 to 12 weeks.",
            "C": "1 to 2 days.",
            "D": "6 to 12 months."
        },
        "correctAnswer": "B",
        "rationale": "B. Cilostazol has an onset of action within 2 to 12 weeks. A, C, D. These timeframes are incorrect for the onset of action.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's laboratory results. An elevated homocysteine level has been linked to damage to the inner lining of blood vessels and promotion of:",
        "options": {
            "A": "Vasodilation.",
            "B": "Blood clotting.",
            "C": "Increased vessel flexibility.",
            "D": "Reduced inflammation."
        },
        "correctAnswer": "B",
        "rationale": "B. A high level of homocysteine has been linked to cardiovascular disease and may also promote blood clotting, and it has been stated that an increase in serum homocysteine can damage the inner lining of blood vessels and promote a thickening and loss of flexibility in the vessel. A, C, D. These are contrary to the effects of elevated homocysteine.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse understands that this medication is a HMG-CoA reductase inhibitor, meaning it works by:",
        "options": {
            "A": "Binding with bile acids in the intestine.",
            "B": "Inhibiting cholesterol absorption in the small intestine.",
            "C": "Inhibiting the enzyme necessary for hepatic production of cholesterol.",
            "D": "Decreasing blood viscosity and improving erythrocyte flexibility."
        },
        "correctAnswer": "C",
        "rationale": "C. Atorvastatin inhibits HMG-CoA reductase, the enzyme necessary for hepatic production of cholesterol. A. This is the mechanism of bile-acid sequestrants. B. This is the mechanism of cholesterol absorption inhibitors. D. This is the mechanism of pentoxifylline.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing patient teaching about peripheral vasodilators. The nurse includes information that these drugs are generally more effective for disorders that result from:",
        "options": {
            "A": "Vessel occlusion.",
            "B": "Arteriosclerosis.",
            "C": "Vasospasm.",
            "D": "Thromboangiitis obliterans."
        },
        "correctAnswer": "C",
        "rationale": "C. Peripheral vasodilators are more effective for disorders that result from vasospasm (Raynaud disease) than from vessel occlusion or arteriosclerosis. A, B, D. These conditions involve vessel occlusion or arteriosclerosis, where vasodilators have limited effectiveness.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse advises the client that complementary therapies such as St. John's wort may have which interaction?",
        "options": {
            "A": "Increase drug levels of statins.",
            "B": "Decrease effect and drug levels of statins.",
            "C": "Potentiate an increase in liver enzymes.",
            "D": "Increase side effects of statins."
        },
        "correctAnswer": "B",
        "rationale": "B. St. John's wort may decrease the effect and drug levels of statins. A. Chinese skullcap and Ginkgo biloba may increase drug levels. C. Black cohosh may potentiate an increase in liver enzymes. D. Cranberry and green tea may increase side effects.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. A triglyceride level of 200 mg/dL is considered:",
        "options": {
            "A": "Desirable.",
            "B": "Low risk.",
            "C": "Moderate risk.",
            "D": "High risk."
        },
        "correctAnswer": "D",
        "rationale": "D. According to Table 44.1, a triglyceride level >190 mg/dL is considered high risk. A. Desirable is 40-150 mg/dL. B. Low risk values vary with age. C. Moderate risk values vary with age.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed pentoxifylline. The nurse should advise the client that this medication is classified as a:",
        "options": {
            "A": "Direct-acting vasodilator.",
            "B": "Antiplatelet drug.",
            "C": "Blood viscosity reducer agent.",
            "D": "Cholesterol absorption inhibitor."
        },
        "correctAnswer": "C",
        "rationale": "C. Pentoxifylline is classified as a hemorrheologic agent or blood viscosity reducer agent. A. Cilostazol is a direct-acting vasodilator. B. Cilostazol is an antiplatelet. D. Ezetimibe is a cholesterol absorption inhibitor.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is explaining the difference between peripheral vasodilators and blood viscosity reducer agents. The nurse states that peripheral vasodilators primarily:",
        "options": {
            "A": "Decrease viscosity of blood.",
            "B": "Increase erythrocyte flexibility.",
            "C": "Dilate vessels that have been narrowed by vasospasm.",
            "D": "Lower blood lipid concentrations."
        },
        "correctAnswer": "C",
        "rationale": "C. Peripheral vasodilators dilate vessels that have been narrowed by vasospasm. A, B. These describe blood viscosity reducer agents. D. This describes antihyperlipidemics.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse emphasizes the importance of annual eye examinations due to the potential for:",
        "options": {
            "A": "Glaucoma.",
            "B": "Retinal detachment.",
            "C": "Cataract formation.",
            "D": "Macular degeneration."
        },
        "correctAnswer": "C",
        "rationale": "C. With all statins, an annual eye examination is needed because cataract formation may result. A, B, D. These are not specifically linked to statin use in the provided text.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin. The nurse understands that this medication is only recommended in specific clinical situations, such as:",
        "options": {
            "A": "LDL levels between 130-159 mg/dL.",
            "B": "Triglyceride levels over 500 mg/dL.",
            "C": "When the client has a history of mild hypertension.",
            "D": "To increase HDL levels as the sole therapeutic goal."
        },
        "correctAnswer": "B",
        "rationale": "B. Niacin is only recommended in specific clinical situations such as triglyceride levels over 500 mg/dL or if intolerant to other treatment. A, C, D. These are not the specific clinical situations for niacin's recommendation.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's medication list. Which medication is a cholesterol absorption inhibitor?",
        "options": {
            "A": "Cholestyramine.",
            "B": "Gemfibrozil.",
            "C": "Ezetimibe.",
            "D": "Atorvastatin."
        },
        "correctAnswer": "C",
        "rationale": "C. Ezetimibe is a cholesterol absorption inhibitor. A. Cholestyramine is a bile-acid sequestrant. B. Gemfibrozil is a fibrate. D. Atorvastatin is a statin.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that the reduction of LDL cholesterol may be seen as early as:",
        "options": {
            "A": "3 to 5 days.",
            "B": "2 weeks.",
            "C": "2 months.",
            "D": "6 months."
        },
        "correctAnswer": "B",
        "rationale": "B. Reduction of LDL cholesterol may be seen as early as 2 weeks after initiating statin therapy. A. 3 to 5 days is when the positive effect of lowering lipids is seen, not the reduction of LDL. C, D. These timeframes are too long for the initial reduction of LDL.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing patient teaching for a client with peripheral arterial disease (PAD). The nurse advises the client not to ingest alcohol with a vasodilator because it may cause:",
        "options": {
            "A": "Hypertensive crisis.",
            "B": "A hypotensive reaction.",
            "C": "Increased blood viscosity.",
            "D": "Increased platelet aggregation."
        },
        "correctAnswer": "B",
        "rationale": "B. Advise patients not to ingest alcohol with a vasodilator because it may cause a hypotensive reaction. A. It would cause hypotension, not hypertension. C, D. These are not direct effects of alcohol with vasodilators.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed fenofibrate. The nurse understands that this medication is a fibric acid derivative that is primarily effective for reducing:",
        "options": {
            "A": "LDL and total cholesterol.",
            "B": "Triglyceride and VLDL levels.",
            "C": "HDL and chylomicrons.",
            "D": "ApoB-100 and cholesterol absorption."
        },
        "correctAnswer": "B",
        "rationale": "B. Fenofibrate is a fibric acid derivative that has similar actions to gemfibrozil, which is more effective for reducing triglyceride and VLDL levels. A. Statins primarily reduce LDL and total cholesterol. C, D. These are incorrect primary targets for fibrates.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. A low-risk HDL level is within which range?",
        "options": {
            "A": "<35 mg/dL.",
            "B": "35-50 mg/dL.",
            "C": "50-60 mg/dL.",
            "D": ">60 mg/dL."
        },
        "correctAnswer": "C",
        "rationale": "C. According to Table 44.1, a low-risk HDL level is 50-60 mg/dL. A. <35 mg/dL is high risk. B. 35-50 mg/dL is moderate risk. D. >60 mg/dL is desirable.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that this medication primarily works by inhibiting cholesterol synthesis in the liver, which leads to a decrease in:",
        "options": {
            "A": "HDL.",
            "B": "ApoA-1.",
            "C": "LDL.",
            "D": "Homocysteine."
        },
        "correctAnswer": "C",
        "rationale": "C. By inhibiting cholesterol synthesis in the liver, statins decrease the concentration of cholesterol and decrease LDL. A. Statins slightly increase HDL. B. ApoA-1 is a component of HDL. D. Homocysteine is an amino acid, not directly affected by statin's primary mechanism.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is educating a client about the importance of apolipoproteins. The nurse explains that ApoA-1 is the major component of:",
        "options": {
            "A": "LDL.",
            "B": "VLDL.",
            "C": "HDL.",
            "D": "Chylomicrons."
        },
        "correctAnswer": "C",
        "rationale": "C. The major component of apoA-1 is HDL. A, B. ApoB is the major component of LDL and VLDL. D. Chylomicrons are composed mostly of triglycerides.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed cilostazol. The nurse should advise the client that common adverse effects of this medication include: (Select all that apply.)",
        "options": {
            "A": "Headache.",
            "B": "Diarrhea.",
            "C": "Abnormal stools.",
            "D": "Bradycardia.",
            "E": "Hypertension."
        },
        "correctAnswer": ["A", "B", "C"],
        "rationale": "A, B, C. Common adverse effects of cilostazol include headache, diarrhea, and abnormal stools. D. Tachycardia, not bradycardia, is a potential side effect. E. Hypotension, not hypertension, is a potential side effect.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is reviewing a client's medication list. Which medication is a combination of ezetimibe and a statin?",
        "options": {
            "A": "Amlodipine and atorvastatin.",
            "B": "Ezetimibe and simvastatin.",
            "C": "Niacin and aspirin.",
            "D": "Gemfibrozil and warfarin."
        },
        "correctAnswer": "B",
        "rationale": "B. Ezetimibe and simvastatin is a combination drug for hypercholesterolemia and hyperlipoproteinemia, combining a cholesterol absorption inhibitor (ezetimibe) and a statin (simvastatin). A. Amlodipine and atorvastatin is an antihypertensive and a statin. C. Niacin and aspirin are two separate drugs. D. Gemfibrozil and warfarin are two separate drugs with a known interaction.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse advises the client that complementary therapies such as cranberry may have which interaction?",
        "options": {
            "A": "Decrease drug levels of statins.",
            "B": "Potentiate an increase in liver enzymes.",
            "C": "Increase drug levels of statins.",
            "D": "Increase side effects of simvastatin."
        },
        "correctAnswer": "D",
        "rationale": "D. Cranberry may increase side effects of simvastatin. A. St. John's wort decreases drug levels. B. Black cohosh may potentiate an increase in liver enzymes. C. Chinese skullcap and Ginkgo biloba may increase drug levels.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. A moderate risk LDL level is within which range?",
        "options": {
            "A": "<100 mg/dL.",
            "B": "100-130 mg/dL.",
            "C": "130-159 mg/dL.",
            "D": ">160 mg/dL."
        },
        "correctAnswer": "C",
        "rationale": "C. According to Table 44.1, a moderate risk LDL level is 130-159 mg/dL. A. <100 mg/dL is desirable. B. 100-130 mg/dL is low risk. D. >160 mg/dL is high risk.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed pentoxifylline. The nurse explains that this medication improves microcirculation and tissue perfusion by:",
        "options": {
            "A": "Directly dilating peripheral arteries.",
            "B": "Inhibiting platelet aggregation.",
            "C": "Decreasing blood viscosity and improving erythrocyte flexibility.",
            "D": "Reducing cholesterol synthesis in the liver."
        },
        "correctAnswer": "C",
        "rationale": "C. Pentoxifylline improves microcirculation and tissue perfusion by decreasing blood viscosity and improving the flexibility of erythrocytes, thus increasing tissue oxygenation. A. This is the action of direct-acting vasodilators. B. This is an action of cilostazol. D. This is the action of statins.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing education about nonpharmacologic methods of cholesterol reduction. The nurse emphasizes that exercise is important because it can:",
        "options": {
            "A": "Increase LDL cholesterol.",
            "B": "Decrease HDL cholesterol.",
            "C": "Reduce cholesterol and increase HDL.",
            "D": "Directly lower endogenous cholesterol production."
        },
        "correctAnswer": "C",
        "rationale": "C. Exercise is an important aspect of the nonpharmacologic method to reduce cholesterol and increase HDL. A, B. Exercise has the opposite effect on LDL and HDL. D. While exercise contributes to overall lipid health, it doesn't directly lower endogenous cholesterol production in the same way statins do.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse understands that this medication is primarily metabolized in the liver and has a half-life of:",
        "options": {
            "A": "1-2 hours.",
            "B": "14-30 hours.",
            "C": "22 hours.",
            "D": "30-50 hours."
        },
        "correctAnswer": "B",
        "rationale": "B. Atorvastatin has a half-life of 14-30 hours. A. 1-2 hours is the peak time. C. Ezetimibe has a half-life of 22 hours. D. Amlodipine has a half-life of 30-50 hours.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. A desirable total cholesterol level is:",
        "options": {
            "A": "Less than 100 mg/dL.",
            "B": "150-200 mg/dL.",
            "C": "200-240 mg/dL.",
            "D": "Greater than 240 mg/dL."
        },
        "correctAnswer": "B",
        "rationale": "B. According to Table 44.1, a desirable total cholesterol level is 150-200 mg/dL. A. Less than 100 mg/dL is desirable for LDL. C. 200-240 mg/dL is moderate risk. D. Greater than 240 mg/dL is high risk.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that if antihyperlipidemic therapy is withdrawn, cholesterol and LDL levels will:",
        "options": {
            "A": "Remain at the desired levels.",
            "B": "Return to pretreatment levels.",
            "C": "Decrease further.",
            "D": "Be unaffected."
        },
        "correctAnswer": "B",
        "rationale": "B. If antihyperlipidemic therapy is withdrawn, cholesterol and LDL levels return to pretreatment levels. A, C, D. These are incorrect outcomes.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is assessing a client for peripheral arterial disease (PAD). Which symptom is characterized by pain and weakness of a limb when walking but no symptoms at rest?",
        "options": {
            "A": "Paresthesia.",
            "B": "Claudication.",
            "C": "Rest pain.",
            "D": "Peripheral neuropathy."
        },
        "correctAnswer": "B",
        "rationale": "B. Claudication is characterized by pain and weakness of a limb when walking but no symptoms at rest. A. Paresthesia is a sensation of tingling or numbness. C. Rest pain is pain that occurs even at rest, indicating more severe PAD. D. Peripheral neuropathy is nerve damage.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin. The nurse should advise the client that which gastrointestinal side effects are common? (Select all that apply.)",
        "options": {
            "A": "Nausea.",
            "B": "Vomiting.",
            "C": "Diarrhea.",
            "D": "Constipation.",
            "E": "Abdominal pain."
        },
        "correctAnswer": ["A", "B", "C"],
        "rationale": "A, B, C. Niacin can cause GI disturbances including nausea, vomiting, and diarrhea. D. Constipation is more common with bile-acid sequestrants. E. Abdominal pain is a general GI symptom but not specifically highlighted as a primary common side effect of niacin in the same way as nausea, vomiting, and diarrhea.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is reviewing the major component of ApoA-1. The nurse understands that ApoA-1 is the major component of which lipoprotein?",
        "options": {
            "A": "LDL.",
            "B": "VLDL.",
            "C": "HDL.",
            "D": "Chylomicrons."
        },
        "correctAnswer": "C",
        "rationale": "C. The major component of apoA-1 is HDL. A, B, D. ApoB is the major component of LDL and VLDL; chylomicrons are mostly triglycerides.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse advises the client that complementary therapies such as Ginkgo biloba may have which interaction?",
        "options": {
            "A": "Decrease drug levels of statins.",
            "B": "Potentiate an increase in liver enzymes.",
            "C": "Increase drug levels of statins.",
            "D": "Increase side effects of statins."
        },
        "correctAnswer": "C",
        "rationale": "C. Ginkgo biloba may increase drug levels of statins. A. St. John's wort decreases drug levels. B. Black cohosh may potentiate an increase in liver enzymes. D. Cranberry and green tea may increase side effects.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. A total cholesterol level of 220 mg/dL is considered:",
        "options": {
            "A": "Desirable.",
            "B": "Low risk.",
            "C": "Moderate risk.",
            "D": "High risk."
        },
        "correctAnswer": "C",
        "rationale": "C. According to Table 44.1, a total cholesterol level of 200-240 mg/dL is considered moderate risk. A. Desirable is 150-200 mg/dL. B. Low risk is <200 mg/dL. D. High risk is >240 mg/dL.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed pentoxifylline. The nurse should advise the client that this medication is typically taken:",
        "options": {
            "A": "On an empty stomach.",
            "B": "With meals.",
            "C": "At bedtime.",
            "D": "Once daily."
        },
        "correctAnswer": "B",
        "rationale": "B. Pentoxifylline should be taken with food (400 mg tid with meals) to minimize gastrointestinal side effects like nausea and vomiting. A, C, D. These instructions are incorrect for pentoxifylline administration.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is explaining the difference between lipids and lipoproteins. The nurse correctly states that lipids are transported in the bloodstream bound to:",
        "options": {
            "A": "Water molecules.",
            "B": "Glucose.",
            "C": "Protein carriers.",
            "D": "Red blood cells."
        },
        "correctAnswer": "C",
        "rationale": "C. Lipidscholesterol, triglycerides, and phospholipidsare bound in the inner shell of protein, a carrier that transports lipids in the bloodstream. A, B, D. These are incorrect carriers.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse understands that this medication is effective for lowering which lipid levels? (Select all that apply.)",
        "options": {
            "A": "LDL.",
            "B": "Total cholesterol.",
            "C": "VLDL.",
            "D": "Triglycerides.",
            "E": "Slightly increasing HDL."
        },
        "correctAnswer": ["A", "B", "C", "D", "E"],
        "rationale": "A, B, C, D, E. Atorvastatin decreases LDL, total cholesterol, VLDL, and triglycerides, and slightly increases HDL cholesterol. All options are correct effects of atorvastatin.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. An HDL level of 40 mg/dL is considered:",
        "options": {
            "A": "Desirable.",
            "B": "Low risk.",
            "C": "Moderate risk.",
            "D": "High risk."
        },
        "correctAnswer": "C",
        "rationale": "C. According to Table 44.1, an HDL level of 35-50 mg/dL is considered moderate risk. A. Desirable is >60 mg/dL. B. Low risk is 50-60 mg/dL. D. High risk is <35 mg/dL.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is prescribed cilostazol. The nurse should advise the client that a desired therapeutic response may take how long?",
        "options": {
            "A": "A few days.",
            "B": "1 to 2 weeks.",
            "C": "1.5 to 3 months.",
            "D": "6 months to a year."
        },
        "correctAnswer": "C",
        "rationale": "C. Inform patients that a desired therapeutic response to cilostazol may take 1.5 to 3 months. A, B, D. These timeframes are incorrect for the desired therapeutic response.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing education about nonpharmacologic methods of cholesterol reduction. The nurse emphasizes that dietary modification alone typically lowers total cholesterol levels by only:",
        "options": {
            "A": "Less than 10%.",
            "B": "10% to 30%.",
            "C": "30% to 50%.",
            "D": "More than 50%."
        },
        "correctAnswer": "B",
        "rationale": "B. Dietary modification alone will typically lower total cholesterol levels by only 10% to 30% because 75% to 85% of serum cholesterol is endogenously derived. A, C, D. These percentages are incorrect.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed cholestyramine. The nurse should advise the client that early signs of peptic ulcer include nausea and abdominal discomfort, followed later by:",
        "options": {
            "A": "Increased appetite and weight gain.",
            "B": "Abdominal pain and distension.",
            "C": "Diarrhea and dehydration.",
            "D": "Headache and dizziness."
        },
        "correctAnswer": "B",
        "rationale": "B. Early signs of peptic ulcer with cholestyramine are nausea and abdominal discomfort, followed later by abdominal pain and distension. A, C, D. These are not specific later signs of peptic ulcer related to cholestyramine.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the different types of hyperlipidemia. Which type is described as being very common and characterized by increased VLDL, increased LDL, increased cholesterol, and triglycerides?",
        "options": {
            "A": "Type I.",
            "B": "Type IIA.",
            "C": "Type IIB.",
            "D": "Type IV."
        },
        "correctAnswer": "C",
        "rationale": "C. Hyperlipidemia Type IIB is described as very common and characterized by increased VLDL, increased LDL, increased cholesterol, and triglycerides. A. Type I is uncommon with increased chylomicrons and triglycerides. B. Type IIA is common with increased LDL and cholesterol. D. Type IV is very common with increased VLDL and markedly increased triglycerides.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse understands that this medication has a peak time after a dose of approximately:",
        "options": {
            "A": "Less than 1 hour.",
            "B": "1 to 2 hours.",
            "C": "3 to 5 days.",
            "D": "14 hours."
        },
        "correctAnswer": "B",
        "rationale": "B. The peak time after a dose of atorvastatin is 1 to 2 hours. A, C, D. These timeframes are incorrect for the peak time.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the reference values for high-sensitivity C-reactive protein (hsCRP). A low risk level is considered:",
        "options": {
            "A": "Less than 1 mg/L.",
            "B": "1 to 3 mg/L.",
            "C": "Greater than 3 mg/L.",
            "D": "Any level below 5 mg/L."
        },
        "correctAnswer": "A",
        "rationale": "A. High-sensitivity C-reactive protein (hsCRP) low risk is less than 1 mg/L. B. 1 to 3 mg/L is moderate risk. C. Greater than 3 mg/L is high risk.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed pentoxifylline. The nurse should advise the client that the most common side effects of this medication are:",
        "options": {
            "A": "Headache and dizziness.",
            "B": "Nausea and vomiting.",
            "C": "Muscle pain and weakness.",
            "D": "Flushing and itching."
        },
        "correctAnswer": "B",
        "rationale": "B. The most common side effects of pentoxifylline are nausea and vomiting. A. Headache and dizziness are common with cilostazol. C. Muscle pain and weakness are associated with statins. D. Flushing and itching are associated with niacin.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing patient teaching for a client taking cilostazol. The nurse advises the client to change position slowly but frequently to avoid which side effect?",
        "options": {
            "A": "Tachycardia.",
            "B": "Orthostatic hypotension.",
            "C": "Angina.",
            "D": "Peripheral edema."
        },
        "correctAnswer": "B",
        "rationale": "B. Encourage patients to change position slowly but frequently to avoid orthostatic hypotension, which is common when taking high doses of a vasodilator like cilostazol. A. Tachycardia is a side effect but not directly managed by slow position changes. C, D. Angina and peripheral edema are adverse effects but not directly related to orthostatic changes.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that statins are also known as:",
        "options": {
            "A": "Bile-acid sequestrants.",
            "B": "Fibrates.",
            "C": "HMG-CoA reductase inhibitors.",
            "D": "Cholesterol absorption inhibitors."
        },
        "correctAnswer": "C",
        "rationale": "C. Statins inhibit the enzyme HMG-CoA reductase in cholesterol biosynthesis; thus statins are called HMG-CoA reductase inhibitors. A. Cholestyramine is a bile-acid sequestrant. B. Gemfibrozil is a fibrate. D. Ezetimibe is a cholesterol absorption inhibitor.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the major component of ApoB. The nurse understands that ApoB is the major component of which lipoproteins? (Select all that apply.)",
        "options": {
            "A": "HDL.",
            "B": "LDL.",
            "C": "VLDL.",
            "D": "Chylomicrons.",
            "E": "Exists in two forms, apoB-100 and apoB-48."
        },
        "correctAnswer": ["B", "C", "E"],
        "rationale": "B, C, E. The major component of apoB is LDL, which exists in two forms, apoB-100 and apoB-48. ApoB-100 also has VLDL as well as LDL. A. ApoA-1 is the major component of HDL. D. Chylomicrons are mostly triglycerides.",
        "type": "sata"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that this medication primarily works by inhibiting cholesterol synthesis in which organ?",
        "options": {
            "A": "Small intestine.",
            "B": "Kidneys.",
            "C": "Liver.",
            "D": "Pancreas."
        },
        "correctAnswer": "C",
        "rationale": "C. Statins inhibit cholesterol synthesis in the liver by inhibiting the enzyme HMG-CoA reductase. A. Cholesterol absorption occurs in the small intestine. B, D. Kidneys and pancreas are not primary sites of cholesterol synthesis inhibition by statins.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is advised not to smoke. The nurse explains that smoking worsens PAD by:",
        "options": {
            "A": "Increasing HDL cholesterol.",
            "B": "Decreasing LDL cholesterol.",
            "C": "Increasing vasospasm.",
            "D": "Improving blood viscosity."
        },
        "correctAnswer": "C",
        "rationale": "C. Advise patients not to smoke because smoking increases vasospasm, which would worsen PAD symptoms. A, B. Smoking increases LDL and decreases HDL. D. Smoking does not improve blood viscosity; it generally has negative effects on blood flow.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's medication list. Which medication is a fibric acid derivative that is more effective for reducing triglyceride and VLDL levels?",
        "options": {
            "A": "Atorvastatin.",
            "B": "Cholestyramine.",
            "C": "Gemfibrozil.",
            "D": "Ezetimibe."
        },
        "correctAnswer": "C",
        "rationale": "C. Gemfibrozil is a fibric acid derivative that is more effective for reducing triglyceride and VLDL levels than for reducing LDL. A. Atorvastatin is a statin. B. Cholestyramine is a bile-acid sequestrant. D. Ezetimibe is a cholesterol absorption inhibitor.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin. The nurse understands that to increase patient tolerance and reduce side effects, which interventions can be implemented? (Select all that apply.)",
        "options": {
            "A": "Careful drug titration.",
            "B": "Concomitant use of aspirin.",
            "C": "Administering very high initial doses.",
            "D": "Taking the medication on an empty stomach.",
            "E": "Providing proper counseling."
        },
        "correctAnswer": ["A", "B", "E"],
        "rationale": "A, B, E. With proper counseling, careful drug titration, and concomitant use of aspirin, the number of patients who can tolerate niacin can be increased. C. Administering large doses initially contributes to poor tolerance. D. Niacin should be taken with meals to decrease GI discomfort.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is reviewing the different types of hyperlipidemia. Which type is described as being very common and characterized by increased VLDL and markedly increased triglycerides?",
        "options": {
            "A": "Type I.",
            "B": "Type IIA.",
            "C": "Type IIB.",
            "D": "Type IV."
        },
        "correctAnswer": "D",
        "rationale": "D. Hyperlipidemia Type IV is described as very common and characterized by increased VLDL and markedly increased triglycerides. A. Type I is uncommon with increased chylomicrons and triglycerides. B. Type IIA is common with increased LDL and cholesterol. C. Type IIB is very common with increased VLDL, LDL, cholesterol, and triglycerides.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that this medication decreases the concentration of cholesterol, decreases LDL, and slightly increases:",
        "options": {
            "A": "VLDL.",
            "B": "Triglycerides.",
            "C": "HDL.",
            "D": "Chylomicrons."
        },
        "correctAnswer": "C",
        "rationale": "C. By inhibiting cholesterol synthesis in the liver, statins decrease the concentration of cholesterol, decrease LDL, and slightly increase HDL cholesterol. A, B, D. Statins typically decrease VLDL and triglycerides, and do not directly increase chylomicrons.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's medication list. Which medication is a cholesterol absorption inhibitor that acts on cells in the small intestine?",
        "options": {
            "A": "Atorvastatin.",
            "B": "Cholestyramine.",
            "C": "Gemfibrozil.",
            "D": "Ezetimibe."
        },
        "correctAnswer": "D",
        "rationale": "D. Ezetimibe is a cholesterol absorption inhibitor that acts on the cells in the small intestine to inhibit cholesterol absorption. A. Atorvastatin is a statin. B. Cholestyramine is a bile-acid sequestrant. C. Gemfibrozil is a fibrate.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed cilostazol for intermittent claudication. The nurse advises the client that the medication should not be administered with which food or beverage?",
        "options": {
            "A": "Orange juice.",
            "B": "Milk.",
            "C": "Grapefruit juice.",
            "D": "Water."
        },
        "correctAnswer": "C",
        "rationale": "C. Cilostazol should not be administered with grapefruit juice, as it will increase drug levels. A, B, D. These are generally acceptable for administration.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. A triglyceride level of 160 mg/dL is considered:",
        "options": {
            "A": "Desirable.",
            "B": "Low risk.",
            "C": "Moderate risk.",
            "D": "High risk."
        },
        "correctAnswer": "C",
        "rationale": "C. According to Table 44.1, a triglyceride level >150 mg/dL (but not >190 mg/dL) would fall into the moderate risk category, as 'values vary with age' for moderate risk, but 160 mg/dL is above desirable and below high risk. A. Desirable is 40-150 mg/dL. D. High risk is >190 mg/dL.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that the beneficial effects of statins include decreasing CAD and reducing:",
        "options": {
            "A": "Blood pressure.",
            "B": "Mortality rates.",
            "C": "The need for exercise.",
            "D": "Dietary fat intake."
        },
        "correctAnswer": "B",
        "rationale": "B. The statin group has been useful in decreasing CAD and reducing mortality rates. A. While statins can be combined with antihypertensives, they don't directly reduce blood pressure as a primary action. C, D. Exercise and dietary fat intake remain crucial even with statin therapy.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the reference values for high-sensitivity C-reactive protein (hsCRP). A high risk level is considered:",
        "options": {
            "A": "Less than 1 mg/L.",
            "B": "1 to 3 mg/L.",
            "C": "Greater than 3 mg/L.",
            "D": "Any level above 1 mg/L."
        },
        "correctAnswer": "C",
        "rationale": "C. High-sensitivity C-reactive protein (hsCRP) high risk is greater than 3 mg/L. A. Less than 1 mg/L is low risk. B. 1 to 3 mg/L is moderate risk.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is prescribed pentoxifylline. The nurse explains that this medication is classified as a:",
        "options": {
            "A": "Direct-acting vasodilator.",
            "B": "Antiplatelet drug.",
            "C": "Hemorrheologic agent.",
            "D": "HMG-CoA reductase inhibitor."
        },
        "correctAnswer": "C",
        "rationale": "C. Pentoxifylline is classified as a hemorrheologic agent or blood viscosity reducer agent. A. Cilostazol is a direct-acting vasodilator. B. Cilostazol, aspirin, and clopidogrel are antiplatelet drugs. D. Statins are HMG-CoA reductase inhibitors.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing education about nonpharmacologic methods of cholesterol reduction. The nurse emphasizes that adherence to dietary restrictions is often short-lived, which explains why:",
        "options": {
            "A": "Dietary modification is not recommended.",
            "B": "Many patients do not respond to diet modification alone.",
            "C": "Pharmacologic therapy is always the first-line treatment.",
            "D": "Exercise is not an important aspect."
        },
        "correctAnswer": "B",
        "rationale": "B. Adherence to dietary restrictions is often short-lived, which explains why many patients do not respond to diet modification alone. A. Dietary modification is recommended as a first step. C. Nondrug therapy should be initiated before drugs are prescribed. D. Exercise is an important aspect of nonpharmacologic methods.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse understands that this medication is primarily excreted through which route?",
        "options": {
            "A": "Kidneys.",
            "B": "Lungs.",
            "C": "Primarily in feces.",
            "D": "Skin."
        },
        "correctAnswer": "C",
        "rationale": "C. Atorvastatin is primarily excreted in feces. A, B, D. These are incorrect excretion routes for atorvastatin.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. An LDL level of 145 mg/dL is considered:",
        "options": {
            "A": "Desirable.",
            "B": "Low risk.",
            "C": "Moderate risk.",
            "D": "High risk."
        },
        "correctAnswer": "C",
        "rationale": "C. According to Table 44.1, an LDL level of 130-159 mg/dL is considered moderate risk. A. Desirable is <100 mg/dL. B. Low risk is 100-130 mg/dL. D. High risk is >160 mg/dL.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed cilostazol. The nurse should advise the client to report which side effects? (Select all that apply.)",
        "options": {
            "A": "Flushing.",
            "B": "Headaches.",
            "C": "Dizziness.",
            "D": "Weight gain.",
            "E": "Increased appetite."
        },
        "correctAnswer": ["A", "B", "C"],
        "rationale": "A, B, C. Instruct patients to report side effects of cilostazol, such as flushing, headaches, and dizziness. D, E. Weight gain and increased appetite are not listed as common side effects of cilostazol.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is reviewing a client's medication list. Which medication is a direct-acting vasodilator that inhibits platelet aggregation?",
        "options": {
            "A": "Pentoxifylline.",
            "B": "Atorvastatin.",
            "C": "Cilostazol.",
            "D": "Gemfibrozil."
        },
        "correctAnswer": "C",
        "rationale": "C. Cilostazol is a direct-acting vasodilator that inhibits platelet aggregation. A. Pentoxifylline is a hemorrheologic agent. B. Atorvastatin is a statin. D. Gemfibrozil is a fibrate.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that this medication is effective for lowering LDL (hyperlipidemia type II) within several weeks. Which statin was the first one used for this purpose?",
        "options": {
            "A": "Atorvastatin.",
            "B": "Rosuvastatin.",
            "C": "Simvastatin.",
            "D": "Lovastatin."
        },
        "correctAnswer": "D",
        "rationale": "D. Lovastatin was the first statin used to decrease cholesterol and is effective for lowering LDL (hyperlipidemia type II) within several weeks. A, B, C. These are other statins, but not the first one introduced.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the different types of hyperlipidemia. Which type is described as being uncommon and characterized by increased chylomicrons and increased triglycerides?",
        "options": {
            "A": "Type I.",
            "B": "Type IIA.",
            "C": "Type IIB.",
            "D": "Type IV."
        },
        "correctAnswer": "A",
        "rationale": "A. Hyperlipidemia Type I is described as uncommon and characterized by increased chylomicrons and increased triglycerides. B. Type IIA is common. C. Type IIB is very common. D. Type IV is very common.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed ezetimibe. The nurse explains that this medication causes only a small increase in which lipoprotein?",
        "options": {
            "A": "LDL.",
            "B": "VLDL.",
            "C": "HDL.",
            "D": "Chylomicrons."
        },
        "correctAnswer": "C",
        "rationale": "C. Ezetimibe causes only a small increase in HDL. A, B, D. Ezetimibe decreases LDL, triglycerides, and apoB levels, but does not increase VLDL or chylomicrons.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is providing education to a client about peripheral arterial disease (PAD). The nurse explains that PAD is also called:",
        "options": {
            "A": "Coronary artery disease (CAD).",
            "B": "Peripheral vascular disease (PVD).",
            "C": "Deep vein thrombosis (DVT).",
            "D": "Raynaud disease."
        },
        "correctAnswer": "B",
        "rationale": "B. Peripheral arterial disease (PAD) is also called peripheral vascular disease (PVD). A. CAD affects coronary arteries. C. DVT affects veins. D. Raynaud disease is a specific vasospastic disorder.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that a serious skeletal muscle adverse effect, although rare, is:",
        "options": {
            "A": "Myasthenia gravis.",
            "B": "Muscular dystrophy.",
            "C": "Rhabdomyolysis.",
            "D": "Fibromyalgia."
        },
        "correctAnswer": "C",
        "rationale": "C. The serious skeletal muscle adverse effect, rhabdomyolysis, has been reported with use of the statin drug class, although it is rare. A, B, D. These are other muscle disorders not directly caused by statins.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the definition of hyperlipidemia. The nurse understands that this condition occurs when there is an excess of one or more of which substances in the blood? (Select all that apply.)",
        "options": {
            "A": "Cholesterol.",
            "B": "Triglycerides.",
            "C": "Phospholipids.",
            "D": "Glucose.",
            "E": "Proteins."
        },
        "correctAnswer": ["A", "B", "C"],
        "rationale": "A, B, C. Lipidscholesterol, triglycerides, and phospholipidsare bound in the inner shell of protein. When there is an excess of one or more lipids in the blood, the condition is known as hyperlipidemia or hyperlipoproteinemia. D, E. Glucose and proteins are not the lipids that, when in excess, define hyperlipidemia.",
        "type": "sata"
    },
    {
        "questionText": "A client is prescribed cilostazol. The nurse should instruct the client that this medication is highly protein bound at what percentage?",
        "options": {
            "A": "50%.",
            "B": "75%.",
            "C": "90%.",
            "D": "95% to 98%."
        },
        "correctAnswer": "D",
        "rationale": "D. Cilostazol is highly protein bound at 95% to 98%. A, B, C. These percentages are incorrect for cilostazol's protein binding.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the different types of hyperlipidemia. Which type is described as being common and characterized by increased low-density lipoprotein (LDL) and increased cholesterol?",
        "options": {
            "A": "Type I.",
            "B": "Type IIA.",
            "C": "Type IIB.",
            "D": "Type IV."
        },
        "correctAnswer": "B",
        "rationale": "B. Hyperlipidemia Type IIA is described as common and characterized by increased low-density lipoprotein (LDL) and increased cholesterol. A. Type I is uncommon. C. Type IIB is very common and includes VLDL. D. Type IV is very common and includes markedly increased triglycerides.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse explains that the full therapeutic effect of statins may take how long to achieve?",
        "options": {
            "A": "As early as 2 weeks.",
            "B": "2 to 4 weeks.",
            "C": "6 to 8 weeks.",
            "D": "Several months."
        },
        "correctAnswer": "B",
        "rationale": "B. It takes 2 to 4 weeks to achieve the full therapeutic effect of statins, although reduction of LDL cholesterol may be seen as early as 2 weeks. A. This is when reduction may be seen, not full therapeutic effect. C, D. These timeframes are generally longer than the typical full therapeutic effect onset.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is explaining the difference between peripheral vasodilators and blood viscosity reducer agents. The nurse states that blood viscosity reducer agents primarily:",
        "options": {
            "A": "Dilate vessels that have been narrowed by vasospasm.",
            "B": "Decrease viscosity of blood and increase erythrocyte flexibility.",
            "C": "Inhibit platelet aggregation.",
            "D": "Lower blood lipid concentrations."
        },
        "correctAnswer": "B",
        "rationale": "B. Blood viscosity reducer agents, such as pentoxifylline, decrease viscosity of blood and increase erythrocyte flexibility. A. This describes peripheral vasodilators. C. This is an action of antiplatelet drugs like cilostazol. D. This describes antihyperlipidemics.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin. The nurse understands that this medication is actually very effective at lowering cholesterol levels, and its effect on the lipid profile is highly desirable, but its use is limited due to:",
        "options": {
            "A": "Its high cost.",
            "B": "Its short half-life requiring frequent dosing.",
            "C": "Numerous side effects and large doses required.",
            "D": "Its inability to affect LDL cholesterol."
        },
        "correctAnswer": "C",
        "rationale": "C. Niacin is very effective at lowering cholesterol, and its effect on the lipid profile is highly desirable. However, because it has numerous side effects and large doses are required, its usefulness is limited. A, B, D. These are not the primary reasons for its limited use as stated in the text.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. A desirable HDL level is:",
        "options": {
            "A": "Less than 35 mg/dL.",
            "B": "35-50 mg/dL.",
            "C": "50-60 mg/dL.",
            "D": "Greater than 60 mg/dL."
        },
        "correctAnswer": "D",
        "rationale": "D. According to Table 44.1, a desirable HDL level is >60 mg/dL. A. Less than 35 mg/dL is high risk. B. 35-50 mg/dL is moderate risk. C. 50-60 mg/dL is low risk.",
        "type": "mc"
    },
    {
        "questionText": "A client with hyperlipidemia is prescribed a statin. The nurse advises the client that complementary therapies such as green tea may have which interaction?",
        "options": {
            "A": "Decrease drug levels of statins.",
            "B": "Potentiate an increase in liver enzymes.",
            "C": "Increase drug levels of statins.",
            "D": "Increase side effects of statins."
        },
        "correctAnswer": "D",
        "rationale": "D. Green tea may increase side effects of statins. A. St. John's wort decreases drug levels. B. Black cohosh may potentiate an increase in liver enzymes. C. Chinese skullcap and Ginkgo biloba may increase drug levels.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. A total cholesterol level of 250 mg/dL is considered:",
        "options": {
            "A": "Desirable.",
            "B": "Low risk.",
            "C": "Moderate risk.",
            "D": "High risk."
        },
        "correctAnswer": "D",
        "rationale": "D. According to Table 44.1, a total cholesterol level >240 mg/dL is considered high risk. A. Desirable is 150-200 mg/dL. B. Low risk is <200 mg/dL. C. Moderate risk is 200-240 mg/dL.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is prescribed pentoxifylline. The nurse explains that this medication has been approved by the FDA for patients with:",
        "options": {
            "A": "Raynaud disease.",
            "B": "Buerger disease.",
            "C": "Intermittent claudication.",
            "D": "Arteriosclerosis obliterans."
        },
        "correctAnswer": "C",
        "rationale": "C. Pentoxifylline has been approved by the FDA for patients with intermittent claudication. B. It has also been prescribed for Buerger disease, but intermittent claudication is the primary FDA approval mentioned. A, D. While it affects peripheral circulation, these are not its specific FDA-approved indications mentioned.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is explaining the concept of apolipoproteins. The nurse states that apolipoproteins are found:",
        "options": {
            "A": "In the bloodstream as free proteins.",
            "B": "Within the lipoprotein shell.",
            "C": "Only in the liver.",
            "D": "Only in dietary fats."
        },
        "correctAnswer": "B",
        "rationale": "B. Apolipoproteins are within the lipoprotein shell and contain apolipoprotein (apo) A-1, B, and E. A, C, D. These are incorrect locations for apolipoproteins.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse understands that this medication is effective for lowering LDL (hyperlipidemia type II) within:",
        "options": {
            "A": "Several days.",
            "B": "Several weeks.",
            "C": "Several months.",
            "D": "A year."
        },
        "correctAnswer": "B",
        "rationale": "B. Lovastatin (a statin like atorvastatin) is effective for lowering LDL (hyperlipidemia type II) within several weeks. A, C, D. These timeframes are incorrect for the initial LDL lowering effect.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's lipid profile. An LDL level of 170 mg/dL is considered:",
        "options": {
            "A": "Desirable.",
            "B": "Low risk.",
            "C": "Moderate risk.",
            "D": "High risk."
        },
        "correctAnswer": "D",
        "rationale": "D. According to Table 44.1, an LDL level >160 mg/dL is considered high risk. A. Desirable is <100 mg/dL. B. Low risk is 100-130 mg/dL. C. Moderate risk is 130-159 mg/dL.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) is prescribed cilostazol. The nurse explains that this medication decreases:",
        "options": {
            "A": "Arterial thrombi.",
            "B": "Venous thrombi.",
            "C": "Blood viscosity.",
            "D": "Cholesterol absorption."
        },
        "correctAnswer": "A",
        "rationale": "A. Cilostazol is an antiplatelet drug that decreases arterial thrombi. B. It does not primarily affect venous thrombi. C. Pentoxifylline decreases blood viscosity. D. Ezetimibe decreases cholesterol absorption.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is explaining the importance of a 12- to 14-hour fasting lipid profile. The nurse states that this test is ordered when:",
        "options": {
            "A": "Only cholesterol levels are high.",
            "B": "Triglyceride levels are high.",
            "C": "Cholesterol, triglycerides, and LDL are elevated.",
            "D": "HDL levels are low."
        },
        "correctAnswer": "C",
        "rationale": "C. If the levels are high (referring to cholesterol and triglycerides), a 12- to 14-hour fasting lipid profile may be ordered. When cholesterol, triglycerides, and LDL are elevated, the patient is at increased risk for CAD. A, B, D. While these individual findings are important, the fasting lipid profile is typically ordered for a comprehensive assessment when multiple lipid components are elevated or to confirm initial high readings.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed niacin. The nurse understands that niacin is a form of which vitamin?",
        "options": {
            "A": "Vitamin B1.",
            "B": "Vitamin B2.",
            "C": "Vitamin B3.",
            "D": "Vitamin B6."
        },
        "correctAnswer": "C",
        "rationale": "C. Niacin is also known as vitamin B3. A, B, D. These are other B vitamins.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing the different types of hyperlipidemia. Which two types are commonly associated with coronary artery disease (CAD)? (Select all that apply.)",
        "options": {
            "A": "Type I.",
            "B": "Type II.",
            "C": "Type III.",
            "D": "Type IV.",
            "E": "Type V."
        },
        "correctAnswer": ["B", "D"],
        "rationale": "B, D. Types II and IV hyperlipidemia are commonly associated with coronary artery disease. A, C, E. These types are less commonly associated with CAD according to the text.",
        "type": "sata"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse understands that this medication is contraindicated in which conditions? (Select all that apply.)",
        "options": {
            "A": "Hepatic disease.",
            "B": "Cholestasis.",
            "C": "Pregnancy.",
            "D": "Breastfeeding.",
            "E": "Alcohol use disorder."
        },
        "correctAnswer": ["A", "B", "C", "D"],
        "rationale": "A, B, C, D. Atorvastatin is contraindicated in hepatic disease/encephalopathy, cholestasis, pregnancy, and breastfeeding. E. Alcohol use disorder is a caution, not a contraindication.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is providing patient teaching for a client with hyperlipidemia. The nurse states that before drugs are prescribed, which type of therapy should be initiated?",
        "options": {
            "A": "Combination drug therapy.",
            "B": "High-dose statin therapy.",
            "C": "Nondrug therapy.",
            "D": "Surgical intervention."
        },
        "correctAnswer": "C",
        "rationale": "C. Before drugs to lower LDL and raise HDL are prescribed, nondrug therapy should be initiated to decrease cholesterol. A, B, D. These are not initial interventions.",
        "type": "mc"
    },
    {
        "questionText": "A client with peripheral arterial disease (PAD) reports numbness and coolness of the extremities. The nurse understands that these symptoms are characteristic of:",
        "options": {
            "A": "Venous insufficiency.",
            "B": "Adequate blood flow.",
            "C": "Inadequate blood flow.",
            "D": "Neuropathic pain."
        },
        "correctAnswer": "C",
        "rationale": "C. Numbness and coolness of the extremities are characteristic of peripheral arterial disease (PAD), indicating inadequate blood flow. A. Venous insufficiency typically presents with warmth, edema, and hyperpigmentation. B. Adequate blood flow would result in warm, pink extremities. D. Neuropathic pain is a type of pain, not a direct indicator of blood flow.",
        "type": "mc"
    },
    {
        "questionText": "The nurse is reviewing a client's medication list. Which medication is a bile-acid sequestrant that comes in a gritty powder?",
        "options": {
            "A": "Colesevelam.",
            "B": "Colestipol.",
            "C": "Cholestyramine.",
            "D": "Ezetimibe."
        },
        "correctAnswer": "C",
        "rationale": "C. Cholestyramine is a bile-acid sequestrant that comes in a gritty powder that is mixed thoroughly in water or juice. A, B. Colesevelam and colestipol are also bile-acid sequestrants, but cholestyramine is specifically mentioned as a gritty powder. D. Ezetimibe is a tablet.",
        "type": "mc"
    },
    {
        "questionText": "A client is prescribed atorvastatin. The nurse understands that this medication can cause which early complaints? (Select all that apply.)",
        "options": {
            "A": "Gastrointestinal disturbances.",
            "B": "Headaches.",
            "C": "Muscle cramps.",
            "D": "Fatigue.",
            "E": "Rhabdomyolysis."
        },
        "correctAnswer": ["A", "B", "C", "D"],
        "rationale": "A, B, C, D. Gastrointestinal (GI) disturbances, headaches, muscle cramps, and fatigue are early complaints with statins. E. Rhabdomyolysis is a serious adverse reaction, not typically an 'early complaint' in the same category as the others, but a severe progression of muscle symptoms.",
        "type": "sata"
    },
    {
        "questionText": "The nurse is explaining the purpose of a 12- to 14-hour fasting lipid profile. The nurse states that this test measures:",
        "options": {
            "A": "Blood glucose and hemoglobin A1C.",
            "B": "Serum cholesterol and triglyceride levels.",
            "C": "Blood pressure and heart rate.",
            "D": "Complete blood count and electrolytes."
        },
        "correctAnswer": "B",
        "rationale": "B. A 12- to 14-hour fasting lipid profile measures serum cholesterol and triglyceride levels, along with LDL and HDL. A, C, D. These are other diagnostic tests, not components of a fasting lipid profile.",
        "type": "mc"
    }
    ];

    let finalQuizData = [];
    let currentQuestionIndex = 0;
    let userAnswers = {};
    let confidenceRatings = {};
    let flaggedForReview = new Set();
    const NUM_QUESTIONS_TO_SELECT = 30;

    const initialScreen = document.getElementById('initial-screen');
    const startBtn = document.getElementById('start-btn');
    const quizForm = document.getElementById('quiz-form');
    const resultsArea = document.getElementById('results-area');

    function prepareQuizData() {
        const shuffledPool = [...fullQuizData].sort(() => 0.5 - Math.random());
        const questionsNeeded = Math.min(NUM_QUESTIONS_TO_SELECT, shuffledPool.length);
        finalQuizData = shuffledPool.slice(0, questionsNeeded);
    }

    function prepareAndStartQuiz() {
        prepareQuizData();
        if (finalQuizData.length === 0) {
            alert("No questions loaded.");
            return;
        }
        initialScreen.classList.add('hidden');
        quizForm.classList.remove('hidden');
        displayCurrentQuestion();
    }

    function displayCurrentQuestion() {
        if (currentQuestionIndex >= finalQuizData.length) return;
        const qData = finalQuizData[currentQuestionIndex];
        
        let optionsHTML = '<div class="options-container">';
        const inputType = qData.type === 'sata' ? 'checkbox' : 'radio';
        
        for (const [key, text] of Object.entries(qData.options)) {
            optionsHTML += `<label><input type="${inputType}" name="answer" value="${key}"> ${text}</label>`;
        }
        optionsHTML += '</div>';

        quizForm.innerHTML = `
            <div class="question-header">
                Question <strong>${currentQuestionIndex + 1}</strong> of ${finalQuizData.length}
            </div>
            <p class="question-text">${qData.questionText}</p>
            ${optionsHTML}
            <div class="question-footer">
                <div class="flag-container">
                    <label><input type="checkbox" class="flag-for-review"> Flag for Review</label>
                </div>
                <div class="confidence-slider-container">
                    <label>Confidence:</label>
                    <input type="range" min="1" max="5" value="3" class="confidence-slider">
                </div>
                 <button type="submit" id="navigation-btn">${(currentQuestionIndex === finalQuizData.length - 1) ? "Submit Exam" : "Next Question"}</button>
            </div>
        `;
    }
    
    function saveAnswer() {
        const qData = finalQuizData[currentQuestionIndex];
        if (!qData) return;

        const selectedOptions = quizForm.querySelectorAll('input[name="answer"]:checked');
        if (qData.type === 'sata') {
            userAnswers[currentQuestionIndex] = Array.from(selectedOptions).map(cb => cb.value);
        } else {
            userAnswers[currentQuestionIndex] = selectedOptions.length ? selectedOptions[0].value : null;
        }

        const flagInput = quizForm.querySelector('.flag-for-review');
        if(flagInput && flagInput.checked) {
            flaggedForReview.add(currentQuestionIndex);
        }

        const confidenceInput = quizForm.querySelector('.confidence-slider');
        if(confidenceInput) {
            confidenceRatings[currentQuestionIndex] = parseInt(confidenceInput.value, 10);
        }
    }
    
    // --- FUNCTION RESTORED ---
    function handleNavigation() {
        saveAnswer();
        quizForm.classList.add('is-transitioning');
        
        setTimeout(() => {
            if (currentQuestionIndex < finalQuizData.length - 1) {
                currentQuestionIndex++;
                displayCurrentQuestion();
                quizForm.classList.remove('is-transitioning');
            } else {
                submitQuiz();
            }
        }, 300);
    }

    function submitQuiz() {
        quizForm.classList.add('hidden');
        resultsArea.classList.remove('hidden');
        displayResults();
    }
    
    function checkAnswerCorrectness(qData, userAnswer) {
        if (userAnswer === null || userAnswer === undefined) return false;
        if (qData.type === 'sata') {
            if (!Array.isArray(userAnswer) || typeof qData.correctAnswer !== 'string') return false;
            const sortedUser = [...userAnswer].sort();
            const sortedCorrect = [...(qData.correctAnswer.split(','))].sort();
            return JSON.stringify(sortedUser) === JSON.stringify(sortedCorrect);
        }
        return userAnswer === qData.correctAnswer;
    }

    function displayResults() {
        let correctCount = 0;
        finalQuizData.forEach((q, i) => { if (checkAnswerCorrectness(q, userAnswers[i])) correctCount++; });
        const score = finalQuizData.length > 0 ? (correctCount / finalQuizData.length) * 100 : 0;

        let resultsHTML = `
            <div class="results-summary">
                 <h2>Exam Complete!</h2>
                 <div class="score-animation-container">
                    <div class="score-animation-circle"></div>
                    <div class="score-animation-inner">
                        <span class="score-animation-text">${score.toFixed(0)}%</span>
                    </div>
                 </div>
                 <p>You answered <strong>${correctCount}</strong> out of <strong>${finalQuizData.length}</strong> questions correctly.</p>
            </div>
        `;
        
        resultsArea.innerHTML = resultsHTML;
        resultsArea.innerHTML += generateConfidenceAnalysis();
        resultsArea.innerHTML += generateStudyFocus();
        resultsArea.innerHTML += generateDetailedReview();

        setTimeout(() => {
            const scoreCircle = document.querySelector('.score-animation-circle');
            if (scoreCircle) {
                scoreCircle.style.background = `conic-gradient(var(--success-green) ${score}%, var(--border-light) ${score}% 100%)`;
            }
        }, 100);

        if (score >= 80) {
            triggerConfetti();
        }
    }

    function generateDetailedReview() {
        let detailsHTML = '<div id="results-details"><h2>Question Review</h2>';
        finalQuizData.forEach((qData, index) => {
            const userAnswer = userAnswers[index];
            const isCorrect = checkAnswerCorrectness(qData, userAnswer);
            
            let resultBodyHTML = '<ul>';
            for (const [key, text] of Object.entries(qData.options)) {
                let li_class = '';
                const isCorrectOpt = qData.type === 'sata' ? qData.correctAnswer.includes(key) : key === qData.correctAnswer;
                const isUserSelect = Array.isArray(userAnswer) ? userAnswer.includes(key) : key === userAnswer;
                if (isCorrectOpt) li_class = 'correct-answer-label';
                if (isUserSelect && !isCorrectOpt) li_class = 'incorrect-answer-label';
                if (!isUserSelect && isCorrectOpt && !isCorrect) li_class = 'missed-correct-answer-label';
                resultBodyHTML += `<li class="${li_class}">${text}</li>`;
            }
            resultBodyHTML += '</ul>';

            detailsHTML += `
                <div class="result-question">
                    <p><strong>Question ${index + 1}: ${qData.questionText}</strong></p>
                    ${resultBodyHTML}
                    <div class="rationale"><strong>Rationale:</strong> ${qData.rationale || 'N/A'}</div>
                </div>`;
        });
        detailsHTML += '</div>';
        return detailsHTML;
    }
    
    function generateConfidenceAnalysis() {
        let correctAndConfident = 0, correctButUnsure = 0, incorrectAndConfident = 0, incorrectButUnsure = 0;
        finalQuizData.forEach((qData, index) => {
            const isCorrect = checkAnswerCorrectness(qData, userAnswers[index]);
            const confidence = confidenceRatings[index] || 3;
            if (confidence >= 4) { if (isCorrect) correctAndConfident++; else incorrectAndConfident++; } 
            else { if (isCorrect) correctButUnsure++; else incorrectButUnsure++; }
        });
        return `
            <div id="confidence-analysis">
                <h3>Confidence Analysis</h3>
                <ul>
                    <li>Correct & Confident: <strong>${correctAndConfident}</strong></li>
                    <li>Correct but Unsure: <strong>${correctButUnsure}</strong></li>
                    <li>Incorrect & Confident: <strong>${incorrectAndConfident}</strong></li>
                    <li>Incorrect but Unsure: <strong>${incorrectButUnsure}</strong></li>
                </ul>
            </div>`;
    }

    function generateStudyFocus() {
        const topicCounts = {};
        finalQuizData.forEach((qData, index) => {
            if (!checkAnswerCorrectness(qData, userAnswers[index])) {
                const topic = qData.section || "General";
                topicCounts[topic] = (topicCounts[topic] || 0) + 1;
            }
        });
        const sortedTopics = Object.entries(topicCounts).sort((a, b) => b[1] - a[1]);
        let focusHTML = '<div id="study-focus"><h3>Personalized Study Focus</h3>';
        if (sortedTopics.length > 0) {
            focusHTML += '<p>Based on your performance, focus your review on these topics:</p><ul>';
            sortedTopics.forEach(topic => { focusHTML += `<li><strong>${topic[0]}</strong> (${topic[1]} item${topic[1] > 1 ? 's' : ''} missed)</li>`; });
            focusHTML += '</ul>';
        } else {
            focusHTML += '<p>Excellent work! No specific weak areas were identified.</p>';
        }
        focusHTML += '</div>';
        return focusHTML;
    }

    function triggerConfetti() {
        const numConfetti = 150;
        for (let i = 0; i < numConfetti; i++) {
            const confetti = document.createElement('div');
            confetti.classList.add('confetti');
            confetti.style.left = Math.random() * 100 + 'vw';
            confetti.style.animationDelay = Math.random() * 3 + 's';
            confetti.style.backgroundColor = `hsl(${Math.random() * 360}, 90%, 60%)`;
            document.body.appendChild(confetti);
            setTimeout(() => confetti.remove(), 6000);
        }
    }

    startBtn.addEventListener('click', prepareAndStartQuiz);
    quizForm.addEventListener('submit', e => { 
        e.preventDefault(); 
        handleNavigation(); 
    });
</script>

</body>
</html>
